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3Abstract
Type I spiral ganglion neurons (SGNs) synapse onto cochlear inner hair cells and
constitute the majority of afferent fibres in the auditory nerve (AN). Better
characterisation of their biophysical properties may identify therapeutic targets for
optimising AN sensitivity. This study aimed to characterise the membrane physiology
underlying the firing properties of post-hearing onset SGNs and investigated whether
their properties could be modified by the presence of native and synthetic lipids.
In dissociated ganglionic cultures, SGNs displayed an intrinsic variation in their firing
properties; this could be correlated with the magnitudes of specific membrane currents.
SGNs were categorised by their response to depolarising current injection; SGNs either
adapted to the stimulus rapidly, slowly or not at all. Rapid adaptation, a mechanism that
preserves temporal precision throughout the auditory system, was found to be regulated
by a dendrotoxin-K (DTX-K) and tityustoxin-Kα (TsTx)-sensitive low-threshold 
voltage-activated (LVA) K+ current, suggesting contribution by Kv1.1 and Kv1.2
subunits. As Kv1.2 channels were known to be positively modulated by membrane
phosphoinositides, we investigated the influence of phosphatidylinositol-4,5-
bisphosphate (PIP2) availability on SGN K+ currents. Inhibiting PIP2 production using
wortmannin, or sequestration using a palmitoylated peptide (PIP2-PP), slowed or
abolished adaptation in SGNs. PIP2-PP specifically reduced SGN LVA currents in a
manner that was partly rescued by intracellular dialysis with diC8PIP2, a non-
hydrolysable analogue of PIP2. PIP2-PP application induced similar levels of current
inhibition in Kv1.1/Kv1.2 channels heterologously expressed in HEK293 cells.
Accordingly, the lipid sensitivity of the Kv1.2 channel was further explored with a
range of native and synthetic free fatty acids. Polyunsaturated fatty acids were found to
be strong inhibitors of Kv1.2 currents, offering further potential candidates for SGN
modulation.
Collectively, this data identifies Kv1.1 and Kv1.2 containing K+ channels as key
regulators of excitability in the AN, and potential targets for pharmacological
modulation.
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Chapter 1
Introduction
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1.1 The physiology of hearing
1.1.1 Transmission of sound to the inner ear
The mammalian ear can be broadly divided into three anatomical regions based on their
function in transmitting and processing sound: the outer, middle and inner ear (Figure
1.1). The outer ear provides two important functions in hearing. Firstly, it acts to collect
sound waves from a large area and concentrates them into the auditory canal. This
significantly increases the sound pressure level (SPL) at the tympanic membrane. This
can be as much as 20-30 decibels (dB) for some frequencies (Bergevin and Olson,
2014). Secondly, the outer ear helps to localise sound. The pinna offers complex ridges
and edges that reflect sound into the auditory canal. Waves reflected from these rims
will travel further than if they enter into the auditory canal directly, offering interference
patterns that can be used as spatial cues (Grothe and Pecka, 2014). These spatial cues
are only available when the wavelength of the sound is short compared to the
dimensions of the pinna; the ability of the outer ear to aid in sound localisation drops off
sharply below 2 kHz in humans (Pickles, 2008).
The middle ear couples the sound energy from the auditory canal to the cochlea. The
primary role of the middle ear is to act as a transformer to match the impedance of the
auditory canal to that of the cochlear fluids (without this, much of the sound would be
reflected). Sound energy is conveyed to the inner ear by the cone-shaped tympanic
membrane. The architecture of the tympanic membrane and ossicles ensure that sound
waves are transmitted solely to the oval window of the cochlea and not the round
window ensuring unidirectional entry of sound to the cochlea (Bergevin and Olson,
2014). Furthermore, the actions of the middle ear muscles can modulate the stiffness of
the middle ear bones. Many functions have been suggested for this modulation
including protecting the inner ear from acoustic overexposure, improving the frequency
response of the middle ear and reducing the masking effect of high intensity, low
frequency stimuli on higher frequencies. For a fuller discussion of the role of the outer
and middle ear in hearing see (Pickles, 2012).
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Figure 1.1 Anatomy of the peripheral auditory system. A schematic of the gross anatomical
features of the outer, middle and inner ear and the beginning of the central auditory system.
1.1.2 Anatomy of the cochlea
The cochlea is embedded deep in the mammalian temporal bone (Figure 1.1). It consists
of a spiral cavity divided longitudinally into three fluid filled compartments. The central
compartment, the scala media, is divided from the scala vestibuli above by a partition
known as the Reissner’s membrane and from the scala tympani below by the basilar
membrane. The two outer scalae are joined at the apex of the cochlea at a point termed
the helicotrema (Figure 1.2). These outer scalae are filled with an extracellular-like fluid
called perilymph. The scala media in contrast is filled with endolymph, a solution which
is more akin to intracellular solution as it has a high K+ and low Na+ concentration.
Consequently, endolymph has a highly positive potential (+80 mV) (Patuzzi, 2011).
The vibrations of the stapes are transferred onto a membrane covered opening in the
cochlea called the oval window, resulting in a displacement of the fluid in the scala
vestibuli and scala tympani. This, in turn, results in a wave-like displacement of the
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basilar membrane and organ of Corti (OC; Figure 1.2A, dotted line) (Sohmer, 2015).
The OC sits on the basilar membrane and contains the mechanosensory hair cells that
are central to the transduction of the physical sound wave into neuronal signals (Lim,
1986). The OC contains a single row of inner hair cells (IHCs) and between three and
five rows of outer hair cells (OHCs) and is covered by a gelatinous flap known as the
tectorial membrane. The hair cell stereociliary bundles contact this membrane so that
vibrations of the basilar membrane and OC result in the physical deflection of the hair
cells’ bundles.
Figure 1.2 Anatomy of the cochlea. A Diagram of the “unrolled” cochlea. The dotted lines
show the effects of fluid displacement as a result of vibrations of the middle ear bones on the
membrane of the oval window. This displacement takes the form of a travelling wave which
causes physical vibrations along the basilar membrane. B Transverse section of the cochlea
duct. The three scalae and associated structures are shown.
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The displacement of the basilar membrane follows a travelling wave which moves from
the base to the apex of the cochlea (Sohmer, 2015). This is important as the position and
pattern of the wave depends on the frequency of the sound. In the case of a single
frequency tone, the vibrations of the basilar membrane are confined to a narrow region
of the cochlea. A functional consequence of the travelling wave is that as the frequency
of the stimulus increases, the position of the vibration maximum moves nearer the base
of the cochlea (Bekesy, 1960, Olson et al., 2012). High frequency tones cause the most
vibration near the base of the cochlea whist low frequency tones cause the most
vibration near the apex. This is the basis for a frequency specific response in the
cochlea. This tuning of the wave is further sharpened by active cochlear mechanics
which feed in additional mechanical energy to the travelling wave producing additional
stimulation of the cochlear hair cells (Neely and Kim, 1986). The exact processes that
underlie this are still unclear. It is understood however that these mechanical processes
are mediated, either directly or indirectly, by OHCs (De Boer, 1996).
In vitro recordings from IHCs reveal that displacement of the stereocilia modulates
current flow through the cell (Russell and Sellick, 1978). Displacement of the hair cell
bundles in the excitatory direction (in the direction of the largest stereocilia) produces
large currents and depolarisation of the cell membrane. Deflections of the IHC
stereocilia open ion channels on the tips of individual stereocilia. Once open, ions
(mainly K+) are driven into the hair cell by a combination of the highly positive
endocochlear potential and the negative intracellular potential of the IHC. This results in
rapid depolarisation of the IHC and Ca2+ channel mediated release of neurotransmitter
onto the terminals of the auditory nerve fibres (ANFs) (Fettiplace and Kim, 2014).
1.1.3 Structure and organisation of the spiral ganglion
The cell bodies (somata) of the SGNs reside in a spiral cavity within the modiolus of the
cochlea. This cavity, called Rosenthal’s canal, runs parallel to the coiled labyrinths of
the cochlea. From here, SGNs project neurites peripherally to the OC as well as
centrally into the auditory nerve (AN) (Figure 1.2 & 1.3). Two distinct populations of
neurons have been described in the SG: type I and type II. These neurons differ in their
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peripheral and central targets, as well as in their size, abundance, protein expression and
electrophysiology (Bernard and Spoendlin, 1973, Jagger and Housley, 2003, Liberman
and Kiang, 1984, Nadol, 1988a) underscoring their divergent function in the auditory
system. Type I SGNs constitute 90-95% of SGN. They are characterised by their large
bipolar structure, prominent organelles and the presence of lipid bodies (Rosenbluth,
1962, Spoendlin, 1981). In contrast, type II SGNs are smaller, bipolar or pseudo-
monopolar structures, highly filamentous and absent the usual organelles (Bernard and
Spoendlin, 1973, Spoendlin, 1971). The central and peripheral processes of type I
neurons are highly myelinated (Thomsen, 1966). Myelination of SGN somata is
observed in some mammalian species but seems to be largely absent in human type I
SGN. Type II SGNs are mostly unmyelinated (Ota and Kimura, 1980) (Figure 1.3).
Figure 1.3 Organisation of SGNs in the inner ear. SGN somata occupy a spiral cavity within
the modiolus of the cochlea. Their processes extend peripherally to the organ of Corti and
centrally to the brainstem. The SG houses two major subpopulations of SGNs: type I and type
II. Type I SGNs are large and highly myelinated. They make up the majority of the total SGNs
and provide afferent innervation to IHCs. Type II SGNs are smaller and less prevalent than type
I neurons and synapse onto the OHCs.
The peripheral target for type I SGNs are the IHCs of the OC. The peripheral processes
of the SGN, called radial fibres, travel through the bony spiral lamina and extend out
through a hole known as the habenula perforate, into the OC. The fibres, now
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demyelinated, synapse onto the bottom of IHCs (Figure 1.3) (Kiang et al., 1982). Here
they form a specialised type of synapse known as a ribbon synapse, named after the
ribbon-like presynaptic projections originally observed at the presynaptic terminal in the
retina (De Robertis and Franchi, 1956). These synapses are equipped with a presynaptic
electron-dense structure known as a “ribbon” to which synaptic vesicles are tethered.
These specialised synapses allow high temporal precision and sustained
neurotransmitter release in response to IHC depolarisation, consistent with their
function in coding acoustic information (Safieddine et al., 2012).
Each type I SGN makes a lone synapse onto an IHC. However individual IHCs are
innervated by multiple type I SGNs. This manifold innervation is thought to enable the
auditory system to encode a wider degree of auditory information (see also Physiology
of the Auditory nerve). Type II peripheral neurites form similar radial projections into
the OC but unlike type I SGN that turn upwards toward the IHCs, type II fibres cross
the tunnel of Corti and then turn toward the basal end of the cochlea (Figure 1.4). These
fibres can travel hundreds of micrometres, and give rise to multiple large boutons under
OHCs (Brown et al., 1988, Kiang et al., 1982). Individual fibres vary in their process
length and number of OHCs innervated. Ultrastructural studies of afferent type II-OHC
interactions also reveal the presence of reciprocal synapses, where a classical “afferent”
synapse, is paired with an “efferent” synapse within the same terminal bouton
(Simmons et al., 1998). Type II SGN reciprocal synapses have been observed across
mammalian species where they mediate bidirectional signalling with OHCs and have
been proposed to constitute a local neural network within OHCs, enabling them to
communicate with each other (Thiers et al., 2008). This is supported by findings that
synaptic vesicle release from OHCs offers only small depolarisation at type II terminals
(Weisz et al., 2009). Given the considerable distance between a SGN’s peripheral and
central target and the fact that type II neurons are unmyelinated, it seems unlikely type
II SGNs would code auditory information directly. Interestingly, type II SGNs receive
both axosomatic and dentritic synapses (Nadol, 1988a, Thiers et al., 2000). This has
raised the possibility of efferent control of type II neurons. These efferent fibres
originate from neurons whose somata reside in the medial and superior olivary
complexes. The exact function of this efferent signalling is still under investigation.
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The exact numbers of IHCs, OHCs and SGNs is highly species dependent. The number
of SGN varies considerably from ~50,000 in cats (Chen et al., 2010) to ~15,000 in rats
(Keithley and Feldman, 1979). Humans and other primates have ~30,000 (Nadol,
1988b). IHC and OHC numbers vary similarly; humans typically have ~3,500 IHCs and
~11,000 OHCs per cochlea (Bredberg, 1968), whilst rats contain ~3,500 OHCs and
~1,000 IHCs respectively (Keithley and Feldman, 1982). Finally, the density of type I
SGN innervation shows a similar species dependence. Initial work on cats estimated
that a single IHC is innervated by ~20 SGNs (Liberman, 1980, Spoendlin, 1979). This
seems to be higher than what is found in humans (9-11) (Dunn and Morest, 1975).
Figure 1.4 Type I and type II SGNs have different peripheral targets and innervation
patterns. Each IHC is the target of multiple type I SGNs. In cats, each IHC is innervated by
between 20-30 type I SGNs (Spoendlin 1979). OHCs, in contrast, are targeted by type II SGNs.
Unlike type I SGNs, type II SGNs can innervate multiple hair cell targets making both en
passant and terminal synapses with their targets.
The central axons of the type I and type II SGNs bundle together to form the AN and
exit the cochlea via the modiolus (Figure 1.2). Both neuron types ascend towards the
brainstem, enter the cochlear nucleus and subsequently bifurcate. This creates two
branches which project to the anteroventral cochlear nucleus (AVCN) and the dorsal
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cochlear nucleus (DCN) respectively (Nayagam et al., 2011). These branches, in turn,
can project multiple smaller collateral projections, creating both en passant and terminal
synapses with the cochlear nucleus (CN). The locations of the SGNs’ central targets are
also related to their frequency organisation. In general, low frequency fibres innervate
the CN ventrally, with progressively higher frequency neurons innervating
progressively more dorsally located regions (Berglund and Brown, 1994). Three
dimensional reconstructions of SGN innervations show the presence of spatially
separate tonotopic or “isofrequency sheets” (Nayagam et al., 2011). SGN branching in
the AVCN terminates at a large, axosomatic terminal, known as the endbulb of Held
(Ryugo and Fekete, 1982). This enormous neuronal junction contains up to 2000
different synaptic release sites in cats (Ryugo et al., 1996). Such a structure suggests
that electrical signalling is carried out at very high fidelity; ensuring neurotransmission
is tightly coupled to acoustic events. This has been suggested to be important in order
for the brain to utilise interaural time cues to localise sound in space (Smith et al.,
1993).
1.1.4 Physiology of the auditory nerve
The activity of single ANFs can be measured by placing an electrode close to the
individual fibres exiting the cochlea. Many fibres exhibit random spontaneous activity.
These spikes are generated at the initial segment of afferent SGN near the synaptic
bouton (Hossain et al., 2005). This region contains a high density of voltage-gated Na+
(Nav) channels that are activated in response to depolarising neurotransmitter
(glutamate) from the ribbon synapse. Recordings from SGN boutons reveal that
excitatory postsynaptic currents (EPSCs) and potentials (EPSPs) are regularly large
enough that almost every depolarising event is sufficient to trigger a spike (Glowatzki
and Fuchs, 2002, Rutherford et al., 2012). This maintains the precise timing needed to
code acoustic information by ensuring short spike latencies that vary little. The
spontaneously active fibres are exclusively made up of type 1 fibres which synapse onto
the cochlear IHCs. Type II fibres display no spontaneous or evoked activity in response
to sound (Robertson, 1984). Single tones presented to the ear during recordings affect
the timing and the rate of ANF spiking. This evoked response is not uniform across
26
sound frequency however. A plot of ANF activity vs the frequency and sound level (dB)
gives a characteristic V-shaped plot known as a representative tuning curve. Each fibre
exhibits particular sensitivity to certain frequencies known as the fibre’s characteristic
frequency (CF). This CF is correlated largely with the position along the cochlea of the
IHC it contacts (Greenwood, 1996). For a recent review of the basic response properties
of ANFs see Heil and Peterson, 2015.
The spontaneous activities of ANFs exhibit a bimodal distribution of spontaneous
discharge rates (SRs). In cats, approximately one quarter of fibres fire at a rate of <20
spikes/sec. A second broader group has an average discharge rate of around 60-80
spikes/sec with some fibres showing as much as 120 spikes/sec (Evans, 1972,
Liberman, 1978). These SRs are correlated with the sound threshold for the fibre. On
this basis, Liberman and colleagues categorised three subpopulations of afferent fibres:
high SR fibres (>18 spikes/sec) with a low sound threshold, medium SR (0.5–18
spikes/sec) fibres with a moderate sound threshold and low SR fibres (<0.5 spikes/sec)
with a high sound threshold. These subpopulations of firing types were also observed in
rabbit (Borg et al., 1988), chinchilla (Relkin and Doucet, 1991), ferret (Sumner and
Palmer, 2012) and guinea pig (Furman et al., 2013). Structurally, differences have also
been reported; high SR fibres typically have a thicker fibre diameter and higher
mitochondrial number than low or medium SR fibres (Kiang et al., 1982, Liberman,
1980). This is consistent with the need for higher metabolism and rapid signal
conduction. The size and location of the afferent bouton at the IHC is also correlated
with SR and threshold (Kiang et al., 1982, Liberman and Kiang, 1984). Boutons from
fibres with low or medium SR synapse predominantly on the modiolar side of the IHCs,
have large post-synaptic terminals and smaller pre-synaptic ribbons. Conversely, fibres
with high SR and low thresholds terminate on the pillar side of the IHCs, have smaller
post-synaptic terminals and larger pre-synaptic ribbons (Figure 1.5). Interestingly,
acoustic overexposure in guinea pigs seems to cause selective loss of fibres with low SR
(Furman et al., 2013).
For any applied frequency, the average spike rate varies as a function of sound pressure
level (SPL). As SPL increases past threshold, ANF spiking increases from the basal SR.
This spike rate increases monotonically before saturating at high SPL. A plot of this
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activity vs SPL (dB) is known as the rate-level function or rate-intensity function
(Figure 1.5B) (Yates et al., 1990). The shape and position of this function varies with
the frequency of sound as well as the afferent type. Low threshold/high SR fibres at or
near the CF display a high sound sensitivity and steep rate-level function, sometimes
called a saturating response (Winter et al., 1990). This period of increase from the basal
spontaneous rate until saturation is termed the dynamic range (Figure 1.5B, grey area).
This reflects the range of sounds pressure level to which an individual fibre can respond
with changes in its spike rate. Figure 1.5B also shows the typical response of a moderate
threshold/medium SR fibre and high threshold/low SR fibre. High threshold/low SR
fibres exhibit a response to sound that is right-shifted compared to low threshold fibres.
High threshold/low SR fibres typically display shallower rate-intensity functions and a
wider dynamic range allowing them to track increases in sound well above the limit of
high SR fibres.
Figure 1.5 IHC afferents exibit heterogeneous physical and physiological properties. A
Animation of a typical IHC and its innervations. High SR fibres synapse onto the modiolar side
of the IHC and typically have a smaller bouton area, thicker peripheral neurites and larger
synaptic ribbons. Low SR fibres, in contrast, synapse onto the pillar side of the IHC and have
larger boutons, thinner peripheral neurites and smaller synaptic ribbons. B Model rate-intensity
plot showing the different afferent responces. High SR fibres typically respond to low sound
pressure level (SPL) and exhibit a steep rate-intensity relationship. This steep response that
reaches plateau rapidly (saturating response) has a narrow dynamic range (grey area). Medium
and low SR fibres exhibit lower sensitivity to sound and a shallower rate-intensity relationship
(wider dynamic range).
28
The utility of such organisation is clear. Manifold innervation of IHCs from fibres with
different rate-level functions allows individual ANFs to code different degrees of sound
intensity from the same IHC. Low threshold/high SR fibres respond to low sound but
saturate at higher levels where high threshold/low SR fibres are only near the bottom of
their rate-intensity functions (Figure 1.5B). In this way the cochlea can sample a wide
range of sound intensities whilst still remaining sensitive to small changes in sound
level (Yates et al., 1990).
The various afferent types have distinct organisations of their central processes, further
vindicating their categorisation into different fibre types. Whilst the main branches of
high and low SR nerve fibres are remarkably similar in their layout and location in the
CN (see Structure and organisation of the Spiral Ganglion), high SR fibres show
considerable less axonal arborisations within the AVCN region compared to low SR
fibres (Fekete et al., 1984). Interestingly, some of this branching from low SR fibres
penetrates into the peripheral borders of the CN, and specifically to a structure called
the small cell cap where they synapse onto the soma and dendrites of small cells
(Ryugo, 2008). These small cell fibres have been shown to send axons to the medial
olivocochlear efferent system (Ye et al., 2000) and implicates low SR fibres in
mediating a high threshold feedback circuit to the inner ear.
Differences in fibre SRs have been ascribed to differences in the rate of
neurotransmitter release at the ribbon synapses (Frank et al., 2009). Differences in
ribbon size and density of voltage-gated Ca2+ channels (Cav), which form Ca2+
microdomains, likely contribute to the differential release of neurotransmitter from
synapses present on the same IHC (Frank et al., 2009). The membrane properties of the
different afferent fibres still remain to be elucidated however. For example, it is unclear
if there are differences between the intrinsic membrane properties of high and low SR
fibres. The principal limitation has been the inability to make whole cell recordings
from SGNs in vivo. SGNs have been studied in vitro however. Interestingly there seems
to be significant variability in the native ionic conductance of these cells suggesting that
some of the heterogeneity observed in vitro may be replicated in the membrane
properties of afferent SGNs (Davis and Crozier, 2015). In vitro studies have already
shown significant differences in the ionic conductances of type I and type II SGNs
(Jagger and Housley, 2003, Reid et al., 2004) underlining their functional diversity.
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Further research is needed on the membrane properties of Type I SGNs to determine if
it contribute to the observed heterogeneity in firing. A comprehensive understanding of
how the AN functions requires an appreciation of how membrane conductances shape
the generation and propagation of action potentials (APs) in the nerve.
1.2 Ion channels
Ion channels are macromolecular, protein pores in the membranes of living cells. They
contain a central narrow, water-filled tunnel which facilitates the diffusion of ions down
their electrochemical gradient. This central pore is often exclusive to a single ion type,
excluding other ions based on their size and charge. They differ from other ion transport
proteins, which involve active processes, by facilitating the passive diffusion of ions
across the membrane. The rate of movement through ion channels is also vastly greater
than in other ion transport proteins, often nearing diffusion-limited rates (107 ions
channel-1s-1) (Sansom et al., 2002).
As early as 1902, Julius Bernstein correctly proposed that excitable cells such as
neurons were selectively permeable to K+ ions at rest. This “membrane hypothesis”
explained how the highly polarised membrane potentials of muscles and nerves could
be established (De Palma and Pareti, 2011). The resting membrane potential is now
known to result from differences in the concentration of a few such ions: Na+, K+, Cl-
and Ca2+. The observed transient excitability which Bernstein referred to as “Membrane
breakdown” in these cells would also later be explained by the opening and closing, or
“gating” of specific sets of ion channels. This gating is controlled by many factors
including changes in membrane voltage and the presence or absence of various ligands.
As well as an electrical gradient, there is also an ion concentration gradient across the
cell membrane. Cells maintain a high concentration of K+ inside the cell relative to the
extracellular solutions. Conversely Na+ and Cl- are kept at relatively low concentrations.
Along with the effects of a selectively permeable membrane, the active transport of ions
by pumps and exchange proteins help establish this gradient (Kurachi and North, 2004).
Under these conditions, the opening of K+ selective channels leads to a rapid efflux of
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K+ ions from the cell. In this way K+ channels play a crucial role in the membranes of
excitable cells; setting the resting membrane potential, establishing the excitatory
threshold at which APs fire and determining the length the AP once fired (Johnston et
al., 2010).
1.2.1 Potassium channel classification
K+ selective channels represent the single largest and most varied family of ion
channels. They are encoded by more than 70 distinct genes within the mammalian
genome and include the voltage-gated (Kv), Calcium-activated (KCa), inward-rectifying
(Kir), and two-pore (K2P) K+ channel families (Figure 1.6) (Gutman et al., 2005). The
largest of these families is the Kv family which include some 40 distinct genes in
humans. K+ channels are principally classified by the architecture of the pore-forming
α-subunits which assemble in the membrane as tetrameric complexes. These ion 
channels are classified by the number of helical transmembrane (TM) domains which
make up the α-subunits; typically 2, 4 or 6 TM domains (Gutman et al., 2005).  
2-TM K+ channels comprise two TM helical domains connected by a short loop region,
known as the P-loop (Figure 1.7). In mammals 2-TM channels are encoded by 15
distinct genes and include the inward rectifying K+ channel family, Kir. The structure of
these channels has been largely determined by solving the KirBac1.1 crystal structure, a
bacterial homolog (Kuo et al., 2003). Several of these channels have important
physiological roles and mutations in their genes have been linked to a number of human
diseases. Kir1.1 channels are involved in recycling K+ in the lumen of the kidneys and
mutations in this gene can cause “Bartter syndrome”, characterised by low potassium
levels or hypokalaemia (Heitzmann and Warth, 2008). These channels lack a voltage
sensor region and therefore their activity is unaffected by changes in membrane voltage,
however some Kir channels are regulated by other signalling pathways such as the G-
protein-coupled Kir3 and the ATP-sensitive Kir6 (Kubo et al., 2005). For a full review
of the structure, functions, and roles of Kir channels, see Hibino et al., 2010.
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Figure 1.6 Phylogenetic tree of human K+ channel genes. K+ channels fall broadly into 3
classes based on the architecture of their pore-forming α-subunits: 2, 4 and 6/7 TM domain K
+
channels. K+ genes are detailed here using the ‘KCN’ nomenclature. For simplicity, KCN has
been omitted from the channel name i.e. KCNA1 is A1 (Adapted from Heitzmann 2008).
K+ channels from the 4-TM family include the leak channels TWIK, TREK and TASK.
The naming of these channels, the “two-pore domain” potassium (K2P) channels, arises
from the distinct topology of their channel subunits. Unlike the 2-TM and 6-TM K+
channels, 4-TM proteins contain two pore-forming loop domains in each subunit.
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Accordingly, K2P subunits dimerise as opposed to tetramerise to yield a functional
channel with four pore loop domains (reviewed in Enyedi and Czirjak, 2010).
Kv and KCa channels combined make up the 6/7-TM family of K+ selective channels. In
humans 40 different genes contribute to this family and their structure is characterised
by 6 TM domains, or 7 in the case of the “slo” family of genes (which include the large
conductance BK channel). 6/7-TM channels contain a voltage-sensing S4 segment,
conferring upon them sensitivity to local changes in membrane voltage. They also
contain two pore-forming TM segments connected by an extracellular loop region,
which can assemble into tetramers in a manner similar to the 2-TM channels (Figure
1.7).
Figure 1.7 Membrane topology of mammalian K+ channel α-subunits. A 2-TM channels
consist of 2 helical transmembrane segments (M1 and M2) connected by an extracellular P-loop
and are exemplified by the Kir channels. Four subunits combine to make up a functional
channel. B 4-TM channels consist of two 2-TM motifs connected in tandem within a single
subunit. As a result each subunit contains two P-loops and only two subunits are required to
form functional channels. The 4TM family include the leak channels TASK and TREK. C 6/7TM
channels make up the largest family of potassium channels and include in the Kv and KCa
channels. As with all K+ channels the central pore region is formed from two 2 helical TM
segments (named S5 and S6) connected by the P-loop region. S4 is known as the voltage
sensor region due to its role in controlling channel gating through its response to changes in
surrounding membrane potential.
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1.2.2 Structure of the K+ channel
The basic structure of a K+ channel is a tetramer with each α-subunit contributing one 
pore-forming domain (Yellen, 2002). The general structure of the pore-forming domain
consists of two TM helices connected by a short loop region, known as the P-loop
(Figure 1.7). This canonical motif is a universal feature of all K+ channels regardless of
the total number of TM domains (Choe, 2002). The central P-loop region, sometimes
known as the H5 region, is composed of four conserved signature sequences (TVGYG)
and serves as an “ion selectivity filter”, a motif it shares with all K+ selective ion
channels (Heginbotham et al., 1994).
1.2.2.1 K+ conduction and ion selectivity
The defining feature of K+ channels is their ability to efficiently and selectively conduct
K+ ions across the membrane in the presence of multiple other small ions in the system.
Despite their similar charge and size K+ channels can effectively discriminate for K+
ions (ionic radius of 1.33 Å) against the smaller Na+ ions (ionic radius of 0.95 Å) whilst
conducting K+ ions at a rate close to the diffusion limit (Nimigean and Allen, 2011).
The exact mechanism of selectivity and conductivity remained speculative until the
solution of the crystal structure of KcsA, a bacterial K+ channel from Streptomyces
lividans (Doyle et al., 1998, Morais-Cabral et al., 2001, Zhou et al., 2001b). The
structure of KcsA revealed that the selectivity filter (SF) essentially consists of four K+
binding sites termed S1–S4 as well as a partly hydrated and partly coordinated site
termed S0 (Figure 1.8). As ions move through the channel they encounter different ionic
environments. From the intracellular side through to the central cavity, ions are
hydrated by a shell of water molecules. K+ ions are then dehydrated in the SF, and
subsequently rehydrated as they enter the extracellular mouth of the pore. Dehydration
of ions is an energetically expensive transition. This energy loss is compensated for by
the presence and orientation of carbonyl oxygens in the TVGYG filter (Figure 1.8B).
Each of these sites provides a cage of tightly packed electronegative oxygen atoms
arranged in a square antiprism geometry for the bound K+ ions, which is able to mimic
the hydration shell of the ion in the water-filled cavity of the channel (5–7 hydrating
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water molecules) (Neilson and Skipper, 1985). This stabilises the free cation and helps
overcome the strong energy barrier of dehydration.
Figure 1.8 Structure of the KcsA channel in complex with K+ ions. A Structure of KcsA, with
the front and rear subunits removed for clarity. Selectivity filter: yellow; K+ ions: green. M1 and
M2 represent the outer and inner helix respectively. B Magnified view showing the region boxed
in A. The K+ ion in the cavity is shown hydrated by eight water molecules (red spheres). This
ionic environment is recapitulated in the channel’s filter region by amino acid backbone
carbonyls. The four ion binding sites are labeled 1–4 and the amino acid residues are shown by
letters (Adapted from Alam and Jiang, 2011).
If these K+ sites bind so tightly however, how does the channel promote the rapid
transfer of ions from one side of the selectivity pore to the other? The near diffusion-
limited rate of ion conductance would suggest a very weak binding of ions to the
channel (Kuang et al., 2015). It has been proposed that only two K+ ions occupy the SF
at any given time (Zhou and MacKinnon, 2004, Zhou and MacKinnon, 2003). K+ ions
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simultaneously occupy either the S2 and S4 sites or alternatively the S1 and S3 sites
(Sites 1-4, Figure 1.8B). The corresponding vacant binding sites are thought to be
occupied by two water molecules. The movement of K+ ions is facilitated by the change
of the 2,4-configuration of K+ ions to a 1,3-configuration. The energy cost of such a
transfer is predicted to be very low (Morais-Cabral et al., 2001). K+ movement through
the channel may be driven by the entry of new ions into the SF or by the repulsive
effects between occupying cations within SF (Zhou and MacKinnon, 2003).
Structural determination has also been used to rationalise the selectivity of the channel.
The identified K+ binding sites, with its cages of carbonyl oxygen ligands, offer a
thermodynamically favourable environment for the cycle of K+ ion dehydration,
transfer, and rehydration. The Na+ ions are thought to be too small to effectively
coordinate with the K+ binding sites, making Na+ binding to the channel
thermodynamically unfavourable (Bezanilla and Armstrong, 1972, Doyle et al., 1998,
Zhou et al., 2001b). This thermodynamically driven process is sometimes called the
“snug-fit hypothesis”. This hypothesis is supported by the inability to detect Na+ in the
SF even when vast excesses of Na+ are employed. Furthermore, observation that high
Na+ conditions were seen to “collapse” the KcsA channel into a non-conducting
conformation has led to the proposal that K+ ions are required to stabilise the SF of K+
channels in a conductive conformation (Valiyaveetil et al., 2006, Zhou et al., 2001b).
However this “snug-fit hypothesis” has been challenged by more recent findings that
that suggest KcsA can bind monovalent ions such as Li+ and Na+ (Thompson et al.,
2009). These results have led to a competing kinetics-based model of ion selectivity.
The evidence for kinetic vs thermodynamic based ion selectivity is comprehensively
discussed in (Nimigean and Allen, 2011).
1.2.2.2 The voltage sensor domain and gating in voltage-gated K+ channels
K+ channels usually occupy one of three conformational states: Activated, inactivated or
rest. Channels move, upon stimulation, from a non-conductive, resting state to a
conductive activated state. Activation is often temporary and followed by the adoption
of one or more non-conducting, inactivated states (Kuang et al., 2015). The opening and
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closing of K+ channels is called “gating” and the mechanisms that control it depend on
the K+ channel under investigation. Some K+ channels open in response to the binding
of specific small molecules, and are known as ligand-gated K+ channels. Other K+
channels open in response to changes in membrane voltage and these are termed
voltage-gated K+ (Kv) channels.
The first successfully cloned K+ channel was the voltage-gated Shaker channel from
Drosophila melanogaster (Papazian et al., 1987). Vertebrates express 12 Shaker-like
channels known as the Kv1 channel proteins, termed Kv1.1, Kv1.2, Kv1.3 etc. encoded
by 12 separate genes (KCNA) (Revest and Longstaff, 1998). Three more Kv channels,
Shab, Shaw, and Shal, were further identified in Drosophila melanogaster (Butler et al.,
1989) and are mirrored in vertebrates in the form of KCNB (Kv2), KCNC (Kv3) and
KCND (Kv4) respectively. In all, 40 genes in all are now known, and according to the
Allen Brain Map (http://brain-map.org/), at least 26 of these Kv subunits have been
detailed in the mammalian brain.
The Kv channel α-subunit is composed of sic TM helices containing five linker regions, 
and an intracellular C and N terminus. The last two TM helices (S5 and S6) are
positioned at the centre of the tetramer and make up the above-mentioned pore region,
with the S5 and S6 helices corresponding approximately to the outer and inner helices
in KcsA respectively (Figure 1.7). The first four TM helices (S1-S4) form the
characteristic voltage-sensing domain (VSD) at the periphery of the channel (Jiang et
al., 2003, Long et al., 2005). The VSD and pore domain (PD) can be viewed as
essentially separate units linked by an intracellular chain termed the “S4-S5 linker”.
Access to the water-filled cavity and SF of the Kv channel is controlled by a gate at the
intracellular side of the channel protein (Figure 1.8). This intracellular gate is comprised
of four S6 helices, one from each monomer, which protrude out into the intracellular
cavity and form a bundle which obstructs ion flow in the closed channel state (Doyle et
al., 1998).
The majority of Kv channels open in response to the depolarisation of its constitutive
membrane and close when the membrane is hyperpolarised (Swartz, 2008). The
function of the VSD therefore is to be responsive to changes in membrane voltage and
couple these changes with the mechanical gating of the central pore. Each VSD is
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composed of four to six basic residues separated by two hydrophobic residues which
create a surface of positive charge along the S4 helix (Blunck and Batulan, 2012). This
feature is what gives rise to the important voltage sensitivity of the channel.
Depolarisation of the membrane results in the S4 helix undergoing conformational
changes within the membrane which eventually results in pore opening. The S4 helix
must negotiate several closed states before attaining the activated state, and only upon
activation of all four S4 helices will the pore open (Zagotta et al., 1994a, Zagotta et al.,
1994b). This voltage sensor movement can be detected experimentally as “gating
currents” caused by the movement of the S4 electrostatic charges though an electrical
field. The exact mechanism of gating after that is somewhat more contentions. Various
models of channel reorientation including a “sliding helix” (Larsson et al., 1996),
“helical screw” (Ahern and Horn, 2005) and “paddle” (Jiang et al., 2003) model have all
been suggested. The current favoured model for the gating movement of the voltage
sensor through the membrane is the single consensus model (Blunck and Batulan, 2012,
Jensen et al., 2012, Yarov-Yarovoy et al., 2012). Briefly, in this model the positive
charges in the S4 helix are paired with corresponding negative charges from the S1-S3
regions. During activation these positive charges move from one negative charge to the
next resulting in the translocation of the S4 domain across the membrane. Subsequent
movements are thought to involve tilting of the S4 helix and rotation around its helical
axis as well as vertical and radial movement within the membrane. This results in
displacement of the S4-S5 linker and consequently pore opening (Blunck and Batulan,
2012). The opening of the pore itself is a result of an uncrossing of the S6 bundle at the
base of the Kv channel. In many Kv channels the S6 bundle contains a kink in its axis as
a result of a strongly conserved proline sequence (PxP or PxG). It is thought that the
movement of the C-terminus to PxP motif away from the central pore facilitates ion
entry to the water-filled cavity of the channel.
Opening of the pore itself however, often results in the subsequent inactivation of the
channel. Channels which enter an inactivated state cease conducting K+ ions freely and
cannot be re-stimulated by membrane depolarisation to open. Two primary forms of
inactivation have been described. Rapid, N-type inactivation is a feature of some Kv
channels and is a result of a flexible ball peptide bound to the N-terminus of the
channel. This N-terminus ball peptide is proposed to interact with the open K+ channel
through electrostatic interactions (Fan et al., 2012, Hoshi et al., 1990, Zhou et al.,
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2001b). N-type inactivation is necessarily limited to K+ subunits which contain the
required ball peptide. In contrast, nearly all K+ channels, both prokaryotic and
eukaryotic, undergo slower C-type inactivation. C-type inactivation results from
activation induced changes in the SF, as well as the elimination of water and K+ ions
from the channel protein (Cuello et al., 2010). Studies on the Shaker K+ channel
indicate C-type inactivation is dependent upon external K+ concentration as well as
mutations in the pore region of the channel (Lopez-Barneo et al., 1993). Studies on
bacterial KcsA suggest that the first inactivation step may be the pinching together of
SF backbone carbonyls (Cuello et al., 2010). This slower inactivation response most
likely plays a role in determining Kv channel function in the context of repetitive
electrical activity or in modulating physiological responses to the accumulation of
extracellular K+ (Yellen, 2002).
1.2.2.3 Ancillary subunits associated with Kv channels
In vivo, the tetrameric assembly of four α-subunits is often complexed with accessory 
subunits. These proteins serve a number of functions including modulating channel
kinetics and surface expression (reviewed in Pongs and Schwarz, 2010). Mutations in
these proteins are associated with a range of human diseases including hypertension,
epilepsy, and paralysis (Abbott et al., 2001, Brenner et al., 2000, Schulte et al., 2006).
Accessory Kv channel proteins exhibit varied structure and expression patterns
reflecting their diverse biological roles. Some accessory subunits are integral membrane
proteins (Orio et al., 2006) whilst other accessory proteins are cytosolic and bind to
cytoplasmic domains of Kv channel (Rettig et al., 1994). Auxiliary subunits include the
Kvβ subunit (Pongs et al., 1999), the BKβ-subunits (Orio et al., 2006) the Kv4 Channels 
auxiliary subunits, KChIP and DPPL (An et al., 2000) and the KCNE subunit (Barhanin
et al., 1996).
In mammals, the Kvβ subunits are encoded by three distinct genes: KCNAB1 (Kvβ1), 
KCNAB1 (Kvβ2) and KCNAB1 (Kvβ3) (Heinemann et al., 1995, Leicher et al., 1996, 
Schultz et al., 1996). The genes, KCNAB1 and KCNAB2 also give rise to splice variants
resulting in Kvβ1 and Kvβ2 subunits with varying NH2-terminal sequences (Kvβ1.1-
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1.3). Kvβ subunits associate into octameric complexes with Kv1 α-subunits in a 1:1 
ratio (Heinemann et al., 1996, Long et al., 2005, Rettig et al., 1994). The site of
interaction is formed by a short loop region in the Kv1α tetramerisation domain and 
complementary interacting sites on the Kvβ protein (Gulbis et al., 2000, Long et al., 
2005). This sequence is highly conserved across Kv1α subunits, providing an 
explanation for the specificity of Kvβ proteins for the Kv1α subunit family.
Kvβ subunits are members of the oxidoreductase superfamily of proteins (Gulbis et al., 
1999), a fact nicely exemplified by its complex with NADPH in the Kv1.2 crystal
structure (Long et al., 2005). This implicates Kvβ subunits in coupling the function of 
the channel to the redox state of the intracellular environment (Pongs and Schwarz,
2010). Kvβ subunits can also influence the gating properties and voltage sensitivity of 
the Kv channel, most notably by conferring rapid inactivation to otherwise non-
inactivating Kv channels (Rettig et al., 1994). Kvβ subunits also alter the 
pharmacological profile of the channel; for instance, by reducing the effects of the
intracellular acting anaesthetics, Bupivacaine and Quinidine (Gonzalez et al., 2002). A
final role has also been proposed for Kvβ proteins in determining surface expression 
and subunit localisation of Kv1 channels (see also Kv channel biogenesis). Kvβ has 
been observed to increase Kv1.2α surface expression and macroscopic currents in 
heterologous expression systems (Accili et al., 1997). Further, Kvβ has been shown to 
target Kv1α subunit to the axonal segments of cultured hippocampal neurons (Gu et al., 
2006). However this is still controversial and knockout studies of Kvβ2 knockout mice 
and Kvβ1/Kvβ2 double knockout mice describe unchanged expression patterns of 
Kv1.1 and Kv1.2 subunits at the surface of cerebellar neurons (Connor et al., 2005,
McCormack et al., 2002).
1.2.3.4 Kv channel biogenesis
Kv channels begin their life at the endoplasmic reticulum (ER). Specific amino acid
sequences in the nascent α-subunit peptide (signal peptide) target the peptide/ribosome 
complex to the ER membrane where synthesis of the peptide is completed.
Alternatively, nascent proteins can be targeted to other organelles such as mitochondria
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by the presence of specific mitochondrial presequences (Stojanovski et al., 2012). At the
ER, the ribosome/polypeptide binds to a translocon, an aqueous pore through which
polypeptides enters the ER lumen (Johnson and van Waes, 1999). Along with providing
access to the ER lumen, the translocon actively facilitates the incorporation of the TM
peptide segments into the ER membrane (Figure 1.9) (Crowley et al., 1994).
Translocation dictates the TM topology or “sidedness” of the growing channel and,
along with chaperone proteins and other topological determinants, ensures the correct
folding and orientation of the channel in the membrane (Deutsch, 2003). Even whilst
the formation of this tertiary structure is still taking place, tetramerisation of Kv
recognition domains is thought to initiate (Deutsch, 2003, Liu et al., 2001). The
coupling of primary, secondary, tertiary and quaternary structural assembly is enabled
by the functioning of multiple intracellular protein complexes in close proximity and in
concert along the length of the polypeptide chain (Deutsch, 2003).
Whilst this translation and incorporation into the ER is taking place, post translational
modification of the peptide occurs. Cleavage of the signal peptide is followed by
glycosylation and oxidation of the peptide (Deutsch, 2002). Kv channels are
glycosylated at important core residues and subsequently undergo further glycosylation
at the Golgi. The cell surface expression, localisation and biophysical function of the
channel are largely unaffected by these modifications (Deutsch, 2003, Liu et al., 2001,
Zhu et al., 2014). Interestingly, S-acylation has been shown to be important in the cell
surface expression of some Kv channels (Zhang et al., 2007).
The ER is also the site where Kv channels are coupled with their partner α-subunits and 
accessory subunits (Nagaya and Papazian, 1997). In fact, excepting some gap junction
proteins, the ER is the site of most ion channel oligomerisation (Das Sarma et al., 2002).
The choice of partner subunit will be determined by many factors, not least the presence
and availability of other subunits within the ER at the time of synthesis. The choice of
partner is not free either; only members of the same Kv1-Kv4 α-subunit family can co-
assemble to from functional tetrameric channels (Covarrubias et al., 1991). This subunit
specificity is primarily driven by recognition domains present on the channel proteins
themselves (Xu et al., 1995). In Kv channels this is a highly conserved hydrophilic
motif near the cytosolic N terminus of the protein. This is called the first tetramerisation
domain or “T1 domain” (Lee et al., 1994, Li et al., 1992). If this recognition domain is
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deleted, Kv subunits will still form stable, functional channels. However, T1-deleted Kv
subunits associate promiscuously with other Kv family proteins (Tu et al., 1996). The
T1 domain prevents homogenisation of Kv channels through random mixing,
persevering discrete repertoires of Kv channels (Deutsch, 2002). Although not
ultimately necessary for the association of Kv subunits the T1 domain is suggested to
police channel assembly by bringing T1-compatible subunits into close proximity,
consequently favouring their assembly kinetically over T1-incompatible monomers
(Zerangue et al., 2000). The specific mechanisms of oligomerisation likely depend on
the specific channel of under investigation, varying with the topology and folding
sequence of the protein.
Of similar interest are the associations which govern the assembly of Kv channel
subunits which contain the same T1 recognition domain. The organising principles
which underlie homo vs heteromeric assembly are of great importance to understand
how cells establish their electrophysiological properties. On one hand, an unbiased
association of T1-compatible monomers might predict a binomial distribution of subunit
containing channels with random stoichiometry (Panyi and Deutsch, 1996). Conversely,
preferential association of some subunits could lead to discrete population of
homomeric channels or non-random association of distinct heteromeric complexes with
discrete stoichiometry. How these subunits assemble at the ER or whether they do so
with any preference is still unclear. What is better understood is the expression of these
functional homo/heteromeric channels at the plasma membranes of biological tissues.
Experimental tools such as immunoprecipitation (Coleman et al., 1999), Kv α-subunit 
concatemerisation (Sokolov et al., 2007) and subunit specific toxins (Dodson et al.,
2002) allow the molecular identity and composition of the native electrophysiology to
be determined. However, as will be discussed, this ultimate distribution and expression
is not just determined by the assembly of subunits at the ER, but by ER retention,
trafficking and subcellular localisation.
After assembly of the Kv α-subunits and auxillary proteins into their channel 
complexes, Kv channels undergo so-called “quality control checkpoint” (Braakman and
Bulleid, 2011). This ensures channels with the correct configuration can leave the ER
membrane and is the major determinant of cell surface expression. The ability of
various Kv1 homo- and heteromeric complexes to reach the plasma membrane is not
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uniform. The subunit composition and stoichiometric as well as the presence or absence
of auxillary proteins have a significant effect on ER exportation of the channels. This
presumably leads to a much narrower range of possible channel types and subunit
combinations than are formed at the ER (Vacher et al., 2008).
Figure 1.9 Kv channel biogenesis. After gene transcription and export of mRNA from the
nucleus, translation of Kv channel peptides is initiated by cytosolic ribosomes. This
peptide/ribosome complex is targeted to the nucleus where the growing peptide is integrated
into the ER membrane by a translocon. Further peptide synthesis and folding occurs, forming
the characteristic 6-TM domain architecture. T1-domain mediated tetramerisation follows, along
with the association with auxiliary proteins. If it has the correct ER export signal, channel
complexes will be transported to the Golgi for distribution to the cell surface.
The Kv1.1 subunit contains a strong ER retention signal within the pore domain of the
channel (Manganas et al., 2001). Homomeric Kv1.1 channels show negligible surface
expression in a mammalian cell line. Furthermore, coexpression of the Kv1.1 subunit
with other Kv1 family members reduces the surface expression of the hybrid channel
(Manganas and Trimmer, 2000). Other channels such as Kv1.4, which do not share this
motif, readily reach the cell surface. Similar to Kv1.1, Kv7.3 subunits displays strong
ER retention and must form heteromeric complexes with other Kv7 members to reach
the cell surface (Schwake et al., 2000). Moreover, export of Kv7.2 from the ER has
shown a dependence on the Ca2+ sensitive protein calmodulin, suggesting that
intracellular Ca2+ levels may play a role in determining Kv7 surface expression. The
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Kv4 family of subunit are largely retained at the ER and require binding of accessory
protein in order to reach the cell surface. K+ channel interacting proteins (KChIPs)
stimulate significant cell surface expression of Kv4 α-subunits and can increase Kv4 
current density by up to 100-fold in expression studies (An et al., 2000).
Once a Kv channel is successfully exported from the ER, it is transported to the Golgi
apparatus. From here Kv channels are assigned to specific post-Golgi transport vesicles
and distributed to various neuronal compartments (Jensen et al., 2011). Precise
subcellular localisation of Kv channels is achieved by unique peptide signals encoded
within the Kv channel polypeptide. In neurons the most fundamental demarcation is
between proteins destined for the dendrites and those for the axon. In Kv1 channels
axonal localisation is determined by the N-terminal tetramerisation (T1) domain
(Campomanes et al., 2002, Gu et al., 2006). In other channels these signals are
conserved peptide sequences and motifs such as the PRC signal present at the C-
terminus of the Kv2 channels (Lim et al., 2000), which help localise the channel to the
soma and dendrites of the neuronal structure. Similar targeting sequences have been
identified for Kv4 channels (Rivera et al., 2003) and Kv7.2/Kv7.3 (Chung et al., 2006).
Finally, Kv channels are inserted at the cell surface through the fusion of Kv-containing
transport vesicles with the plasma membrane. This may also contribute to the
localisation of ion channels by limiting the insertion event to specific microdomains
(Jensen et al., 2011). However, very little is known about these ion channel fusion
events. Once inserted Kv channels are most likely tethered to large molecular scaffolds
or kept in place by molecular crowding (Jensen et al., 2011). Kv7 tethering in the axon
initial segment is most likely effected by their binding to ankyrin-G (Chung et al., 2006,
Pan et al., 2006, Rasmussen et al., 2007) whilst Kv1 channels are able to bind a number
of PDZ-domain scaffolding proteins by virtue of a PDZ binding motif at the
intracellular C-terminus (Ogawa et al., 2008).
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1.2.4 Kv channels in neuronal firing
Voltage-gated K+ channels play a major role in the function of excitable cells. They
help set the resting membrane potential of the cell and aid the rapid repolarisation of the
membrane once an AP has been triggered. Mutations in Kv channel genes result in
various forms of neuronal and cardiac dysfunction including epilepsy, episodic ataxia,
cardiac arrhythmias, and congenital deafness (Adelman et al., 1995, Imbrici et al., 2006,
Jentsch, 2000, Neyroud et al., 1997).
1.2.4.1 Determining the role of Kv channel function in neurons
The role of Kv channels in neurons has been primarily driven by the discoveries of the
biophysical properties of recombinant Kv channels in heterologous expression systems.
However these studies provide only a limited understanding of the role of the Kv
channel complexes in functional nerves. Assortments of molecular and pharmacological
tools are now available to dissect out the role of different Kv channel subtypes in situ.
Channel specific toxins can be employed to block specific Kv channel subtypes. This
allows the relative contribution of various Kv channel subtypes to be assessed in native
tissue. Knockdown or knockout of Kv genes has also been used extensively to try and
assess the role of Kv channels. However interpretation of these experiments is
notoriously challenging. The tetrameric nature of Kv channels and their ability to
heteromerise means that knockout of specific Kv genes may not significantly alter the
level of functional ion channel available but rather alter the channel composition. This
can lead to contradictory or unexpected changes in ion channel biophysics and
expression. A good example of this is the finding that knocking out low-voltage-
activated (LVA) Kv channel, Kv1.2, paradoxically results in enlarged neuronal LVA
currents (Brew et al., 2007). This is thought to arise due to the increased contribution of
the more hyperpolarised Kv1.1 subunit in the knockout animal, adjusting the
biophysical properties of the channel accordingly, rather than altering Kv1 channel
density. As discussed above, altering subunit composition and stoichiometry through
gene knockout or knockdown could drastically change the export and trafficking of
channels to the cell surface. Results from knockout/knockdown studies should be
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interpreted with caution and validated with other available tools where possible.
Transgenic and “Knockin” mice have offered a somewhat more subtle approach to
examining Kv channel function; the introduction of specific genetic aberrations into the
Kv channel subunit in vivo allows the examination of non-functional channel mutants
without the confounding effects introduced by simple genetic ablation i.e. differences in
channel composition and stoichiometry or differences in membrane trafficking (Doyle
et al., 2012).
Another difficulty in analysing Kv channel contribution to neuronal electrophysiology
is the membrane architecture of the cell. High quality voltage-clamp data can be
difficult to obtain for large or arborous neurons which make space-clamp imperfect.
Furthermore, neurons often display large magnitudes of outward current resulting in
large voltage-clamp errors, even with series resistance compensation (Williams and
Mitchell, 2008).
1.2.4.1 Kv channels shape the action potential in of a nerve
Neurons use the distinct biophysical and gating properties of Kv channel subfamilies to
regulate excitability and determine the shape of APs. Some channels, such as Kv1, Kv4
and Kv7 are sensitive to changes in voltage close to the neuron’s resting membrane
potential and respond to small depolarisations of the membrane to prevent AP firing, i.e.
during an EPSP (Figure 1.10) (Coetzee et al., 1999, Johnston et al., 2010). LVA Kv
channels also help set the resting membrane potential of the cell by opening at or near
the RMP of the cell. Effective pharmacological blockers now exist and the effect of
blocking these Kv subfamilies can be assessed in neuronal tissues. In some cases, where
toxins are available, it is even possible to assess the relative contributions of a single
channel subtype to the firing of a neuron (Dodson et al., 2002).
In contrast, high-voltage-activated (HVA) channels such as the Kv2 and Kv3 family of
channel proteins only open in response to significant depolarisations of the membrane,
like those seen during AP firing (Figure 1.10). In combination with the rapid
inactivation of Nav channels, HVA Kv channels act to repolarise the neuronal
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membrane (Johnston et al., 2010). TEA is a cationic blocker of all Kv channels, but at
low concentrations, TEA can act as an effective blocker of the HVA Kv3 channels. In
rapidly firing neurons, inhibition of Kv3 current increases the length of the AP and
reduces the frequency of firing (Winlove and Roberts, 2011).
Figure 1.10 The different biophysical characteristics of Kv channels underlie their utility
in excitable cells. A Under voltage clamp it is possible to examine biophysical properties of Kv
channels in heterologous expression systems. Some channels, such as Kv1, 4 and 7 are
activated by small membrane depolarisations whilst others (Kv2 and 3) require much higher
depolarisations (such as those encountered during an AP) to open. B The different biophysical
properties of Kv channels means they contribute differently to the initiation and propagation of
an AP. The temporal activities of the different Kv channel families are roughly demonstrated
here by the coloured bars/arrows: Low-threshold voltage-activated (LVA) channels, as
exemplified by the Kv1 channels (red) open on depolarisation from typical resting potentials,
therefore influencing the threshold for AP firing. High Voltage Activated (HVA) channels,
exemplified here by the Kv3 family of channels, need further depolarisation, and hence activate
during an AP to aid repolarisation. Kv2 channels (blue) act even later in the waveform due to
their slower kinetics. It is the action of different populations of Kv channels working in concert
that give rise to the characteristic AP waveform, as well as the length of the AP duration and
threshold at which it fires (adapted from Johnston et al., 2010).
The kinetics of the channel is also important; slowly activating Kv channels do not play
a significant role in shaping the immediate AP due to their slower response properties.
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Kv channels with slower response kinetics often serve other functions such as setting
the resting membrane potential of the neuron (Kv7) or influencing the firing properties
of neurons in response to repeated electrical activity (Kv2; see Figure 1.10B). Some Kv
channels such as Kv4 exhibit “A-type” behaviour. They display a significant initial
conductance upon depolarisation which inactivates as depolarisation persists, requiring
hyperpolarisation before becoming available for conduction again (Maffie and Rudy,
2008).
Finally, the targeting of Kv channels to specific subcellular locations is a key
determinant for their biological function. Kv1 family subunits are localised to
multiplicity of microdomains in both the central nervous system (CNS) and the
peripheral nervous system (PNS; reviewed in Lai and Jan, 2006) where they likely
influence different aspects of neuronal activity. Kv1 expression at the presynaptic
terminals of CNS neurons helps regulate neurotransmitter release (Lambe and
Aghajanian, 2001) whilst Kv channels located to axonal and dendritic compartments
influence AP propagation along the neuron (Trimmer and Rhodes, 2004). Kv1 currents
at the post synaptic side of the calyx of Held determine the threshold of depolarisation
required for AP generation (Ishikawa et al., 2003) ensuring only large EPSCs result in
APs. The biophysical properties of Kv channels and their distinct spatial localisation
combine to create a neuron’s unique response properties.
1.2.5 Lipid modulation of Kv channels
Lipids are fundamental biomolecules for life. Thousands of different lipids have now
been identified in mammalian cells with eukaryotes dedicating ~5% of all genes to their
synthesis (Fahy et al., 2009). Lipids serve three primary functions in mammals: energy
storage, as a basis for the plasma membranes and as a first or secondary messenger
system in signal transduction (for review see van Meer et al., 2008). Polar lipids, which
contain both hydrophilic and hydrophobic elements, spontaneously self-assemble into
micelles and bilayers in aqueous environments providing the physical basic for the
formation of plasma membranes. The six TM segments of the Kv channel structure
traverse this lipid bilayer in functional channels and the gating of these channels
48
involves the movement of TM domains through this hydrophobic environment. This
fact makes Kv channels (and ion channels in general) ideal candidates for lipid
modulation.
The major lipids in eukaryotic membranes are glycerophospholipids which include
phosphatidyl, phosphatidylethanolamine, phosphatidylserine, phosphatidic acid and
phosphatidylinositol (PI). Phosphatidylcholine accounts for more than 50% of
membrane phospholipids in most eukaryotes (van Meer et al., 2008). Other membrane
lipids include sterols, sphingolipids, glycolipids and free fatty acids. Many models have
been proposed to explain lipid regulation of membrane ion channels. The direct
interaction of negatively charged lipids with K+ channels may facilitate gating and
prevent C-type inactivation (Valiyaveetil et al., 2002), raising the possibility of
conserved lipid interaction sites within K+ channels. Furthermore lipids may be
necessary for electromechanical gating. Kv7 channels have been shown to require the
presence of anionic lipid for VSD coupling to the pore (Zaydman et al., 2013). But
these broad explanations most likely do not account for the molecule specific effects
observed between lipids.
1.2.5.1 Phosphoinositides
Phosphoinositides (PIs) are a family of closely related phospholipid molecules which
play a number of keys roles across a range of biological processes. They are involved in
the control of intracellular vesicle trafficking, lipid transport, cytoskeleton organisation,
ion channel regulation and are also substrates for both receptor-stimulated
phospholipase C (PLC) signalling cascades as well as phosphoinositide 3-kinase (PI3K)
signalling pathways (Balla, 2013). PIs are amphiphilic, ensuring they localise to the
intracellular leaflet of the plasma membranes of cells. Their chemical structure
comprises a glycerol backbone, with two non-polar fatty acids which embed in the
hydrophobic cell membrane, and a phosphate group linking this backbone to an inositol
head group. The inositol head group may also be phosphorylated at the 3-, 4-, or 5-
position on the inositol ring. There are seven PIs excluding the parent molecule
phosphatidylinositol, PI (Figure 1.11). The seven family members; PI(4)P; PI(4,5)P2;
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PI(3,4,5)P3; PI(3,4)P2; PI(3,5)P2; PI(3)P and PI(5)P differ in their relative abundance
and location within cells. The different PIPs are synthesised and broken down by
specific phosphoinositide kinases and phosphatases that catalyse phosphorylation and
dephosphorylation at different positions on the inositol head group (Figure 1.11)
(Lemmon, 2008).
Figure 1.11 Phosphoinositides and their metabolism. The basic phosphoinositide (PI)
molecule is comprised of a highly polar inositol 1-phosphate group and a hydrophobic
diacylglycerol moiety (Acyl groups are shown for phosphatidylinositol (PI) but were otherwise
cropped out for clarity). Shown are the major pathways and important enzymes for the
synthesis and breakdown of the phosphoinositide family members. P, phosphate; PI3K, PI4K,
and PI5K, phosphoinositide 3-kinase, phosphoinositide 4-kinase, and phosphoinositide 5-
kinase, respectively; MTM, myotubularin; PI(3)P, phosphatidylinositol 3-phosphate; PI(3,5)P2,
phosphatidylinositol 3,5-bisphosphate; PI(5)P, phosphatidylinositol 5-phosphate; PI(4,5)P2,
phosphatidylinositol 4,5-bisphosphate; PIP2 4 ptase, phosphatidylinositol 4,5-bisphosphate-4-
phospatase; PTEN, phosphatase and tensin homolog; PIKfyve, FYVE finger-containing
phosphoinositide kinase; SHIP, Src homology 2 containing inositol 5-phosphatase; PI(3,4,5)P3,
phosphatidylinositol 3,4,5-trisphosphate; PI(4)P, phosphatidylinositol 4-phosphate; PI(3,4)P2,
phosphatidylinositol 3,4-bisphosphate.
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PI(4,5)P2, commonly known as “PIP2” is the most abundant of the phosphoinositides
outside of the parent PI, and is arguably the best studied of the PIPs in mammalian
tissues (Lemmon, 2008). PIP2 interacts with a large variety of cellular proteins and
processes including membrane bound ion channels and receptors, GTPases and actin
regulatory proteins (McLaughlin et al., 2002), as well as nuclear proteins (Barlow et al.,
2010). PIP2 is also an important regulator of ionic membrane properties (Hilgemann and
Ball, 1996, Zhang et al., 1999, Suh and Hille, 2002). PIP2 directly binds and enhances
the activity many K+ channels; its presence is obligatory for the functioning of many of
these channels (for a full review see Suh and Hille, 2008). PIP2 can also regulate ion
channel activity through downstream effector pathways. Similarly, mutations in ion
channel proteins which directly affect the affinity of the channel for PIP2 has been
linked to important channelopathies and diseases (Logothetis et al., 2010).
1.2.5.2 Free fatty acids
Fatty acids are ubiquitous within the plasma membrane. However the vast majority of
the fatty acid motif is bound up as fatty acid tails, esterified to glycerol. In this form
they make up the carbon backbone of membrane glycerophospholipids (Figure 1.12).
Here they play a structural role making up the hydrophobic interior of the lipid bilayer.
The influence of fatty acids on membrane proteins in this form is limited; however the
phospholipid fatty acid length and the degree of saturation can impact physical
properties of membranes such as the lateral mobility and fluidity of lipids and proteins
(Lee, 2004).
Free fatty acids (FFAs) only exist as a fraction of the total fatty acid motif in the
membrane but temporal and local increases in the FFA concentration is possible by
cleavage from membrane glycerophospholipids. These temporary and inducible
increases in FFA concentration make it an ideal signalling molecule. Activation of
specific G-protein coupled receptors results in the enzyme-mediated hydrolysis of
membrane phospholipids, which liberates non-esterified fatty acids. Phospholipase A2
(PLA2) generated FFAs in a single step by hydrolysis of an acylester bond in
phospholipids, yielding a FFA (mostly arachidonic acid and docosahexaenoic acid) and
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a lysophospholipid (Figure 1.12) (Farooqui and Horrocks, 2004). FFA can also be
produced in a two-step process by the actions of Phospholipase C and phospholipase D
(PLD) producing diacylglycerol or monoacylglycerol respectively. The subsequent
actions of diacylglycerol- or monoacylglycerol-lipase yield further FFAs.
Figure 1.12 Receptor-mediated release of fatty acids from membrane phospholipids. Fatty
acids can be formed in a single enzymatic step by the action of phospholipase A2 on membrane
phospholipids. In this example free arachidonic acid (AA) is liberated from one of
phosphatidylcholine, phosphatidylserine or phosphatidylethanolamine giving the free fatty acid
and a lysophospholipid (Lyso-PAF). AA can, in turn, act as a substrate for other signalling
pathways. AA can be used to synthesis the important inflammatory mediator prostaglandin H2
and leukotriene through the actions of cyclooxygenases (COX) and lipooxygenases (LOX)
respectively. Alternately, AA can signal directly through a variety of methods
Once cleaved, FFAs diffuse through the membrane where they may enter into further
metabolic pathways as substrates for the production of diglycerides, ceramides,
prostaglandins, leukotrienes and thromboxanes (Figure 1.12) (Tassoni et al., 2008).
Unlike other membrane lipids, fatty acids have intrinsically high dissociation rates from
the membrane and can diffuse into aqueous environments (Balsinde et al., 2002).
Therefore in addition to providing the basis for other bioactive molecules, some FFAs
may function directly as second messengers. Free arachidonic acid has been shown to
have direct modulatory effects on a range of cellular proteins, including protein kinase
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C (Khan et al., 1995), G proteins (Abramson et al., 1991) and adenylate cyclase
(Murphy, 1985). Furthermore, FFAs can directly regulate cellular events such as
exocytosis by their direct interaction with the cellular machinery involved (Darios et al.,
2007). Finally, FFAs can also diffuse into the extracellular space. One suggested
implication of this is that FFAs may act as retrograde signalling molecules, modulating
the presynaptic terminals of brain neurons and playing a role in synaptic plasticity
(Bazan, 2005). Extracellular FFA signalling also regulates energy metabolism through
their action on free fatty acid receptors (Hara et al., 2014); inflammation through their
effects on Toll-like receptors (Glass and Olefsky, 2012); and gene expression through
their activation of peroxisome proliferator-activated receptors, toll-like receptors and G
protein-coupled receptors (Georgiadi and Kersten, 2012).
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1.3 Aims and objectives
There were two major aims of this study. The first was to examine the firing features of
SGNs from post-hearing onset animals. Systematic investigation of SGNs’ firing
features and membrane conductances have up to now been primarily carried out in pre-
hearing animals. Given the significant maturation of the cochlea around the onset of
hearing and after, characterisation of neurons from hearing animals is of great
importance. The second aim was to investigate whether the firing features of
functionally mature SGNs could be modulated. This study focused, in particular, on the
effect of membrane lipids on SGN activity. Membrane lipids are ideally situated for
modulating SGNs’ firing behaviour and membrane conductances and this study aimed
to examine the physiological effects of adjusting the levels of these membrane lipids.
Individual objectives working towards these aims were also pursued. The most
important task was to develop a robust and stable tissue preparation that allowed whole
cell patch clamp recordings to be obtained from the soma of the SGNs. Secondly, in the
absence of genetic tools, pharmacological methods to adjust the levels of membrane
bound PIP2 were investigated. These involved complimentary experimental approaches,
combining traditional strategies of PIP2 reduction, such as inhibiting phosphoinositide
synthesis, with recently developed strategies for PIP2 sequestration and capture.
Another important objective was to develop a heterologous expression system. This
could be employed to correlate the effects of PIP2 modulation on specific SGNs
conductances with similar effects observed on the expressed Kv subunits in isolation.
This would help provide the molecular basis for any observed modulatory effects.
Furthermore, once this molecular basis had been established, a heterologous expression
system would provide an ideal tool to screen other native and synthetic lipids for their
potential modulatory effects in SGNs
Understanding the molecular basis of SGN firing could provide a better understanding
of the heterogeneous firing patterns observed in ANFs in vivo. An analysis of the lipid
modulation of SGN activity could provide two important outcomes. First, it could shed
light on potential lipid-mediated regulatory pathways available to SGNs. Secondly, it
could identify new targets for pharmacological intervention and provide a novel
mechanism of adjusting the sensitivity and output of the auditory nerve.
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Chapter 2
Materials and Methods
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2.1 Materials
2.1.1 Reagents and solutions
All reagents and solutions were obtained from Sigma Aldrich unless otherwise stated
2.1.1.1 Neuronal cell culture solutions
Neuronal cell culture medium was made up of Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with foetal calf serum (FCS; 10%), 10 mM HEPES and 1%
penicillin/streptomycin (Invitrogen). Brain-derived neurotrophic factor (BDNF; Insight
Biotechnology LTD) was made up as a stock solution in DMEM to 500 ng/ml before
being aliquoted and stored at -20⁰C until use. Trypsin was made up as a solution of
0.25% w/v in PBS, aliquoted, frozen and stored until use. A stock solution of poly-L-
lysine hydrobromide, (Molecular weight >70,000; M P Biomedicals UK) was made up
as 1 mg/ml in cell culture H20 (ccH20), aliquoted and frozen until use. A working
concentration of 50 µg/ml (1:20 dilution) poly-L-lysine in ccH20 was made up on the
day of use. 11 mm diameter glass coverslips (VWR International LTD) were incubated
in the 50 µg/ml poly-L-lysine for 1 hr in 35 mm dishes (Corning) and washed three
times with 2 ml of ccH20 before use.
2.1.1.2 HEK293 cell culture solutions
HEK293 cell culture medium was composed of DMEM:F12-HAM 1:1 supplemented
with 10% FCS, 2 mM L-glutamine, and penicillin/streptomycin (Invitrogen).
Trypsin/EDTA (1x) was obtained as a solution (Sigma) and used directly. HEK293
cryopreservation medium was composed of DMEM F12: HAM 1:1 supplemented with
20% FCS, 2 mM L-glutamine and 10% dimethyl sulfoxide (DMSO).
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2.1.1.3 Electrophysiology and pharmacology
The extracellular solution (ECS) was made up of (mM): NaCl, 145; KCl, 4; MgCl2, 1;
CaCl2, 1.3; HEPES, 10; glucose, 5; pH adjusted to 7.3 with aq. NaOH. The intracellular
pipette solution (ICS) was made up of (mM): K-gluconate, 130; KCl, 5; MgATP, 2;
Na2ATP, 2; Na3GTP, 0.3; Na2Phosphocreatine, 10; HEPES, 5; EGTA, 1; pH adjusted
to 7.2 using aq. KOH.
Drug stocks: With the exception of wortmannin and LY294002, which were added to
the neuronal culture medium prior to patch-clamp recording, and diC8PIP2, which was
added to the intracellular pipette solution, all drugs were dissolved in AP and added
through the bath perfusion system. Dendrotoxin-K (DTX-K) and tityustoxin-Kα (TsTx) 
were obtained from Alomone Labs and made up as a stock solution in ddH2O at 50 µM
and 100 µM, respectively. Toxins were stored at -20°C before dilution in ECS (100 nM)
for patch-clamp recordings. Wortmannin (Santa Cruz Biotechnology) was prepared as a
1 mM stock in ddH2O and stored at -20⁰C before dilution to 100 nM or 10 µM in
neuronal cell culture medium. LY294002 was prepared as 10 mM stock in ddH2O and
stored at -20°C before added to neuronal cell culture medium (5 µM). Oxotremorine-M
(Oxo-M) and m-3M3FBS were prepared as 10 mM stocks in ddH20and stored at -20⁰C
before dilution to the appropriate concentration in ECS. XE991 (Tocris Bioscience) was
prepared as 1 mM stock in ddH2O stored at -20⁰C and dilution to the appropriate
concentration in ECS on the day of use. PIP2 binding peptides and their analogues:
PIP2-PP, Fluoro-PP and PolyK-PP (generous gifts from Dr Jon Robbins, Kings College
London), were obtained as a 10 mM stock solution, aliquoted into single use aliquots
and stored at -20⁰C until use. The Non-Pal PIP2 Peptide and Neutral-PP analogues were
obtained from Biomatik and made up as a stock solution in ddH2O at a concentration of
10 mM before being aliquoted and stored at -20⁰C until use. Commercial fatty acids,
obtained from Sigma Aldrich, were made up as a stock solution in DMSO at a
concentration of 100 mM before being aliquoted, frozen and stored until use. Fatty acids
were then diluted in bath solution as required. Aromatic fatty acids were synthesised as
described below, made up as a stock solution in DMSO at a concentration of 100 mM
before being aliquoted, frozen and stored until use.
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2.1.2 Animals
The present study was carried out on Sprague Dawley rats (P2–P12) and C57BL6 mice
(P4-P21) of either sex, reared at University College London. All procedures were
carried out in accordance with the United Kingdom Animals (Scientific Procedures) Act
of 1986, and were approved by the UCL Animal Ethics Committee. Animals were
killed by inhalation of CO2 and cervical dislocation.
2.2 Methods
2.2.1 Immunofluorescence of cochlear tissue
P2–P12 rats were killed by inhalation of CO2. The rats were decapitated and the
cochleae were exposed by hemisection of the cranium in ice cold artificial perilymph.
They were fixed in a solution of 4% paraformaldehyde in PBS for 1-2 hrs at room
temperature or left overnight at 4°C. P2 cochleae could be sliced directly but P6 and
P12 were rat cochleae were decalcified in an EDTA solution for 24 hrs prior to being
sliced on a vibrating blade microtome (Vibratome Series 1000 Plus, Intracel Ltd).
Block and permeabilisation of slices was achieved by incubation with 10% goat serum
and 0.1% Triton in PBS for 40 mins at room temperature. The slices were labelled using
primary antibodies: rabbit polyclonal anti-Kv1.1 antibodies and mouse monoclonal anti-
acetylated tubulin antibodies obtained from Alomone and Sigma respectively. These
were used at a 1:400 and a 1:1000 dilution respectively, in 0.1 M lysine and 0.1% Triton
overnight at 4°C. Primary antibody labelling was visualised using Alexa Fluor-coupled
secondary antibodies. Following washes in PBS, primary antibody labelled slices were
incubated in secondary antibodies: goat-anti rabbit Alexa488 (Invitrogen) and goat anti-
mouse Alexa555 (Invitrogen) antibodies were used to visualise the primary antibodies
and phalloidin-Alexa633 was used to visualise actin. This was carried out in 0.1 M
lysine and 0.1% Triton in PBS for 1 hr at room temperature. The slices were then
washed 3 times in PBS before being mounted on glass slides with a ground cavity and
overlaid with a coverslip in Vectashield with DAPI (Vector Labs, Peterborough, UK).
Imaging was carried out using a laser scanning confocal microscope (LSM510; Carl
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Zeiss MicroImaging). Z-stack confocal images were acquired at 2-3 µm intervals and 5-
6 images were acquired per stack. Image processing and analysis were performed on
images derived from each Z-stack series using Zeiss LSM Image Browser and ImageJ.
Images were imported into Inkscape (Inkscape.org, Version 0.48) for optimal contrast
and brightness. All images were oriented with the modiolus at the left hand side for
comparison.
2.2.2 HEK293 cell handling and transfection
2.2.2.1 HEK293 cell maintenance
HEK293 cells, obtained from Sigma Aldrich, were cultured in a 25 cm2 flask containing
5 ml of HEK293 cell culture medium. Cells were maintained in a humidified incubator
at 37⁰C and 5% CO2. When cells reached ~90% confluence they were passaged into a
new 25 cm2 flask. To passage, cells were washed once with PBS and then incubated
with ~0.5 ml trypsin/EDTA for 1-5 mins until cells fully detached from the flask. The
enzymatic reaction was quenched by addition of 4 ml HEK293 cell culture medium and
the cells were further dissociated by gentle trituration through a pipette. 0.5 ml of the re-
suspended cells was added to 4.5 ml of fresh HEK293 cell culture medium in a new flask.
2.2.2.1 Transient transfection of HEK293 cells
Rat cDNAs of Kv1.1 and Kv1.2 (a generous gift from Dr Martin Stocker, UCL), were
cloned into pcDNA3 (Invitrogen) by Dr. Katie Smith. Accession numbers: Kv1.1
(Kcna1), NM_173095; Kv1.2 (Kcna2), NM_012970. 1-2 days before transfection, cells
were plated in 35 mm dishes to obtain a density of ~80%. A total of 2.5 µg of the DNA
(see Table 1) was pre-incubated with the transfection reagent, Lipofectamine 2000
(Invitrogen) for 15 mins. The 2.5 µg DNA was made up to 1.2 µg of pcDNA3
containing either Kv1.1 (pcDNA-Kv1.1) or Kv1.2 (pcDNA-Kv1.2); 1.2 µg of the empty
pcDNA3 or the alternate pcDNA-Kv1.1/ pcDNA-Kv1.2 and finally 0.14 µg of plasmid
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DNA containing EGFP to visualise transfected cells. Table 1 show the possible
permutations.
Table 2.1 Transient transfection of HEK293 cells with Kv1 DNA
Kv channel expression Kv1.1 DNA (µg) Kv1.2 DNA (µg) pcDNA3 (µg) EGFP (µg)
Homomeric Kv1.1 1.2 0 1.2 0.14
Homomeric Kv1.2 0 1.2 1.2 0.14
Heteromeric Kv1.1/1.2 1.2 1.2 0 0.14
After 4 hrs, the Opti-MEM media and transfection complex were replaced with normal
growth medium. After 18 hrs, cells were trypsinised and re-plated onto 11 mm glass
coverslips at low density. After a short recovery (~3 hrs), coverslips with transferred to
a recording chamber for patch-clamp recordings.
2.2.2.2 Stable transfection of HEK293 cells with Kv1.2 DNA
In order to create a stable Kv1.2 expressing cell line, transiently transfected HEK293
cells were exposed to positive selection by the antibiotic G418 (Geneticin). Positive
selection was possible because of the neomycin selection marker present in pcDNA3. In
order to determine the optimal selection dose, G418 was titrated against untransfected
HEK293 cells. HEK293 cells were plated in a 24 well plate and exposed to
concentrations of G418 between 50 and 1000 mg/ml which exhibited effective
cytotoxicity at concentrations above 500 mg/ml.
HEK293 cells transiently transfected with pcDNA-Kv1.2 as described above (but
without empty pcDNA3 or EGFP) were trypsinised and re-plated into a 6 well plate
(Corning), with one well containing untransfected HEK293 cells (Control). Cells were
incubated in standard HEK293 cell culture medium supplemented with 500 mg/ml
G418 until all cells in control well had died (~5 days) and visible colonies appeared in
the transfected wells (~1-2 weeks). Small colonies (<100 cells) were isolated,
trypsinised and re-plated into 24 well plates at a density of ~1-2 cells per well and
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maintained in standard HEK293 cell culture medium. 24 well plates were monitored
closely for the appearance of monoclonal colonies. Selected colonies were trypsinised
and seeded to a 35 mm dish, where their electrophysiological properties were examined
for Kv1.2 currents. Once the presence of Kv1.2 currents was confirmed, cells were
seeded to a 25 cm2 flask where they were maintained as above.
2.2.2.3 Cryopreservation of HEK cells
For freezing, cells were grown to near confluency in a 75 cm2 flask. Cells were washed
once with PBS and then incubated with ~1 ml trypsin/EDTA for 1-5 mins until cells
fully detached from the flask. Cells were subsequently resuspended in 5 ml of HEK293
cell culture medium. To quantity the approximate total number of cells, 10 µl of the cell
suspensions was removed, diluted 1/10 and enumerated in a counting chamber. Cells
were centrifuged at 1000 rpm for 3 min and the pellet was resuspended in HEK293
cryopreservation medium to a concentration of 3x106 cells/ml. Aliquots of 3 million
cells were apportioned to individual cryo-vials and placed into a Nalgene cryo container
containing propan-2-ol. Cryo-vials and propanol container were stored in a -80⁰C
freezer overnight then transferred into liquid N2 for long term storage.
2.2.3 Dissociated spiral ganglion neuron preparation
Several preparations of dissociated neuronal cultures have been described previously
(Whitlon et al., 2006, Chen, 1997, Santos-Sacchi, 1993) and our method is similar to
those reported. Cultures were prepared from P12-P21 mice. Following decapitation, the
cochleae were exposed by hemisection of the midsagittal plane of the cranium. The
outer cochlear capsule was removed, followed by the peeling off of the lateral wall and
the removal of the spiral limbus and the OC. The whole dissected ganglia were divided
into thirds along the cochlear spiral to give apical, mid and basal derived tissues which
were digested separately in 10 µl 0.25% Trypsin/PBS for 30 mins at 37⁰C in a small
falcon tube. Digestion was ceased by addition of neuronal cell culture medium. The
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digested tissue was mechanically dissociated using a P1000 pipette, triturating the
cellular suspension 10-12 times. The suspension was centrifuged at 2000 rpm for 10
mins, the supernatant removed, and the cells resuspended in neuronal cell culture
medium. 30 µl of the cell suspension was administered onto each poly-L-lysine coated
glass coverslip and placed inside 35 mm petri dishes. These were then incubated at
37°C and 5% CO2 levels for 2 hrs to allow the cell suspension to settle and adhere to the
coverslips. 2 ml of neuronal cell culture medium was then added to the 35 mm dish,
supplemented with BDNF to a final concentration of 20 ng/ml. The cultures were
subsequently incubated at 37°C and 5% CO2 levels for 2-3 days during which time the
neurons shed their myelin coating.
2.2.4 Electrophysiology
Recordings from SGNs and HEK293 cells were carried out in whole-cell configuration
using a patch clamp amplifier (Axo-patch 200B; Axon Instruments) and a Digidata
board (Axon Instruments) under the control of computer software (pClamp version 8;
Axon Instruments). Cells were visualised using an upright microscope (E600FN, Nikon,
Tokyo, Japan) equipped with a x40 water-immersion objective. Patch clamp recordings
were performed under infrared differential interference contrast (IR-DIC) video-
microscopy, using a CCD video camera and IR-DIC optics mounted on the microscope.
Patch pipettes were fabricated on a vertical two-stage puller (Narishige, PC-10) from
borosilicate capillary tubes (GC120TF-10; Harvard Apparatus), coated with molten ski
wax and positioned using a piezoelectric micromanipulator (PCS-5000 Series, exfo-
lifesciences). The pipette resistance was 2.5-4.6 MΩ when measured in the bath 
solution. All drugs were applied to the cell bath directly by perfusion using a Gilson
MINIPULS® 3 peristaltic pump. Capacitance transients were cancelled online and series
resistance was compensated 70% in order to limit the voltage error. Series resistance
typically was around 3-10 MΩ, and recordings which exceeded series resistance of 15 
MΩ were rejected. Leak currents were not subtracted for SGN recordings; leak 
subtraction using a P/4 method was routinely performed as part of whole cell recordings
from HEK293 cells. Measurement of membrane voltage was carried out in the ‘fast’
current clamp mode of the amplifier. All experiments were carried out at room
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temperature (20-25oC). The liquid junction potential was measured using a KCl salt
bridge filled with 3 M KCl. Liquid junction potential was measured at -13 mV and
subtracted offline.
2.2.5 Data analysis and statistics
Analysis was performed using Clampfit (Axon Instruments), and Igor (WaveMetrics
Inc.). The voltage dependence of activation was calculated by fitting conductance-
voltage data with the Boltzmann function:
Gnorm = Gmin + (Gmax - Gmin)/(1 - exp((V1/2 + Vm)/k))
where G is conductance, V1/2 is the half-maximal activation, Vm is the membrane
potential, and k is the slope. Single exponential fitting, where used, took the form:
y = Aexp(-x/τ) 
where x is time and τ is the time constant. Statistics were performed on Origin software 
(version 9, Microcal Software Inc.) with a P-value less than 0.05 considered significant.
2.2.5 Chemistry
2.2.5.1 General
All starting materials were commercially available from Sigma Aldrich. Reactions were
monitored by thin-layer chromatography (TLC) on silica gel plates (60 F254, Merck),
visualizing with ultraviolet light and by liquid chromatography-mass spectrometer
(LCMS). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker
Avance III 600 Cryo (600 MHz). 1H NMR chemical shifts are reported in parts per
million downfield from tetramethylsilane. Accurate Mass was reported by UCL
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Chemistry Mass Spectrometry Facility. All compounds were at least 95% pure as
assayed by LCMS (electrospray +ve).
2.2.5.2 General synthesis for 1,2,3-triazole fatty acids
To a solution of the bromoalkane (1.1 eq., 0.4 mmol) in methanol (2 ml) was added the
alkyne (1.0 eq., 0.36 mmol), sodium azide (2.0 eq., 0.8 mmol, 56 mg) and Copper oxide
(0.1 eq., 0.04 mmol, 6 mg). The contents were reacted at 40⁰C overnight before the
methanol was removed under reduced pressure. The precipitate was redissolved in
EtOAc, and the pH adjusted to ~3 using before the addition of ddH2O (10 ml). The
mixture was extracted three times with EtOAc (5ml) and the combined organic phases
were extracted further with brine (10 mL), dried over magnesium sulphate (1 g), filtered
and concentrated under reduced pressure.
2.2.5.2.1 LPB-01 [4-(1-pentyl-1H-1,2,3-triazol-4-yl)butanoic acid]
Appearance: Waxy solid (yield 15%);  δH (600 MHz, Acetone-d6) 0.89 (t, 3H, CH3),
1.29 (dt, 2H, CH2), 1.35 (m, 2H, CH2), 1.89 (m, 2H, CH2), 1.95 (m, 2H, CH2), 2.38 (t,
2H, CH2), 2.74 (t, 2H, CH2), 4.37 (t, 2H, CH2N), 7.77 (s, 1H, aromatic); δC (75.5 MHz,
Acetone-d6) 173.529, 146.653, 121.353, 49.577, 33.038, 31.755, 29.956, 28.244,
24.566, 24.669, 14.349; Monoisotopic Mass (EI); Calculated (C11H19N3O2): 225.1477,
Found: 224.5925 (M-1).
2.2.5.2.2 LPB-02 [3-(1-pentyl-1H-1,2,3-triazol-4-yl)propanoic acid]
Appearance: Waxy solid (yield 17%);  δH (600 MHz, Acetone-d6) 0.87 (t, 3H, CH3),
1.28 (m, 2H, CH2), 1.34 (m, 2H, CH2), 1.87 (m, 2H, CH2), 2.69 (t, 2H, CH2), 2.95 (t,
2H, CH2), 4.35 (t, 2H, CH2N), 7.73 (s, 1H, aromatic); δC (75.5 MHz, Acetone-d6)
174.137, 146.998, 122.362, 51.881, 34.202, 32.090, 29.995, 22.959, 21.688.
Monoisotopic Mass (EI); Calculated (C10H17N3O2): 211.1321, Found: 212.1396 (M+1).
2.2.5.2.3 LPB-03 [10-(4-pentyl-1H-1,2,3-triazol-1-yl)decanoic acid]
Appearance: Waxy solid (yield 42%);  δH (600 MHz, DMSO-d6) 0.91 (t, 3H, CH3) 1.25-
1.50 (m, 16H, 8xCH2), 1.65 (m, 2H, CH2), 1.88 (m, 2H, CH2), 2.66 (t, 3H, CH2), 3.27 (t,
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3H, CH2), 4.34 (t, 3H, CH2), 7.72 (s, 1H, aromatic); δC (75.5 MHz, Acetone-d6)
179.929, 148.478, 120.583, 50.339, 34.489, 32.044, 31.083, 30.398, 29.892, 28.792,
28.236, 26.787, 25.635, 22.721, 22.667,19.473, 14.331. Monoisotopic Mass (EI);
Calculated (C17H31N3O2): 309.2416, Found: 310.2480 (M+1).
2.2.5.2.4 LPB-04 [4-(1-tetradecyl-1H-1,2,3-triazol-4-yl)butanoic acid]
Appearance: Waxy solid (yield 37%);  δH (600 MHz, DMSO-d6) 0.88 (t, 3H, CH3),
1.25-1.50 (m, 22H, 11xCH2) 1.59 (m, 2H, CH2), 1.85 (m, 2H, CH2), 3.33 (t, 2H, CH2),
3.47 (t, 2H, CH2), 4.35 (t, 2H, CH2N), 7.71 (s, 1H, aromatic); δC (75.5 MHz, DMSO-d6)
179.053, 147.958, 123.632, 51.603, 34.226, 33.542, 33.080, 32.811, 32.156, 31.928,
31.075, 30.420, 29.610, 29.282, 29.127, 28.304, 26.506, 24.663, 18.125, 14.886.
Monoisotopic Mass (EI); Calculated (C20H37N3O2): 379.3199, Found: 380.3271 (M+1)
2.2.5.2.5 LPB-05 [10-(4-decyl-1H-1,2,3-triazol-1-yl)decanoic acid]
Appearance: Waxy solid (yield 54%);  δH (600 MHz, DMSO-d6) 0.87 (t, 3H, CH3),
1.25-1.50 (m, 26H, 13xCH2) 1.63 (m, 2H, CH2), 1.86 (m, 2H, CH2), 2.35 (m, 2H, CH2),
2.65 (t, 2H, CH2), 4.30 (t, 2H, CH2N), 7.25 (s, 1H, aromatic); δC (75.5 MHz, DMSO-d6)
174.837, 148.609, 121.883, 51.945, 34.816, 34.192, 33.613, 33.231, 32.644, 31.024,
30.728, 30.253, 30.033, 29.787, 29.081, 28.778, 28.022, 27.380, 26.650, 26.161,
23.124, 14.900. Monoisotopic Mass (EI); Calculated (C22H41N3O2): 379.3199, Found:
380.3271 (M+1)
2.2.5.2.6 LPB-06 [9-(1-tetradecyl-1H-1,2,3-triazol-4-yl)nonanoic acid]
Appearance: Waxy solid (yield 59%); 0.86 (t, 3H, CH3), 1.25-1.50 (m, 30H, 15xCH2)
1.67 (m, 4H, 2CH2), 1.86 (m, 2H, CH2), 2.29 (m, 2H, CH2), 2.69 (t, 2H, CH2), 4.29 (t,
2H, CH2N), 7.24 (s, 1H, aromatic); δC (75.5 MHz, Acetone-d6) 174.475, 147.403,
120.993, 50.977, 35.004, 34.232, 33.661, 33.737, 33.654, 31.534, 31.238, 30.980,
30.743, 30.549, 30.091, 29.872, 29.512, 29.101, 28.551, 27.110, 26.789, 26.589,
26.311, 23.131, 14.498. Monoisotopic Mass (EI); Calculated (C25H47N3O2): 421.3668,
Found: 422.3730 (M+1)
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Chapter 3
A molecular basis for the heterogeneous excitability of
SGNs in post-hearing onset mice
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3.1 Introduction
3.1.1 Investigating the heterogeneity of the auditory nerve
ANFs display significant heterogeneity in their activity and response to sound stimuli.
Fibres differ in their frequency tuning, sound threshold of activation, spontaneous spike
rate and dynamic range (Kiang et al., 1965, Evans, 1972, Liberman and Kiang, 1978,
Heil and Peterson, 2015). This heterogeneity allows the cochlea to encode the full range
of acoustic information in terms of frequency/pitch and loudness. The first successful in
vivo recordings from individual ANFs were achieved by Tasaki in 1954 from
anaesthetised guinea-pigs (Tasaki, 1954). This study and subsequent investigations into
the activity of ANFs typically involved positioning a high resistance electrode close to
the nerve exiting the cochlea, and recording their responses to sound stimuli (Borg et
al., 1988, Evans, 1972, Kiang et al., 1965, Tasaki, 1954). Subsequently, recordings from
IHC afferent synapses were also achieved by the opening of the otic capsule and
insertion of the electrode close to the IHC synapse (Palmer and Russell, 1986, Siegel
and Dallos, 1986, Siegel, 1992). These studies revealed important insights into the
spontaneous and sound evoked activity of the AN in vivo. Nonetheless, a
comprehensive understanding of the physiology of the AN also requires knowledge of
the molecular electrophysiology and intrinsic membrane properties of the constituent
SGNs. To this end, the structure and organisation of the cochlea has so far precluded in
vivo patch clamp recordings from SGNs within the AN. However a wealth of
information has been gleaned from in vitro studies, using a variety of tissue preparations
to examine the properties of isolated neurons. These include mechanically isolated
neuronal preparations (Santos-Sacchi, 1993), gangliotopic preparations (Mo and Davis,
1997) and preparations where the cochlea was sectioned and patched in situ (Jagger et
al., 2000).
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3.1.2 The intrinsic excitability of isolated spiral ganglion neurons
The first successful patch clamp recordings from SGNs were achieved in 1993 by Joe
Santos-Sacchi. SGNs from adult guinea pigs were obtained non-enzymatically by
crushing the cochlear modiolus and triturating in a nominally Ca2+ free medium.
Neurons were plated on glass coverslips and incubated until they were observed to have
lost their myelin sheath (~10 mins). Whole-cell patch clamp recordings showed the
presence of fast inward tetrodotoxin (TTX)-sensitive Na+ currents and somewhat slower
outward K+ currents. Brief current injections produced graded APs with an after
hyperpolarisation that lasted several milliseconds (Santos-Sacchi, 1993). Subsequent
work by Chu Chen in 1997, using the same preparation, identified a significant inward,
non-inactivating current in response to hyperpolarizing voltage steps. Likewise, Chen
demonstrated notable depolarising sag in the membrane voltage during hyperpolarizing
current injections. This also resulted in an overshoot or a rebound firing upon
termination of the current injection (Chen, 1997).
Consistent with the large diversity in responses from fibres within the AN in vivo, SGNs
were also found to display intrinsic variability in their firing properties in vitro. The first
reports of the heterogeneous nature of SGN membrane properties were published
independently in studies by Xi Lin, and Mo and Davis. Whole-cell recordings from P0-
1 gerbil (Lin, 1997) displayed either single APs or trains of actions potentials in
response to sustained current injections. Mo and Davis reported similar findings in
SGNs which had been explanted and cultured from P1-6 mice (Mo and Davis, 1997).
The variation was classified broadly into two categories based on a neurons ability to
“adapt” to the depolarising stimulus. Adaptation can be defined as a decline in neuron
firing rate in response to constant current injection (Granit et al., 1963). Neurons were
described as rapidly adapting (RA) or slowly adapting (SA) based on the number of
APs fired over a period of depolarizing current injection. Further work from the same
group also showed that SGNs from postnatal mice (P3-P8) displayed firing features
which were related to their original position along the tonotopic axis (Adamson et al.,
2002b). Interestingly, this heterogeneity could not be replicated in enzymatically
isolated guinea pig SGNs which displayed only RA responses to current injection
(Szabo et al., 2002).
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Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3), two
neurotrophins released during early development and expressed differentially in the
cochlea, are also important determinants of firing behaviour (Adamson et al., 2002a). In
early postnatal development (P3-P8) BDNF exposure favours an RA phenotype while
NT-3 exposure produces cells with SA characteristics. This tonotopic dependence and
neurotrophic influence on firing phenotype was correlated with differences in the
densities of important ion channel such as KCa, Kv1.1, Kv4.2 and Kv3.1 (Adamson et
al., 2002a, Adamson et al., 2002b). A vast array of ion channels are now known to
contribute to the firing features observed in mammalian SGN, including many different
Cav, Navs and hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels, as
well as Kv7, Kir and others (see Table 3.1 for a comprehensive list).
A significant technical advance has been the ability to make patch clamp recordings in
situ. A technique for slicing the rat cochlea around the onset of hearing was developed
by Jagger and Housley in 2000. This allowed whole-cell patch clamp recordings to be
made from acutely prepared rat SGNs without the need for tissue explant or dissociation
(Jagger et al., 2000). This helps maintain the SGN and their peripheral and central
neurites that are typically lost during trituration and explant. Furthermore, this technique
allowed Lucifer yellow labelling of SGNs and their peripheral projections to provide
post-hoc identification of type I and type II fibres (Jagger and Housley, 2003).
Despite much characterisation of the electrophysiological properties of early postnatal
SGNs (Adamson et al., 2002b, Jagger et al., 2000, Lin, 1997, Mo and Davis, 1997,
Szabo et al., 2002), the characterisation of the firing properties of SGNs from animals
post-onset of hearing has been somewhat ignored. Though the initial work from Santos-
Sacchi and Chen did record from adult SGNs, little characterisation of the firing
features was carried out. Apart from the notable exception of Lv et al. in 2010, which
examined mice as old as 17 months, little investigation into the firing properties of
SGNs from post-hearing onset animals has been conducted (Lv et al., 2010).
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Table 3.1 Ion channels in the spiral ganglion. Abbreviations: BK, large-conductance calcium-
activated potassium channel; HCN, hyperpolarisation-activated cyclic nucleotide-gated channel;
SK, small conductance calcium-activated potassium channel; TASK, two-pore-domain channel;
THIK, tandem pore domain halothane-inhibited K+ channel; MAP, microtubule-associated
protein channel; MBP, myelin basic protein; SGN, neuronal soma; Ax, axon; M, myelin; LM,
loose myelin; SC, satellite cells; NSC, non-myelinating Schwann cells; MSC, myelinating
Schwann cells; P, postnatal; A, adult; E, embryonic; EP electrophysiology; I,
immunocytochemistry; ISH, in situ hybridisation; R, polymerase chain reaction of RNA; W,
Western blot. (Adapted from (Davis and Crozier, 2015)
Ion
channel
Location Age/species Method Reference
BK SGN E, P, A/Mouse;
A/Guinea pig
EP, I, ISH,
R
(Chen and Davis, 2006, Hafidi et al., 1992,
Langer et al., 2003, Skinner et al., 2003,
Adamson et al., 2002a)
BKβ1  SGN P/Rat ISH, R (Langer et al., 2003)
BKβ4 SGN P/Rat ISH, R (Langer et al., 2003)
CaV1.2 SGN,
NSC,
MSC
P, A/Mouse;
A/Chinchilla;
A/Guinea pig
EP, I, R (Chen et al., 2012, Chen et al., 2011,
Layton et al., 2005, Lin, 1997, Xie et al.,
2007, Zuccotti et al., 2013, Lopez et al.,
2003)
CaV1.3 SGN P, A/Mouse; P,
A/Rat
EP, I, W, R (Chen et al., 2012, Chen et al., 2011, Lv et
al., 2014, Lv et al., 2012)
CaV2.1 SGN,
NSC,
MSC
P, A/Mouse;
A/Chinchilla
EP, I, R (Chen et al., 2011, Lopez et al., 2003, Lv
et al., 2012)
CaV2.2 SGN P, A/Mouse;
A/Chinchilla
EP, I, R (Chen et al., 2011, Lopez et al., 2003, Lv
et al., 2012)
CaV2.3 SGN,
NSC,
MSC
P, A/Mouse;
A/Chinchilla
E, I, R (Chen et al., 2011, Lopez et al., 2003, Lv
et al., 2012)
CaV3.1 SGN,
NSC,
MSC
P, A/Mouse EP, I, R (Chen et al., 2011, Lv et al., 2012)
CaV3.2 SGN P, A/Mouse EP, I, R (Chen et al., 2011, Lv et al., 2012)
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CaV.3.3 SGN P, A/Mouse EP, I, R (Chen et al., 2011, Lv et al., 2012)
HCN1 SGN P, A/Mouse;
A/Guinea pig
EP, I, W (Kim and Holt, 2013, Liu et al., 2014b, Yi
et al., 2010, Bakondi et al., 2009)
HCN2 SGN P, A/Mouse;
A/Guinea pig
EP, I, R, W (Bakondi et al., 2009, Kim and Holt, 2013,
Yi et al., 2010)
HCN3 SGN A/Guinea pig I, W (Bakondi et al., 2009)
HCN4 SGN P, A/Mouse;
A/Guinea pig
EP, I, R, W (Bakondi et al., 2009, Kim and Holt, 2013,
Liu et al., 2014a, Yi et al., 2010)
KV1.1 SGN, SC,
Ax
P, A/Mouse;
A/Guinea pig
EP, I, R, (Adamson et al., 2002a, Chen and Davis,
2006, Liu et al., 2014a, Mo et al., 2002,
Reid et al., 2004, Bakondi et al., 2008,
Wang et al., 2013, Smith et al., 2015)
KV1.2 SGN, SC,
Ax
P/Mouse;
A/Guinea pig
EP, I (Liu et al., 2014a, Bakondi et al., 2008,
Wang et al., 2013, Smith et al., 2015)
KV3.1 SGN P, A/Mouse;
A/Guinea pig
I, R (Chen and Davis, 2006, Adamson et al.,
2002a, Bakondi et al., 2008, Smith et al.,
2015)
KV3.3 SGN P/Mouse I, R (Chen and Davis, 2006)
KV4.2 SGN P, A/Mouse;
A/Guinea pig
I, R (Chen and Davis, 2006, Adamson et al.,
2002a, Bakondi et al., 2008)
KV7 SGN P, A/Mouse EP, I, R (Beisel et al., 2005, Lv et al., 2010)
Kir SC, NSC P, A/Rat I, R (Hibino et al., 1999)
NaV1.1 SGN A/Rat I, R (Fryatt et al., 2009)
NaV1.6 SGN A/Mouse & Rat I, R (Fryatt et al., 2009, Hossain et al., 2005)
NaV1.7 SGN A/Rat I, R (Fryatt et al., 2009)
SK1 Absent or
below
detection
P, A/Rat ISH (Dulon et al., 1998)
SK2 SGN P, A/Rat ISH (Dulon et al., 1998)
SK3 SGN P, A/Rat ISH (Dulon et al., 1998)
TASK-1 P/Mouse R (Chen and Davis, 2006)
TASK-3 P/Mouse R (Chen and Davis, 2006)
THIK-2 P/Mouse R (Chen and Davis, 2006)
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TRAAK P/Mouse R (Chen and Davis, 2006)
TREK-1 P/Mouse R (Chen and Davis, 2006)
TWIK1 SGN P/Mouse I, R (Chen and Davis, 2006)
MAP2 SGN P/Mouse;
A/Human; P,
A/Rat
I (Anniko et al., 1995, Chen et al., 2011,
Hafidi et al., 1992)
MBP MSC P, A/Rat;
A/Guinea pig
I (Toesca, 1996, Liu et al., 2014c)
Characterisation of the mature neurons is essential to determine if the features observed
in immature SGNs are relevant to the working ear, and not just a feature of
development. For instance, in the mammalian cochlea before the onset of hearing, IHCs
fire spontaneous APs that are believed to be vital for the development of the higher
auditory system. However, these APs are not characteristic of IHCs in the mature
sensory system (Johnson et al., 2011). Further, SGN electrophysiology is highly plastic.
BDNF and NT-3 expression, which notably alter firing in SGNs (Davis, 2003), varies
over the course of development with SGNs likely experiencing changing humoral cues
up to and past the post-hearing onset (Fritzsch et al., 2004). In this chapter, the firing
properties of post-hearing onset SGNs were investigated. Initial work focused on
determining a practical neuronal preparation in order to facilitate robust and stable
recordings. Proceeding work then investigated the firing properties of mature SGNs,
and examined the ionic properties which underlie differences in firing. Ultimately, this
chapter attempts to elucidate the molecular components underlying differences in firing
behaviour between SGNs originating from common locations in the cochlea.
3.2 Results
3.2.1 Identifying SGN subtypes in a dissociated ganglion preparation
To investigate the electrophysiology of mature SGNs from post-hearing onset animals,
isolated sections of the spiral ganglion derived from apical, mid and basal thirds of the
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cochlea from mice around the age of hearing onset (P12-15) and one week post-onset
(P20-21) were dissociated using enzymatic and mechanical treatment followed by cell
culture. These “neuronal cultures” contained a variety of cell types derived from the
cochlea. Morphologically, SGNs were identifiable by their large, round cell body,
asymmetric nucleus and single large nucleolus (Figure 3.1A-C; Neurons identified by
*). The neuronal identity of SGNs was confirmed by their ability to fire APs in response
to depolarisation current injection. Consistent with reports from pre-hearing animals,
voltage clamp recordings from mature SGNs showed large inward Na+ transients,
significant outward K+ currents and a slowly activating hyperpolarisation-activated
inward currents (Figure 3.1D) (Santos-Sacchi, 1993). The majority of these recordings
are assumed to come from type I SGNs. Although type II SGNs cannot be
unambiguously distinguished from type I SGN without post hoc labelling to ascertain
their innervation patterns, a small minority of cells displayed morphology and ionic
conductances consistent with the characterised electrophysiology of type II neurons
(Jagger and Housley, 2003). Putative type II SGNs were physically smaller (Figure
3.1B, 5-9 pF, n = 3) than type I SGNs (Figure 3.1A, 5-43 pF n = 82). They also
displayed lower K+ current amplitudes, slower activation kinetics and more prominent
inactivation of their outward K+ currents (Figure 3.1E). As type I SGNs are the focus of
this study putative type II SGNs, once identified, were excluded from further analysis.
Within these cultures some neurons with very large somata and extensive processes
were observed (Figure 3.1C, G). These neurons have been reported elsewhere (Mo and
Davis, 1997, Jagger and Housley, 2003) and have variously been suggested to
correspond to large cell type II neurons (Berglund and Ryugo, 1987) or to the
speculative type III neurons reported in an ultrastuctural study by Romand and Romand
(Romand and Romand, 1987). These neurons often possessed somata with a measured
whole cell-capacitance (Cm) of 30 pF or higher, and shared common
electrophysiological characteristics such as the activation of very large outward K+
currents (often >20 nA) and the generation of spontaneous APs. Other cell types
observed in the preparation were glial like cells (Hansen et al., 2001). These were
morphologically distinct by their elliptical soma and bipolar morphology and can be
seen on the right of Figure 3.1A.
73
Figure 3.1 Voltage activated currents from cultured P12 SGNs. Enzymatically dissociated
SGN cultures contained a variety of cell types derived from different tissues within the cochlea.
SGNs, labelled here by *, have large, round cell bodies, asymmetric nuclei and single large
nucleoli. A Type I SGNs, as expected, make up the majority of cultured neurons. Also visible
are putative glial cells, characteristic by their small oval soma and bipolar morphology. B Type I
SGNs display large inward Na+ transients, slowly or non-inactivating outward K+ currents and
hyperpolarisation-activated inward currents. C DIC image of a putative Type II SGN in culture.
Type II SGN make up 5-10% of neurons in vivo and cannot be distinguished by morphology
alone but were typically smaller than Type I SGNs. D Type II SGNs have distinctly lower current
magnitudes, slower activation kinetics and increased inactivation of their outward K+ currents. E
Large cell SGNs were a subpopulation observed in neuronal cultures defined here as a cell with
Cm >25pF. F “Large cell” SGNs exhibited large inward Na+ transients and large non-inactivating
outward K+ currents (both often exceeding 20 nA). Scale bar: 10 µM for all images.
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3.2.2 Heterogeneous firing properties of post-hearing onset SGNs
In order to investigate the firing properties of SGNs, whole-cell current clamp
recordings were made from the soma of cultured SGNs. Neurons were held at a
potential of -73mV and APs were evoked by depolarising current injection. In total, 85
recording of SGNs firing responses were successful obtained. Consistent with previous
observations from pre-hearing SGNs (Mo and Davis, 1997), a broad range of firing
properties were observed in response to injected depolarising current. Neurons either
fired a single AP in response to the injected current i.e. adapting rapidly to the stimulus,
or fired multiple APs i.e. adapting more slowly or not at all (Figure 3.2B). Spontaneous
APs were also observed in a number of cells in the absence of a depolarising stimulus.
Figure 3.2A shows the distribution of firing responses observed across all recordings for
a single 200 ms current injection of +100 pA. SGNs from both age groups and all three
tonotopic regions displayed these diverse firing properties, suggesting the tonotopic
determination of firing type observed in early postnatal animals (Adamson et al., 2002b)
is not maintained beyond the onset of hearing. In this chapter no distinction was made
between neurons that adapted slowly and neurons that failed to adapt at all e.g. Figure
3.2B, lower trace; all neurons that fired >1 AP in response to +100 pA injection were
classified as SA. This is in line with most studies (Mo and Davis, 1997, Adamson et al.,
2002b). However, further demarcation of the SA classification into slowly and non-
adapting phenotype is carried out in the next chapter.
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Figure 3.2 Heterogeneous excitability in populations of SGNs cultured from post-hearing onset mice. A Scatter-plot of the number of APs
(#APs) in response to a depolarizing current injection versus the Cm. 200 ms current injections of +100 pA were applied from a holding potential of -73
mV (n = 85). B Firing responses of two neurons. Neurons display different responses to injected current, requiring different quantities of current to
stimulate an AP and display varying ability to adapt to sustained current injections.
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Subpopulations of RA and SA neurons exhibited other discernible differences in their
excitability. Spontaneous activity, defined here as the observation of APs in the absence
of injected current, was a common occurrence in SA cells (19/44 cells exhibited
spontaneous activity, 42.2%). Examples of some of these kinds of activity are shown in
Figure 3.3A. This activity included intense regular firing (12/19, left panel), sporadic or
irregular firing (6/18, middle panel) and once as a burst-like firing (1/19, right panel). In
contrast, no example of spontaneous activity was observed in RA cells (0/41, 0%,
Figure 3.3B). RA and SA neurons also displayed different sensitivities to injected
current. In SA neurons all but one neuron (43/44, 97.8%) fired an AP in response to the
minimum current injection examined (+50 pA). In the RA population however, only
15/40 (37.5%) did so. The median current injection in order to evoke an AP was +100
pA, but many SGN needed as much as +200 pA in elicit firing (Figure 3.3C, P<0.001,
unpaired Student’s t-test).
The variability in sensitivity to depolarising stimuli led to comparison of the voltage-
gated currents present in the two populations. Voltage clamp experiments obtained from
the same neurons in Figure 3.4, revealed distinct differences in the voltage-activated
currents between the two groups. RA and SA neurons both displayed prominent
outward K+ currents (Ik) in response to depolarising voltage steps, but the voltage at
which Ik was first activated was shifted between the neuronal phenotypes (Figure 3.4B).
In SA neurons a much greater depolarisation was required in order to evoke comparable
levels of IK. The current-voltage (I-V) plots in Figure 3.4B shows a prominent shift, ~20
mV in the low voltage region. Figure 3.4A shows current traces obtained from typical
RA (left panel) and SA (right panel) neurons. RA neurons displayed characteristic low-
threshold voltage-activated (LVA) K+ currents which were largely absent from SA
neurons. LVA K+ currents are known to be important in setting the RMP of neurons,
increasing the threshold for AP firing and reducing excitability (Johnston et al., 2010).
These results are consistent with the observations in pre-hearing mice that LVA K+
currents are an important determinant of rapid adaptation in SGN (Mo et al., 2002).
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Figure 3.3 Adaptation is correlated with spontaneous activity and firing threshold. A
Spontaneous firing i.e. AP firing in the absence of any current injection, was observed in a
number of recordings. Spontaneous firing was usually observed as either a constant train of
APs (left panel), a sporadic or irregular firing pattern (middle), or in consistent bursts (right). The
lower panels correspond to an expanded 100 ms period denoted by a line in the upper panels.
B Spontaneous firing is an exclusive property of slowly adapting (SA) cells. Spontaneous
activity was observed in 0/41 (0%) cells in rapidly adapting (RA) neurons whilst occurring in
19/45 (42.2%) of slowly adapting cells. C Cells which display rapid adaptation to an injected
current also required more current to evoke an AP. Under current clamp conditions slowly
adapting cells almost exclusively fired APs in response to the lowest injected current stimulus of
50 pA (43/44, 97.8%). In cells which display rapid adaptation, this was considerably lower
(15/40, 37.5%) with some cells requiring as much as 200 pA of current to elicit a response.
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Figure 3.4 Rapid adaptation is correlated with the magnitudes of specfic ionic
conducatances. A Representative voltage clamp traces for two cells which showed either rapid
adaptation (left panel) or slow adaptation (right panel) previously under current clamp. Cells
were held at a holding potential of -73 mV and stepped from -153 mV to +17 mV in 10 mV
steps. Each step was held for 200 ms before returning to the holding potential. Inward sodium
transients were cropped from current traces for expedience but could exceed 20 nA. B Mean
normalised steady-state current-voltage (I-V) relationships for rapidly adapting (white squares)
or slowly adapting (black squares) neurons. Steady-state currents were measured 10 ms from
the end of the voltage steps described for A and normalised steady-state currents were
obtained by divided the current by the measured whole-cell capacitance (Cm). C Calculated low
threshold voltage-activated (LVA) K+ currents for RA (white) or SA (black) cells. LVA K+ currents
were calculated by subtracting currents measured at -73 mV from those at -53 mV. D Measured
RMP for RA (white) or SA (black) cells. E Mean normalised steady-state I-V plot showing
hyperpolarisation-activated (Ih) inward currents. F Calculated Peak Ih currents for rapidly
adapting (white) or slowly adapting (black) cells. Peak Ih currents were measured 5 to 15 ms
before the end of a 200 ms step to -153 mV. *P<0.05 **P<0.01 ***P<0.001.
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Due to the role of LVA K+ current in setting the RMP of neurons (Johnston et al.,
2010), RA and SA neurons were investigated to determine whether they displayed
significant differences in their measured RMP. An estimate of the RMP was obtained
by recording the potential at which there was absence of current flow (I = 0 mode of the
amplifier). In both populations of SGNs, large variations in measured RMP were
observed (RA: -51 to -73 mV, SA: -49 to -73mV), and the mean RMP did not vary
significantly between the two populations (Figure 3.4C, RA: -64.9 ± 1 mV, SA: -63.2 ±
1.2 mV, P = 0.27, unpaired Student’s t-test). This was surprising as in other studies
blocking LVA K+ current from adult guinea-pig SGNs caused a notable depolarisation
in the RMP (Szabo et al., 2002). Multiple conductances contribute to setting the RMP of
a neuron however, and the activity of other channels may help maintain a consistent
RMP in the absence of hyperpolarising LVA K+ current: constitutively active M-
currents or hyperpolarising-activated cation currents (Ih) for example. For this reason we
analysed the relative contributions of Ih in the two populations. HCN-mediated Ih is a
prominent feature of both rapidly and slowly adapting SGNs in vitro (Liu et al., 2014b,
Chen, 1997). There was a significant difference in the mean magnitudes of Ih displayed
in RA and SA neurons. RA neurons displaying Ih current magnitudes of 1½ times that of
the SA population (Figure 3.4E, P<0.001, paired Student’s t-test, Figure 3.4F). This
difference might help to explain the lack of variation in RMP between populations.
3.2.3 Dendrotoxin-K blocks LVA K+ currents and increase excitability in
post-hearing onset SGNs
In pre-hearing SGNs (P3-8) rapid adaption has been shown to be regulated by an α-
dendrotoxin (α-DTX) sensitive conductance. Furthermore, dendrotoxin-K (DTX-K) 
demonstrated potent current inhibition and identified Kv1.1 subunits as an important
contributor to the adaptive response (Mo et al., 2002). Accordingly, the effects of DTX-
K were investigated here in post-hearing onset SGNs. 100 nM DTX-K was applied
through the bath to RA neurons from P12-15 mice (Figure 3.5A, C). DTX-K typically
enhanced the excitability of SGNs, as determined by the number of APs fired in
response to a depolarising current injection. It also reduced the amplitude of the
stimulus current required to first evoke an AP (Figure 3.5A, 2/5 cells). In the presence
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of 100 nM DTX-K the number of APs was increased in 4/5 cells in response to a 100
pA depolarising current step (Figure 3.5B), with one cell displaying spontaneous firing
as a result of DTX-K application (shown in Figure 3.5C). This was an important finding
as spontaneous firing is a property normally only observed in SA neurons (Figure 3.3A,
B). The increased excitability observed after DTX-K application confirmed that Kv1.1
subunits remain an important contributor to rapid adaptation in after hearing onset.
Figure 3.5 DTX-K increases the excitability of SGNs cultured from post-hearing onset
mice. A Adaptation was slowed in RA neurons (P12-15) following bath application of
dendrotoxin-K (DTX-K, 100 nM). From a holding potential of -73 mV, responses to 50 pA
current injections are shown before (left) and after (right) the application of DTX-K. The required
current to evoke AP firing was reduced following DTX-K application. B The number of APs
elicited during a +100 pA current injection increased in 4/5 SGNs following application of DTX-
K. Numbers of recorded cells are indicated in parentheses. C DTX-K evoked spontaneous firing
in 1/5 cells, a feature normally observed exclusively in slowly adapting cells. The left hand
traces of both Control and DTX-K panels correspond to a 1 second recording in the absence of
any current clamp (I = 0). The right hand panels are 50 mS enlargement corresponding to the
annotated line in the left traces.
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The effect of DTX-K on the SGN voltage-gated currents was also examined (Figure
3.6). The application of 100 nM DTX-K resulted in a substantial reduction in LVA K+
current amplitudes (Figure 3.6A, B) consistent with the observations from pre-hearing
mice that Kv1.1 subunits are an important contributor to LVA K+ currents (Mo et al.,
2002). In order to quantify the amount of LVA current inhibition, currents activated by
a 20 mV depolarising step from -73 mV were compared before and after DTX-K
application. DTX-K reduced LVA current in 6/6 cells with a mean reduction of 82.2 ±
6.9% (Figure 3.6C, Control LVA: 146 ± 34 pA; DTX-K LVA: 16 ± 9 pA, P = 0.009, n
= 6, paired Student’s t-test). DTX-K block was rapid and irreversible, reaching
maximum block ~2 minutes after bath perfusion began (Figure 3.6E).
Figure 3.6 Rapid adaptation-associated LVA K+ currents are blocked by the Kv1.1-subunit
specific DTX-K. A Representative outward current responses during 200 ms voltage steps in
10 mV increments from a holding potential of -73 mV, before (Control, upper panel) and after
(middle panel) bath application of 100 nM DTX-K. Subtracted DTX-K-sensitive currents are
shown in the lower panel. B Mean steady-state current-voltage relationships before and after
DTX-K application (n = 6). C Comparison of evoked LVA current from neurons in 5B. LVA
current was calculated by subtracting any steady-state current present at the -73 mV holding
potential from the evoked steady-state current measured at -53 mV. DTX-K application
significantly reduced the measured LVA current. P<0.01. D Normalised G-V plot of the DTX-K-
sensitive component. E The rate of DTX-K inhibition, as measured by reduction in normalised
slope conductance between -63 mV and -53 mV.
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3.2.4 Kv1.1 is expressed in SGNs around the onset of hearing
Following the pharmacological identification of functional Kv1.1-subunit containing
channels in post-hearing onset animals, immunofluorescence experiments were
performed in order to detail the distribution of Kv1.1 around the onset of hearing
(Figure 3.7 & 3.8). Cochleae were fixed and sectioned along the modiolar plane, which
exposed the individual spiral ganglion and cochlear nerve (Figure 3.7A, B). The cell
bodies of SGNs reside in the spiral ganglion (SG), and their peripheral neurites (PN)
extend from the sensory IHCs in the organ of Corti (OC). Their central neurites project
towards the brainstem (Figure 3.7C, D). As predicted by the previous
electrophysiological recordings, strong immunofluorescence was observed in the SGN
somata; Kv1.1 labelling was also observed in the peripheral and central neurites (Figure
3.7E, F). There was no obvious difference in labelling intensity between apical and
basal SGN as has been reported elsewhere (Adamson et al., 2002b, Liu and Davis,
2007) but no quantitative analysis was carried out. Kv1.1 labelling of the SGN and its
neurites was not seen when the anti-Kv1.1 primary antibody was excluded from the
staining process, nor if the secondary antibody was pre-incubated with a control Kv1.1
peptide (Figure 3.7G, H).
In order to examine the developmental expression of Kv1.1 around the onset of hearing,
cochleae from P2, P6 and P12 animals were fixed and labelled for the Kv1.1 subunit. In
order to avoid any potential tonotopic gradients in subunit expression the basal turn
from each animal was compared. As shown before, P12 SGN displayed clear Kv1.1
labelling which could be localised to SGN somata and neurites (Figure 3.8G-I). In P6
sections, Kv1.1 staining was moderately weaker but still clearly present in both the
somata and neurites of the SGNs (Figure 3.8D-F). In P2 animals however, staining was
completely absent from neuronal structures (Figure 3.8A-C). This points to a clear
developmental increase in Kv1.1 subunit expression in the early postnatal period, and
suggests the appearance of Kv1.1-mediated LVA currents in SGN is important for the
normal functioning of the mature cochlea.
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Figure 3.7 Kv1.1 subunit expression in the spiral ganglion. A DIC image of a cochear cross-
section from a P12 cochlea. Individual regions of the spiral ganglion (SG) can be distinguished.
B Confocal image of the same cross-section showing anti-acetylated tubulin (AcT) antibody
labelling of microtubules (red). Anti-AcT labelled several cochlear tissues, but prominent
labelling of axonal bundles was also observed (also see D) C DIC image of the P12 apical turn
region of the SG and the peripheral neurites (PN) extending from the organ or Corti (OC). Also
labelled is the bony spiral limbus (SL). D Confocal image of the apical SG region. SGN somata
and their peripheral neurites were labelled by anti-AcT. Nuclei were stained with DAPI (Blue). E,
F. P12 SGN were immunolabelled for the Kv1.1 subunit. Anti-Kv1.1 immunofluorescence
(green) was detected in SGN somata and their neurites, in both basal and apical turns of the
cochlea. G No Primary control: P12 basal turn SGN labelled as in E and F but excluding the
primary anti-Kv1.1 antibody. No labelling of the SGN somata or PN was observed. H Kv1.1-
Peptide control: P12 basal turn SGN labelled as in E and F but pre-incubating the primary
antibody with a control Kv1.1 peptide. No labelling of the SGN somata or PN was observed.
Scale bar: 50 µm for all panels.
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Figure 3.8 Developmental expression of the Kv1.1 subunit in SGN. A-C P2 basal turn SGN
labelled for the Kv1.1 subunit. No anti-Kv1.1 immunofluorescence (green) was detected in SGN
somata or neurites. Cell nuclei were labelled with DAPI (Blue). D-F P6 basal turn SGN labelled
for the Kv1.1 subunit. Kv1.1 immunofluorescence (green) was detected in SGN somata and
neurites. G-I P12 basal turn SGN labelled for the Kv1.1 subunit. Kv1.1 immunofluorescence is
observed in SGN somata and neurites. Scale bar: 50 µm is the same for all panels.
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3.2.5  Tityustoxin-Kα blocks LVA K+ currents in post-hearing onset SGNs 
The Kv1.1 subunit can form functional channels by homomeric tetramerisation or by
heteromerically tetramerising with other K+ subunits. Kv1.1 is heteromerised with
Kv1.2 subunits in neurons (Wang et al., 1994, Dodson et al., 2002). To examine the
possibility of Kv1.2 subunit involvement in LVA K+ current in SGNs, sensitivity to the
Kv1.2-specific toxin tityustoxin-Kα (TsTx) was investigated (Werkman et al., 1993). 
Bath application of 100 nM TsTx resulted in a substantial reduction in the LVA K+
current amplitude (Figure 3.9A, B) in RA neurons. In order to quantity the amount of
LVA K+ current inhibition, the currents from a 20 mV depolarising step were compared
before and after 100 nM TsTx application. 100 nM TsTx reduced LVA current in 3/3
cells with an average reduction of 65.9 ± 7.5% (Figure 3.9C, Control LVA: 457 ± 153
pA; TsTx LVA: 141 ± 49 pA, n = 3,). TsTx block was rapid; reaching maximum block
~1.5 minutes after bath perfusion began (Figure 3.9E). In contrast to DTX-K however,
the effects of TsTx could be washed off, albeit slowly. TsTx-sensitive current traces and
I-V plots (Figure 3.9A, D) resembled those of DTX-K-sensitive currents, although
maximal current block was more depolarised in the TsTx-sensitive current-voltage plot
(-23 mV to -3 mV).
Table 3.2 Boltzmann parameters for toxin-sensitive SGN conductances.
Toxin V ½ (mV) k (mV) n
DTX-K -66.2 ± 3.5 6.4 ± 1.3 6
TsTx -47.2 ± 5.1 10.2 ± 1.6 3
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Figure 3.9 SGN LVA K+ currents are sensitive to Kv1.2-subunit specific tityustoxin. A
Representative outward current responses during a 200 ms voltage steps in 10 mV increments
from a holding potential of -73 mV, before (Control, upper panel) and after (middle panel) bath
application of 100 nM tityustoxin (TsTx). Subtracted TsTx-sensitive currents are shown in the
lower panel. B Mean steady-state I-V relationships before and after TsTx application (n = 3). C
Comparison of evoked LVA current from neurons in B. LVA K+ current was calculated by
subtracting any steady-state current present at the -73 mV holding potential from the evoked
steady-state current measured at -53 mV. D Normalised G-V plot of the TsTx-sensitive
component. E The rate of TsTx inhibition, as measured by reduction in slope conductance
between -63 mV and -53 mV. TsTx inhibition reached maximum block after ~1.5 minutes.
3.3 Discussion
In this chapter, the membrane properties of SGNs, obtained from post-hearing onset
mice, were investigated. Whole cell recordings from the somata of these neurons
showed diverse heterogeneity in responses to depolarisation. This heterogeneity could
be correlated with differences in ionic conductances such as Ih and LVA K+ current.
Rapidly adapting neurons displayed large LVA K+ currents and smaller Ih than their
slowly adapting counterparts. SGN LVA K+ currents were found to be highly sensitive
to both DTX-K and TsTx channel block, demonstrating that LVA K+ currents must be
mediated, at least in part, by Kv1.1 and Kv1.2 subunits. The developmental expression
of Kv1.1 was also documented, demonstrating that Kv1.1 is not strongly expressed at 2
days after birth. However, by the onset of hearing, strong Kv1.1 expression is seen in
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both the somata and neurites of SGNs suggesting LVA K+ currents play an important
role in the mature cochlea.
3.3.1 Whole cell recordings from post-hearing onset SGNs required
dissociation and cell culture
Preliminary investigation in this project focused on the development of a robust
preparation of adult SGNs for whole-cell patch clamp recordings. A search of the
literature highlighted three well developed approaches: a dissociated cell culture
preparation (Santos-Sacchi, 1993, Szabo et al., 2002), a gangliotypic or explant
preparation (Liu and Davis, 2007, Mo and Davis, 1997) and a cochlear slice preparation
(Jagger and Housley, 2003, Jagger et al., 2000). The cochlear slice preparation is the
closest ex vivo representation of SGN in their native physiological state and was
therefore assessed first. The gradual ossification of the cochlea in the days following
birth made slicing of the mounted cochlea difficult however. Whole-cell access to
neurons from P2 mice was attained but no further success could be achieved in older
cochlea. Despite being the most physiologically representative model, the technical
difficulties encountered at older ages resulted in other models being investigated. The
gangliotypic or explant preparation (the former being distinguished from the latter by
maintaining the entire ganglion in a single piece (Liu and Davis, 2007)) of SGN was
subsequently assessed. Whole sections of spiral ganglion tissue were removed from the
cochlea by careful dissection and cultured. The method was adapted from Adamson et
al., 2002. Again however, electrophysiological recordings from P12-14 explanted tissue
were largely unsuccessful; pipette access of cells was the largest hindering factor. Non-
neuronal structures, such as unshed myelin and other glial cells, likely comprised the
obstructing material. Removal of this material by positive pressure down a large access
pipette or by mechanical abrasion using a second glass pipette proved fruitless. The lack
of success employing this method in older animals was considered to be an age-related
phenomenon. Until 2014, P8 murine SGN cultures were the oldest anyone had reported
success from using this approach. During the progress of this study however successful
recordings from mice as old at P14 were reported from explanted cultures (Davis and
Crozier, 2015). Due to the practical difficulties encountered with the first two models
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investigated, results obtained in this study were from cultures of enzymatic and
mechanical isolated neurons. This was based upon the preparation described in
(Whitlon et al., 2006). Robust and stable recordings from dissociated neurons up to one
week after the onset of hearing (P20-21) were readily achievable by this approach.
Success with mice as old as 17 months has been reported using a similar approach (Lv
et al., 2010) further emphasising its utility in the examination of post-hearing onset
SGN properties.
It is difficult to speculate on the effects of the different preparations on cell
electrophysiology but it would be surprising if there were none. The use of
neurotrophins to maintain SGNs in culture has already been shown to induce significant
changes in firing phenotypes (Adamson et al., 2002a, Zhou et al., 2005). Further,
neurotrophic maintenance of SGNs in culture may have a selective survival effect for
subpopulations of neurons and therefore the distributions of phenotypes observed may
not be representative of the real distribution in animals (Davis, 2003). For this reason,
analysis of the distributions of firing phenotypes from cultures should be treated with
caution and was largely avoided in this study except to note their variation (Figure 3.2).
Some clear preparation-based differences have been documented; gangliotypic
preparations of early post-natal murine SGNs (P3-8) were significantly less excitable
than their enzymatically dissociated counterparts despite identical culture conditions.
Similarly acutely prepared cochlear slice recordings show almost exclusively RA
behaviour with little or no spontaneous or SA cells (Jagger and Housley, 2003, Jagger
and Housley, 2002). Whether this represents a trend towards reduced excitability is
uncertain, but future work should focus on validating the effects observed in neuronal
cultures in more acutely dissected preparation to avoid variation due to neurotrophic
effects. Before discussing the functional properties of SGNs it is important to note that
along with the considerable difficulties discussed above, several other problems hinder
the assessment of the their ionic currents and firing features. Amongst other difficulties,
SGN currents and firing properties show considerable interspecies variability. In vivo
studies and cochlear imaging also demonstrate a well-documented maturation of the
SGNs in early post-natal development with spontaneous firing rates with ABR
thresholds and ion channels expression changing markedly in this time (Rusznak and
Szucs, 2009).
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3.3.2 Heterogeneous excitability is a functional feature of SGNs
Spontaneous activity in the absence of sound is a feature of primary ANFs in vivo.
Results from this study and from others have demonstrated that spontaneous APs can be
generated in isolated SGNs somata (Lin and Chen, 2000, Lv et al., 2010). Spontaneous
activity in vivo is thought to result from the spontaneous release of glutamate at the
ribbon synapse of IHCs (Glowatzki and Fuchs, 2002). However, glutamate receptor
antagonism only reduces spontaneous firing and fails to abolish it entirely (Cousillas et
al., 1988, Puel et al., 1989). This suggests that a portion of the spontaneous activity
observed is as a result of the intrinsic excitability of SGNs. In this study spontaneous
activity was shown to be a feature exclusively of slowly adapting neurons and that
spontaneous activity could be induced in previously non-spontaneous cells by inhibition
of a DTX-K-sensitive LVA K+ current. Spontaneous activity has also been reported as a
feature of ~10% of SGNs around the onset of hearing (Wang et al., 2013). Interestingly,
in the same study Kv1.2 null mutants were shown to have an increased tendency for
spontaneous activity (~18% of total neurons) despite having a more hyperpolarised
RMP, increased current thresholds to generate APs and larger LVA K+ currents. This
suggests LVA currents alone may not be predictive of spontaneous activity.
Each IHC receives multiple innervations from anything between 10 and 30 ANFs
depending on the tonotopic location and species (Bohne et al., 1982, Stamataki et al.,
2006). Despite being stimulated by a single IHC, these multiple ANFs display a
heterogeneity in the spontaneous discharge rates (SR) and as well as in their thresholds
of acoustic stimulation (See Physiology of the auditory nerve). The fibre population
provides a gradient of firing properties, ranging from high-threshold low-spontaneous
rate fibres, to low-threshold, high-spontaneous rate fibres. In this study two separable
subpopulations of cells with distinct differences in their excitability and sensitivity to
depolarisation were observed. In contrast to other studies (Adamson et al., 2002b, Lv et
al., 2010) RA and SA neurons were identified in all tonotopic regions of the cochlea and
at both age ranges investigated.
It is tempting to speculate about a possible connection between the heterogeneity
observed in ANFs thresholds and SRs and the heterogeneity in firing features observed
in SGNs in vitro. There is little direct evidence for this relationship however. Possible
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evidence has been suggested to come from in vivo cat ANF responses to click stimuli
(Adamson et al., 2002a). In these experiments, some neurons could be shown to fire
repetitive APs at intervals corresponding to the period of the cell’s characteristic
frequency. But notably, other neurons were found only to fire singly in response to the
click (Kiang et al., 1965, Ruggero et al., 1992). The current consensus however is that
differential release of neurotransmitter between ribbon synapses gives rise to the
observed heterogeneity. Nevertheless SGNs show significant intrinsic variation in their
firing features and ionic currents.
Studies in pre-hearing cultured SGNs have typically suggested a base-to-apex gradient
in excitability, with basally derived cells comprised exclusively of RA neurons and
apical cells comprising of a mix of RA and SA neurons (Adamson et al., 2002a,
Adamson et al., 2002b). Developmental changes within the cochlea make interpretation
of these results difficult however. The development of the cochlea is not uniform either;
rather it matures with a base to apex gradient with the basal region displaying mature
adult characteristics earlier than the apex (Rubel, 1978, Romand, 1983). Furthermore,
the presence of neurotrophins is graded in the developing cochlea: BDNF is localised
primarily to the apex of the cochlea during development, whilst NT-3 localises in the
base (Farinas et al., 2001). SGN firing shows a high sensitivity not just to the presence
of NT-3 and BDNF, but also their concentrations (Zhou et al., 2005). Increasing levels
of NT-3 exposure slows adaptation, up to a concentration 10 ng/ml. Subsequent
increase in NT-3 however result in an increase in adaptation rate. This complex
interaction between SGNs and neurotrophins casts further doubt on the reliability of
using pre-hearing cultured SGNs as representative of the functionally mature cochlea.
Of the few studies examining the firing features of SGNs in post-hearing onset animals,
the results have been inconsistent. As mentioned, this study reported the presence of
both RA and SA neurons in all regions of the cochlea and at both the onset of hearing as
well as one week after. In other studies, recordings from cultured mouse explants
around the onset of hearing (P10-14) showed little heterogeneity in firing with RA
neurons making up the majority (>75%) of all cells recorded (Davis and Crozier, 2015).
The tonotopic variation observed by the same group in earlier studies was also markedly
reduced, with a RA firing pattern dominating in both apical and basal cultures.
However, the same study noted a large impact of holding potential upon the measured
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excitability. RA was the dominant feature of SGNs when measured from a holding
potential of -80 mV. However, RA neurons made up <30% of the total firing behaviours
when the same cells were measured at -60 mV. This is an interesting finding as reported
RMPs for SGNs vary considerable between -77 and -61 mV (Jagger and Housley, 2003,
Jagger et al., 2000, Santos-Sacchi, 1993, Szabo et al., 2002). Here APs were stimulated
from a holding potential of -73 mV. Contrary to these results, other studies from post-
hearing onset animals have reported a strong tonotopic gradient in firing features (Lv et
al., 2010, Lv et al., 2014). Surprisingly however, the gradient in excitability was in
diametric opposition to that reported for pre-hearing mice; RA was an exclusive
property of apical neurons whilst nearly all basal neurons displayed a SA phenotype (Lv
et al., 2010, Lv et al., 2014). This firing pattern was consistent in mice as young as two
weeks and up until the age of 17 months. However, there is little explanation that can be
offered to account for these markedly different findings but to note their discrepancy
with the results presented here and elsewhere.
The development of vestibular ganglion cells (VGCs) shares many commonalities with
SGNs. VGCs, like SGN, are bipolar afferent neurons whose processes form synapses
with sensory hair cells. These hair cells, however, are located in the utricle, saccule and
semicircular canals. Instead of sound information they relay information relating to
balance. Like SGNs they display an intrinsic heterogeneity in their firing properties
(Iwasaki et al., 2008). Two prominent subpopulations of “tonic” or “phasic” phenotypes
can be identified, with a small number of “intermediate” firing types also present.
Consistent with the results here, the reported phasic firing cells (RA cells in our study)
were also distinguishable for the presence of a prominent LVA K+ current. This LVA
K+ current also displayed DTX-K and TsTx sensitivity and increased excitability was
reported in neuronal firing upon exposure to the LVA K+ current inhibiting toxins
(Iwasaki et al., 2008). There were also significant developmental changes in the
prevalence of different firing types; in early postnatal animals (P5-7) phasic firing
predominated but at older ages and beyond (P12-22) tonic firing begins to dominate.
This is interesting as this shift toward tonic firing is the opposite of what is observed in
the spiral ganglion maturation (Davis and Crozier, 2015).
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3.3.3 Rapid adaptation is dependent on LVA K+ currents in murine SGNs
Rapid adaption in SGNs is determined by a LVA K+ current (This study, Mo et al.,
2002). In pre-hearing SGNs this current shows sensitivity to DTX-I, DTX-α, DTX-K 
and low doses of 4-aminopyridine (Mo et al., 2002, Szabo et al., 2002, Jagger and
Housley, 2002). This study showed the LVA K+ current in post-hearing onset animals
was sensitive to both DTX-K and TsTx. This provides evidence that LVA K+ current in
SGNs is mediated by both Kv1.1 and Kv1.2 containing channels. Consistent with this,
strong immunolabelling was observed for the Kv1.1 subunit as early as six days after
birth. Kv1.1 expression was observed in the somata as well as in the peripheral and
central neurites. This indicates a key role for Kv1.1 in the generation and maintenance
of APs in acoustic coding. Interestingly, no Kv1.1 expression was observed in P2 SGN.
Kv1.1 expression in SGNs only begins after the first few days postnatally, and
expression then continues to increase up to the onset of hearing (~P12). This temporal
expression pattern of Kv1.1 might be expected to lead to adaptation becoming more
prominent as animals mature. Recent evidence has offered support to this idea.
Recordings from explanted SGN tissue from P1-P2 mice revealed a very small
prevalence of RA SGNs (1.5%). By P6–P8 however, RA SGNs made up more than half
of all recordings and by P10-P14 RA SGNs accounted for >75% of neurons (Davis and
Crozier, 2015). Allowing for differences in species variation, these results suggest that
the SGN’s LVA K+ current is established in the early postnatal period (1-2 weeks) and
that rapid adaptation is the predominant phenotype by the onset of hearing.
Notwithstanding these results, some inter-species differences in the response of SGN to
LVA K+ current inhibition have cast doubt on the role of Kv1.1 in adaptation.
Application of DTX-K to isolated guinea pig SGNs depolarised the RMP of the neuron
but did not slow adaptation (Szabo et al., 2002). Despite this reported effect of DTX-K
on RMP, the role of Kv1.1 in setting the RMP in SGN has not been the focus of much
study. It was noted however that in acute cochlear slice preparations of rat SGNs there
seemed a notable hyperpolarising of RMP during development. SGNs from P2–6 rats
were reported as having a mean RMP of −61 mV (Jagger 2002) which dropped to −77 
mV by P7-10 (Jagger 2003). This would be consistent with our observations that Kv1.1
expression increased significantly in the first week after birth and played an important
role in setting the neuronal RMP.
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Functional Kv1 channels are made up of four pore-forming subunits arranged together
as homomeric or heteromeric complexes. In this work, it was demonstrated that the
SGN LVA K+ current was highly sensitive to the actions of both DTX-K and TsTx. The
high levels of block (82.2% and 65.9% respectively) was suggestive that SGN LVA K+
currents are made up of at least some Kv1.1 and Kv1.2 containing heteromers, rather
than unique populations of Kv1.1 and Kv1.2 homomeric channels (Dodson 2002).
Analysis of the voltage dependence of the DTX-K and TsTx-sensitive LVA components
show that the DTX-K-sensitive component has more negative V1/2 than the TsTx-
sensitive components (-66 mV vs -47 mV; Table 3.2). In heteromeric expression
systems, Kv1.1 homomeric channels display a significantly more negative V1/2 that
Kv1.2 homomer channels (Al-Sabi et al., 2013). The different voltage dependences of
the toxin sensitive currents therefore also suggest the presence of homomeric
populations of Kv1 channels.
Further work from our lab has since characterised the block of Kv1 mediate LVA K+
currents further. Co-application experiments using sequential addition of Kv1.1 and
Kv1.2 specific toxins have provided strong evidence that this current is indeed mediated
by Kv1.1/Kv1.2-containing heteromers as opposed to discreet populations of Kv1.1 and
Kv1.2 homomeric channels (Smith et al., 2015). Furthermore confocal
immunofluorescence experiments localised both Kv1.1 and Kv1.2 subunits to specific
neuronal microdomains. These include the somatic membranes of the SGNs, as well as
the juxtaparanodes of the central and peripheral neurites. Kv1.1 and Kv1.2 subunits
were also localised to the first heminode, which forms the spike initiation site of the AN
(Smith et al., 2015). Taken together, these results suggest a key role for Kv1.1/Kv1.2-
containing heteromeric channels in the initiation and propagation of APs in the AN.
3.3.4 The role of rapid adaptation in SGN coding
Rapid adaptation is a key feature of post-synaptic recordings from SGNs boutons
(Glowatzki and Fuchs, 2002). SGNs fire single AMPA-receptor mediated AP spikes in
response to large depolarizing stimuli. This phasic response ensures the high fidelity
encoding of ribbon synapse neurotransmitter release (97% of excitatory post synaptic
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currents result in successful APs) (Rutherford et al., 2012). The result is a system that is
adapted for high temporal precision and phase synchronisation to acoustic signals
(Johnston et al., 2010).
LVA currents have been reported in whole cell recordings from the terminal boutons of
SGNs (Yi et al., 2010). Combined with findings from our lab that Kv1.1 and Kv1.2
subunits are expressed together at the first heminode near the proposed spike initiator
site (Smith et al., 2015), this suggests an important role for Kv1-mediated LVA K+
conductances in AP initiation. The notably large EPSCs and relatively low failure rate
(97% of all EPSC events result in APs) suggest that LVA currents are not acting in a
significant fashion to filter out subthreshold EPSC events. Rather, LVA K+ currents
most likely inhibit spiking in response to slow stimuli and prevent temporal summation
of inputs ensuring a minimum rate of depolarisation is required (Rutherford et al.,
2012). This reduces temporal variations that could arise from normal variation in the
EPSC waveform. This dependency on the rate of rise of membrane voltage is mirrored
in Octopus cells in the CN which require a minimal depolarisation rate of between 5 and
15 mV/ms. Firing in neighbouring T stellate cells, which lack strong dendrotoxin-
sensitive LVA K+ conductances, depends much less strongly on the rate of voltage rise
(Ferragamo and Oertel, 2002).
This provides some interesting questions as the basis for future research. If rapid
adaptation is a feature of all neurons, as is reported in SGN bouton recordings, why do
neurons display such heterogeneity in their intrinsic firing properties? Do differences in
LVA K+ conductances between individual neurons contribute to the difference in
spontaneous firing rates in vivo? What effect does modulating SGN LVA currents have
on signalling in vivo and do SGN modulate their ionic conductances in response to
external or internal signalling, such as in response to input from the Efferent System?
Answers to these questions would significantly improve our understanding of how the
AN encodes sound at the molecular level.
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Chapter 4
PIP2 regulation of SGN spike adaptation via Kv1
heteromeric channels
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4.1 Introduction
The excitability and firing properties of a neuron is established by its
electrophysiological architecture. The abundance, type and location of ion channels in
the plasma membrane combine to give a neuron its characteristic electrical responses. In
physiological situations however, neurons are more than the sum of their ion channels,
adjusting and modifying the influences of different ion channels, allowing them to adapt
and respond to changing external signals. Phosphoinositides (PI) are now recognised as
key regulators of neuronal electrophysiology, coupling the external activation of
membrane bound receptors to electrical changes in the cell and acting as important
cofactors for the functioning of a variety of native ion channels.
In many experimental systems, neuronal excitability has been shown to be influenced
by PI signalling. The most common mediator of phosphoinositide-based neuronal
regulation is phosphatidylinositol 4,5-bisphosphate (PIP2). PIP2 regulates excitability by
acting as a cofactor in the functioning of specific PIP2-sensitive ion channels or via its
hydrolysis into other potent signalling molecules which mediate downstream effects.
The best studied example of PIP2 control over excitability is through its regulation of
the neuronal M-current. In hippocampal CA1 pyramidal neurons for instance, PIP2-
mediated M-currents ‘clamp’ the membrane potential to a hyperpolarised level and so
reduce AP firing (Shah et al., 2002). Stimulating muscarinic acetylcholine receptors
(mAChRs) with muscarinic agonists causes increased neuronal excitability through the
activation of PLC and the resulting PIP2 hydrolysis (Brown and Passmore, 2009).
Angiotensin II’s ability to regulate neuronal excitability in superior cervical ganglion
sympathetic also converges upon this mechanism of neuronal modulation. Activation of
the AT1 receptor results in a PLC-dependent PIP2 hydrolysis, leading to an increase in
excitability (Zaika et al., 2006). M-current inhibition, however, is not the only example
of PIP2 determined excitability. Recently, PIP2 and diacylglycerol (DAG) were shown
to determine the excitability of thalamocortical relay (TC) neurons (Bista et al., 2015).
TC neurons exhibit distinct excitatory states depending upon sleep and wakefulness
behaviour, and fire APs either in high frequency bursts or slower tonic sequences
respectively. PIP2 and DAG determine these distinct excitatory states via their actions
on the two-pore domain potassium channels TASK and TREK. Similarly, muscarinic
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inhibition of K2P channels enhances the excitability of cerebellar granule neurons via
the PIP2 hydrolysis product DAG (Wilke et al., 2014). Another interesting case study of
PIP2 modulation is in thalamic intergeniculate leaflet neurons where PIs act to
upregulate the function of hyperpolarisation-activated cyclic nucleotide-gated channels
HCNs (Ying et al., 2011). The presence of PIP2 results in low-threshold burst firing,
whilst its depletion profoundly inhibits excitability. PI mediated excitability changes
can also result from the production of their potent downstream effectors. For example,
Dopamine D2 receptor stimulation reduces excitability in medium spiny neurons by
suppressing transmembrane Ca2+ currents (Hernandez-Lopez et al., 2000). In this
instance, PI regulation is effected by PIP2 hydrolysis yielding inositol 1,4,5-triphosphate
(IP3), and the subsequent release of intracellular pools of Ca2+ activating calcium-
dependent phosphatase calcineurin.
Whilst PIP2 is the principal PI regulator of neuronal excitability, PIP3 also plays an
important role. Whilst some short-term effects of PIP3 signalling have been
documented, the most notable effects of PIP3 on neuronal excitability occur over longer
timescales than the mechanisms discussed above. PIP3 acts through the AKT/mTOR
pathway to affect processes such as protein translation, cell proliferation and cell
growth. In the CNS, knockout of the phosphatase and tensin homolog (PTEN) protein (a
lipid phosphatase that dephosphorylates PIP3, see Figure 1.11) affects somatic, dendritic
and axonal growth, spine maturation, and results in reduced synaptic plasticity, and
reduced intrinsic excitability (Garcia-Junco-Clemente and Golshani, 2014). Conversely,
mTOR hyper-activation is associated with enhanced synaptic transmission and plasticity
and epileptogenesis, highlighting its impact on neuronal excitability (Lasarge and
Danzer, 2014).
4.1.1 Experimental methods of phosphoinositide modulation
In this chapter the effects of manipulating the levels of PI in SGNs, in particular the
levels of PIP2, were investigated to determine if this could modulate the firing
properties of the neurons. Manipulating the levels of membrane-bound PIP2 in an
experimental setting presents many challenging aspects. The role of PIP2 and its
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metabolic products as signalling molecules, along with its potential for dynamic
interconversion with other PI family members, introduces many potential mechanisms
of action which may confound any simple explanation for a given effect. Additionally,
many of the current methods of PIP2 modulation are crude or represent exaggerated
forms of PIP2 addition or depletion and care must be taken in interpreting these results
and placing them within a physiological context (Suh and Hille, 2008). The methods of
PIP2 depletion employed in this study are discussed here, with a brief discussion of
other methods of PIP2 modulation.
4.1.2 Inhibition of phosphoinositide synthesis
A metabolic focused approach to PI modulation is to interrupt synthesis of PIP2 and
PIP3 by inhibiting the enzymes that synthesise them. In the case of PIP2, this requires
the inhibition of one of two lipid kinases: Phosphatidylinositol 4-kinase (PI4K) or
Phosphatidylinositol 5-kinase (PI5K). PIP3 synthesis requires the inhibition of
Phosphatidylinositol 3-kinase (PI3K; Figure 1.11). Inhibition of PI synthesis is typically
achieved by pharmacological agents such as wortmannin (Suh and Hille, 2005).
Wortmannin, a fungal steroid metabolite, is one of the most widely used modulators of
cellular PI synthesis. This is due to many favourable properties such as cell
permeability, commercially availability, and the fact it is largely ineffective against
other signalling molecules (Wymann et al., 1996). Another useful property is its
difference in affinity for PI3Ks vs PI4Ks. Wortmannin is a potent inhibitor of PI3Ks at
low nanomolar concentrations (Yano et al., 1993), whilst inhibiting PI4K with an
affinity of an order of magnitude lower (Figure 4.1) (Fruman et al., 1998). This
difference provides a diagnostic method of examining the relative contributions of PIP2
and PIP3 to biological processes. LY294002 is a synthetic inhibitor of PI3Ks, which like
wortmannin binds to the ATP binding site of PI3K. It displays low micromolar affinity
against PI3K enzymes in vitro (Walker et al., 2000) but unlike wortmannin however, it
binds reversibly to the enzyme.
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4.1.3 Genetic approaches to PIP2 modulation
One area of investigation which will be briefly mentioned here is the recent
development of a number of genetic based techniques for the modulation of PIs.
Conventional cell biology approaches involving overexpression of important enzymes
or knockdown and knockout using siRNA and gene deletion have long been seen as
unsatisfactory due to the fact these methods alter PI levels over a period of hours or
even days. More recent techniques have focused on rapid and inducible methods of PI
perturbation. These methods, which act over a period of seconds rather than hours,
typically act by recruiting transfected enzymes, such as lipid 5-phosphatase (which
converts PIP2 to PIP) to the cell membrane. Current methods involve a rapamycin-
induced dimerisation, or light-induced optogenetic dimerisation which brings the
phosphatase into proximity with the PIP2 rich plasma membrane (Suh and Hille, 2008).
Of most use to electrophysiological investigation has been the development of a
voltage-sensing lipid phosphatase (VSP). The major advantage is that the enzyme itself
can be activated by depolarizing voltage pulses in whole-cell patch clamp recordings,
allowing both the PIP2 modulation and current measurements to be carried out almost
simultaneously (Suh and Hille, 2005). Although, these approaches provide a sensitive
method of examining the effects of phosphoinositide modulation in cellular systems, the
necessity for genetic manipulation makes their application to primary cell culture a
considerable challenge.
4.1.4 PIP2 sequestration
Certain strategies employed to deplete membrane bound PIP2 levels involve some form
of phosphoinositide capture or sequestration. The popularity of these techniques is
explained by their obvious practicality. Patches of channel rich membrane can be
excised with a patch pipette and PIP2 sequestering agent (often polycations such as
Mg2+, neomycin, polylysine or spermine) directly applied to the exposed cytoplasmic
surface (Suh and Hille, 2007). Specific PIP2 antibodies can also be employed for this
purpose (Suh and Hille, 2008). In fact, PIP2 sequestration may not even be necessary;
post-excision, PIP2 synthesis may slow or even stop and PIP2 becomes depleted over a
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short period. Channel function may decrease in tandem in a process called “channel
rundown”. Conversely PIP2 or other lipids can also be applied to the surface to observe
their effects on ion channel activity (Suh and Hille, 2005).
Recently, innovative new strategies for PIP2 sequestration and capture have been
pursued through the design of targeted peptides (Robbins et al., 2006). These molecules
consist of a peptide with high affinity for PIP2 and a long chain fatty acid group
(palmitoylation) to target it to the plasma membrane (Figure 4.2). This PIP2-binding
palmitoylated peptide (PIP2-PP) consists of a 10 amino acid polypeptide, palmitoylated
on the terminal histidine (Pal-HRQKHFEKRR). This 10 amino acid chain is identical to
the putative PIP2 binding sequence of the Kv7.2-7.5 (Figure 4.2) (Zhang et al., 2003).
The PIP2-PP has some significant practical advantages over tradition polycationic PIP2
sequestering agent. Most notable, PIP2-PP can be applied externally during whole cell
patch clamp recordings and sequester PIP2 at the inner leaflet of the membrane.
4.2 Results
4.2.1 Inhibition of PIP2 synthesis increases excitability in SGNs
To examine the effects of PIP2 and PIP3 modulation on the electrophysiology of SGN,
the synthesis of these PIs were inhibited by pharmacological means. Accordingly, basal
turn cultures were pre-treated for one hour with wortmannin at either a low dose (100
nM), targeting PI3Ks only (Yano et al., 1993), and thus reducing the pools of PIP3
available to the cell, or a high dose (10 µM) to target both PI3Ks and PI4Ks, therefore
also depleting PIP2 levels in the membrane (Fruman et al., 1998). A simplified form of
this pathway and its inhibition is shown in Figure 4.1B. After incubation with drug
concentration or vehicle alone (0.1% DMSO), cells were transferred to the recording
chamber and recordings were made using the current clamp mode of the amplifier to
determine SGN responses to depolarising current injections. Cells were pooled by
number of APs fired in response to a 200 ms depolarizing current injection of 100 pA:
rapidly-adapting, 0-1 APs; slowly-adapting, 2-9 APs; non-adapting, ≥10 APs (Figure 
4.1C).
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Figure 4.1 Excitability in cultured SGNs is dependent on availability of PIP2. A Chemical
structures of the phosphoinositide inhibitors, wortmannin and LY294002. B Simplified schematic
of phosphoinositide metabolism showing the site of action of the various inhibitors. C The
distribution of adaptation phenotypes within the population of cultured SGN exposed to varying
conditions of phosphoinositide inhibition. SGN pre-incubated for 1 hour in 0.1% DMSO (Control,
n = 12) display a predominance of rapidly-adapting phenotypes, as do SGN pre-incubated in
100 nM Wortmannin (‘Low WT’, n = 10). SGN pre-incubated in 10 μM wortmannin, (‘High WT’, n 
= 18) display an increase in excitable firing behaviour, with a reduced proportion of rapidly-
adapting cells. When diC8PIP2 (100 µM) is included intracellularly during recordings from SGN
pre-incubated in 10 μM Wortmannin (‘High WT+diC8PIP2’, n = 8), the proportion of rapidly-
adapting cells returns to near control levels. SGN preincubated with the PI3K inhibitor
LY294002 (‘LY294002’, n = 10) also resembles the control population.
Under control conditions, where cells were pre-incubated with vehicle alone, 75%
(9/12) matched a rapidly-adapting phenotype, with the remaining 25% (3/12) exhibiting
slow adaptation. Pre-incubation of SGN cultures with 100 nM wortmannin had little
effect on the rapidly-adapting phenotype. However, pre-incubation with 10 µM
wortmannin resulted in a substantially reduced proportion of rapidly-adapting neurons
(39%; 7/18), and an increased proportion of non-adapting neurons (33%; 6/18), with the
remaining neurons slowly-adapting (28%; 5/18). Broadly, pre-incubation with 10 µM
wortmannin resulted in a significantly more excitable population of SGN neurons than
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under control conditions. Accordingly, incubation with 10 µM wortmannin produced a
small increase in the proportion of spontaneously active cells, i.e. cells which fired APs
at rest in the absence of any depolarising injection, though this was not significant
(28%; 5/18 in 10 µM wortmannin-treated cells compared to 17%; 2/12 in control). In a
subset of cells pre-incubated with 10 µM wortmannin, a non-hydrolysable PIP2
analogue diC8-PIP2 (100 µM) was added to the intracellular pipette solution. Under
these conditions the proportion of rapidly-adapting cells was identical to the control
(75%; 6/8).
Figure 4.2 Transient application of LY294002 blocks Kv channels in SGNs. A Current
traces evoked by depolarising voltage step protocol in the presence and absence of the PI3K
inhibitor LY294002. Cell was held at -73 mV and stepped to +17 mV in 10 mV increments.
Perfusion of 5 μM LY294002 across the cell caused significant inhibition of steady state IK. 
Peak Ik however showed little to no reduction. Upon washing the Ik quickly recovered. B I-V
trace showing the steady state Ik in the presence and absence of the LY294002 as well as 3
mins after washing off.
In separate experiments, cultures were pre-treated for one hour with the reversible PI3K
inhibitor LY294002 (5 µM). Pre-incubation with LY294002 resulted in a modest
decline in the occurrence of rapid adaptation (60%; 6/10). Together these results
suggested PIP2 availability could be an important determinant in the rapid adaptation of
cells but conversely that PIP3 availability did not seem to influence SGN excitability.
Interestingly, transient bath application of LY294002 resulted in a marked effect on the
outward current which was not observed upon transient application of the other PI3K
inhibitor, wortmannin. Figure 4.2A shows the effects of 5 µM LY294002 perfused over
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a SGN for 3 mins. LY294002 increased the rate of inactivation of outward K+ currents,
an effect that was rapid and reversible, reaching maximum effect after 80 s and
subsequently washing out in a similar period, to recover the initial current inactivation
kinetics (Figure 4.2). It seems therefore, that the LY294002 pre-incubation experiment
should be interpreted with caution due potential non-PI3K related effects.
4.2.2 Sequestration of PIP2 increases excitability in SGN
To further explore the role of PIP2 in the regulation of SGN excitability, other methods
of altering PIP2 availability were explored. To this end, a novel membrane-targeting
palmitoylated peptide with high affinity for cellular PIP2 was employed (Robbins et al.,
2006). In current clamp mode, bath application of 3 µM PIP2-PP enhanced the
excitability of rapidly adapting SGNs (P12-15; Figure 4.3C, D). The extent of this
enhancement was variable, however, with most SGNs becoming more slowly adapting,
firing 2-5 APs instead of 1 (7/10), whilst others became non-adapting, continuing to fire
as long as the current stimulus was applied (Figure 4.3C). In addition to increasing the
number of APs, PIP2-PP also reduced the amount of current required to fire an AP in
2/9 cases, and induced spontaneous firing in the absence of any injected current in those
two cells. Furthermore, PIP2-PP significantly increased the steady-state voltage in
response to depolarising current injection steps (n = 4, p<0.001, two-way ANOVA;
Figure 4.3E), indicating an increased membrane resistance.
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Figure 4.3 A PIP2 sequestering peptide enhances the excitability of post-hearing onset
SGNs. A Cartoon of the structure of the PIP2-binding palmitoylated peptide (PIP2-PP). B
Putative mechanism of action of the PIP2-PP. The PIP2-PP is proposed to act by sequestering
membrane bound PIP2 and making it unavailable for interaction with membranous ion channels.
C Voltage response from a P13 rapidly adapting SGN to depolarizing current injections, before
(Control, left) and after the bath application of 3 μM PIP2-PP (right). 200 ms current injections
were applied in +50 pA increments from a holding potential of -73 mV. Typically, PIP2-PP
slowed the rate of adaptation or removed it entirely, and reduced the current required to elicit
AP firing. D Summary of the effect of 3 μM PIP2-PP on the number of APs (#APs) elicited in
response to a +100 pA current step (number of cells is shown in parentheses). E Comparison of
the mean voltage-current relationship before (Control) and after the bath application of 3 μM 
PIP2-PP (n = 4). Steady-state voltage was measured 10 ms from the end of 600 ms current
injections applied in +20 pA increments from a holding potential of -73 mV.
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The increased membrane resistance following application of the PIP2-PP possibly
indicated a decreased activity of Kv channels, and so separate voltage clamp
experiments were performed to further elucidate the effects of PIP2 sequestration on
SGNs. Bath application of 3 µM PIP2-PP resulted in a prominent inhibition of outward
K+ currents. Furthermore, PIP2-PP was found to have differential effects between HVA
and LVA K+ currents (Figure 4.4A, B). PIP2-PP markedly reduced the outward current
amplitude measured at -53 mV (74.2 ± 2.9%), but had less effect on currents at -13 mV
(34.5 ± 4.6%; P<0.001, n = 15). Subtraction of the PIP2-PP exposed trace from the
control trace gave the PIP2-PP-sensitive component (Figure 4.4A, lower trace), a LVA
current with a V1/2 of -51.1 ± 1.1 mV and slope of 6.7 ± 0.5 (Figure 4.4C). The effects
of the peptide were rapid, with maximal inhibition obtained within ~2 mins of the onset
of the application (Figure 4.4D, control). The effects of the peptide could not be washed
out, either using extracellular solution or extracellular solution supplemented with FBS.
To further examine if PIP2 depletion was the mechanism behind LVA inhibition,
diC8PIP2 was included in the intracellular recording solution. Under control conditions
LVA current inhibition by PIP2-PP reached a maximum after about 2 mins of its
application (Figure 4.4D, control), and this rate of current inhibition could be fitted
using a standard single exponential decay function (τcontrol = 28.4 ± 5.3 s). Inclusion of
diC8PIP2 in the recording pipette was found to significantly slow the rate of LVA
current inhibition by PIP2-PP (τdiC8PIP2 = 115.5 ± 16.6 s, p = 0.002, paired Student’s t-
test, Figure 4.4D). Similarly, the mean% currents remaining after 2 mins of drug
application was significantly higher in the presence of the diC8PIP2 intracellular solution
(23.4 ± 3.9%, n = 5) than with the control solution (59.5 ± 5.4%, n = 5, p = 0.002,
unpaired Student’s t-test). These findings further support the hypothesis that the
channels underlying the LVA current in SGNs are regulated via binding of PIP2.
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Figure 4.4 PIP2 sequestration inhibits a Kv1-like, LVA current in SGNs. A Representative
current responses to 200 ms voltage steps in 10 mV increments from a holding potential of -73
mV. Traces shown are before (Control, upper panel) and after (middle panel) bath application of
3 μM PIP2-PP. PIP2-PP-sensitive currents are shown in the lower panel and were obtained by
subtraction of PIP2-PP from control currents. B Mean steady-state current-voltage relationships
before (Control, open squares), and after (PIP2-PP, filled squared) PIP2-PP application (3 μM; n 
= 15). Steady-state currents were measured between 15 ms and 5 ms from the end of the
voltage steps described. C Normalised G-V plot of the PIP2-PP-sensitive component. D Effects
of PIP2-PP application on normalised slope conductance (Gs), calculated from a voltage ramp
protocol applied every 10 s (Gs; measured between -63 mV to -53 mV). Gs decreases during the
bath application of PIP2-PP (Control; 1 μM; n = 5) reaching near maximal inhibition ~2 mins post 
application. Inclusion of diC8PIP2 (200 μM) in the intracellular solution significantly slows the 
effect of PIP2-PP (diC8PIP2; n = 7). E Comparison of the rates of Gs inhibition in the absence
(Control; n = 5) and presence of diC8PIP2 (200 μM) in the intracellular solution (diC8PIP2; n = 7).
The time constant of Gs inhibition was calculated by fitting mono-exponential functions to the
data in D. *P<0.05.
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Figure 4.5 The effect of PIP2-PP analogues on SGN LVA currents. A Design of the various
PIP2-PP analogues. These analogues were designed to examine the important structural
features which gave rise to ability to sequester PIP2. The Grey filled box indicates the peptide
structure with positively charged residues in red, negatively charge residues in green and
neutral residues in black. B (Replicated from Figure 4.4B) Mean steady-state current-voltage
relationships before (Control, open squares), and after (PIP2-PP, filled squared) PIP2-PP
application (3 μM; n = 15). C Mean current-voltage relationships before and after application of
an unpalmitoylated analogue of PIP2-PP (Non-Pal PIP2 Peptide, 3 μM; n = 7). D Mean current-
voltage relationships before and after application of a neutrally charged analogue of PIP2-PP
(Neutral-PP, 3 μM; n = 5). E Mean current-voltage relationships before and after application of a
Poly K-palpeptide, a poly-cationic analog of PIP2-PP. (Poly K-PP, 3 μM; n = 5). F Timecourse of
the effect of PIP2-PP application and its various analogues as measured by normalised slope
conductance (Gs). G The effects of PIP2-PP and its analogues on SGN LVA steady-state K+
currents (measured at -53 mv). *P<0.05 .
In order to better characterise the mechanism of action of PIP2-PP and identify the
important structural features which give rise to its pharmacological properties, a set of
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PIP2-PP analogues was designed and tested. These peptides explored the importance of
palmitoylation as well as both the presence and position of cationic peptide residues
within palmitoylated peptide (Figure 4.5A). The importance of the lipid modification
was tested with a non-palmitoylated analogue of PIP2-PP (“Non-Pal PIP2 Peptide”)
which was identical in sequence to the PIP2-PP but was missing the membrane-targeting
acyl group. Robbins and co-workers originally characterised this Non-Pal PIP2 Peptide
as an inactive analogue of PIP2-PP (Robbins et al., 2006). Although a small current
reduction was observed in 2/7 cells, there was no significant effect of the Non-Pal PIP2
Peptide on LVA currents (Figure 4.5B, C, G). The average current remaining after 2
mins of Non-Pal PIP2 Peptide application was 84.6 ± 10.3%, significantly higher than
that of the PIP2-PP (pre- vs post-application: P = 0.187, n = 7, paired Student’s t-test;
PIP2-PP vs Non-Pal PIP2 Peptide application, P<0.001, n = 15 vs n = 7, unpaired
Student’s t-test, Figure 4.5C,G).
The second modification of the PIP2-PP examined was the importance of cationic
residues using a neutrally charged peptide (“Neutral-PP”) where the four positively
charged residues were substituted for uncharged alanine residues in the manner
R2AK8AR9AR10A, to yield an overall neutrally charged, albeit zwitterionic, peptide
(Figure 4.5A). In this case the peptide contained the membrane-targeting palmitoyl
group and only the peptide sequence differed from PIP2-PP. This peptide was not
described in the initial Robbins et al., study but since then other groups have reported
the Neutral-PP to be an inactive analogue and successfully employed it as a negative
control for the PIP2-PP (Buchmayer et al., 2013, Hamilton et al., 2014). The Neutral-PP
showed no activity against LVA current in SGNs. The average current remaining after
Neutral-PP application was 99.6 ± 2.8% (pre- vs post-application: P = 0.5, n = 5, paired
Student’s t-test; PIP2-PP vs Neutral-PP application, P<0.001, n = 15/5, unpaired
Student’s t-test, Figure 4.5D, G).
In order to examine if this cationic charge was the determining factor for PIP2 binding
or whether the specific peptide sequence was also important, a poly cationic analogue of
PIP2-PP (“Poly K-PP”) was tested. In Poly K-PP all the residues in the peptide sequence
were replaced with positively charged lysine residues (Figure 4.5A). The Poly K-PP
mirrored the effect of the original PIP2-PP, inhibiting the LVA current in all of the cells
tested. The average current remaining after Poly K-PP application was 32.1 ± 8.3%
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(pre- vs post-application: P = 0.004, n = 5, paired Student’s t-test; PIP2-PP vs Poly K-
PP: Peptide application, P = 0.36, n = 15/5, unpaired Student’s t-test, Figure 4.5E, G). It
also exhibited a very similar time course of action; a maximal steady-state inhibition
was reached after about 2 mins of perfusion into the bath (Figure 4.5F). This is
consistent with the findings of Robbins et al., that observed that Poly K-PP could induce
similar levels of Kv7 inhibition as PIP2-PP. Additionally, this suggests that it is not the
specific peptide sequence that is required for activity but rather the strong cationic
character which helps it interact with the PIP2 (and most likely other) anionic
phospholipids. Finally, we examined the localisation of a Fluorescein-tagged analogue
of Pal-PIP2 (Fluoro PIP2-PP) under confocal microscopy. 2 mins before examination, 10
µM Fluoro PIP2-PP was added to cultured HEK293 cells. Fluoro PIP2-PP was observed
to localise to the plasma membranes of the cells (Figure 4.6A-C). Very little
fluorescence was observed within the cell cytoplasm suggesting the peptide exerts its
effect by interaction with plasma membrane bound lipids rather than other intracellular
candidates.
Figure 4.6 Fluorescein-tagged PIP2 palpeptide (Fluoro PIP2-PP) localises to the plasma
membrane of HEK293 cells. A Confocal image of cultured HEK293 cells with 10 μM Fluoro 
PIP2-PP in the bathing solution. Fluoro PIP2-PP localises strongly to the plasma membrane.
Excitation wavelength, 488 nm; emission, 543 nm. B DIC image of the same cells. C Combined
confocal and DIC image. Scale bar: 20 μm. 
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In summary, these control experiments demonstrated that PIP2-PP targets the neuronal
plasma membranes and highlighted the importance of palmitoylation and cationic
residues to the efficacy of PIP2-PP in inhibiting SGN LVA currents. Furthermore, the
similarity in the structure-activity relationship between this work and the previous
characterisations provide evidence that the PIP2-PP is acting via PIP2 depletion and not
through an alternate mechanism e.g. direct interaction with the Kv channels.
Figure 4.7 PIP2-PP and DTX-K block the same LVA K+ current componant in SGNs. A
Mean current-voltage relationships of SGNs before (Control, open squares), and after
sequential application of PIP2-PP (PIP2-PP; 3 µM, black squares), and subsequent application
of PIP2-PP with DTX-K (+DTX-K; 100 nM; n = 3, grey triangles). Application of PIP2-PP blocks
an LVA current as discussed but there is no additive effect observed upon the addition of DTX-
K to the bath. B There was no additive effect when the drugs were applied in reverse order (n =
3). C Normalised G-V plots showing a comparison of the PIP2-PP-sensitive component (open
squares) and PIP2-PP+DTX-K-sensitive component (black squares) obtained from the SGN
currents in A. D Similar comparison of the currents obtained from B.
To confirm whether PIP2-PP was inhibiting Kv1-mediated currents, co-application
experiments using both channel toxins and peptide were performed. Following initial
application of 3 μM PIP2-PP, addition of 100 nM extracellular DTX-K failed to further
reduce the LVA current amplitude (Figure 4.7A). A reversal of the order of application
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of the PIP2-PP and DTX-K similarly did not show any enhancement of inhibition after
application of the latter agent (Figure 4.7B). Overlaying the conductance-voltage
relationship of the two groups in both cases show comparable plots (Figure 4.7C, D).
This suggests that the PIP2-mediated LVA currents in SGNs are mediated by Kv1.1-
containing channels.
Figure 4.8 Inhibition of low-threshold voltage-activated current in SGNs is consistent one
week after the onset of hearing. A Mean steady-state current-voltage relationships, from P12-
P15 mice, before (Control, open squares), and after (PIP2-PP, filled squared) PIP2-PP
application (3 μM; n = 11). Steady-state currents were measured at the end of the voltage steps 
described for Figure 4.4A. B Mean steady-state current-voltage relationships, from P20-P21
mice. (n = 4). C The % current inhibition after application of 3 μM PIP2-PP was not significantly
different between the two ages for either LVA currents (measured at -53 mV) or HVA currents
(measured at +17 mV). D Normalised G-V plots showing the PIP2-PP-sensitive components of
P12-P15 and P20-P21 mouse SGN currents.
The inhibitory effect of PIP2-PP was analysed in mice of different developmental ages.
Of the 15 SGN exposed to PIP2-PP in this study, they could be divided into roughly 2
groups by their age - animals at the onset of hearing (P12-15) and animals one week
after the onset of hearing (P20-21). PIP2-PP showed little difference in its inhibitory
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effect on SGN from P12-15 and P20-21 mice (Figure 4.8A, B). In SGN from P12-15
mice the current remaining at -53 mV after PIP2-PP application (77.2 ± 3.3%, n = 11)
was not significantly different to that in SGN from P20-21 mice (66.2 ± 4.2%, n = 4, P
= 0.094, unpaired Student’s t-test). Analysis of the voltage dependence of the PIP2-PP-
sensitive components showed a small but significant difference in the V1/2 (P12-15: -
49.4 ± 0.9 mV, n = 11; P20-21: -55.7 ± 1.6 mV; P = 0.004, unpaired Student’s t-test;
Table 4.1). This suggests the PIP2-PP-sensitive LVA current established by the onset of
hearing may continue to mature at least one week after hearing onset.
Table 4.1 Boltzmann parameters for PIP2-PP sensitive SGN conductances
Age V ½ (mV) k (mV) n
P12-15 -49.4 ± 0.9 6.35 ± 0.44 11
P20-21 -55.6 ± 1.6 7.71 ± 1.4 4
4.2.3 Inhibition of Kv7 mediated current does not increase excitability
Kv7 subunits are encoded by the KCNQ family of genes and form low-threshold
voltage-gated K+ channels when expressed in cell membranes. The Kv7 family are
composed of five members: Kv7.1-Kv7.5, of which four, Kv7.2–Kv7.5, have been
identifies in the neurons (Brown and Passmore, 2009, Robbins, 2001). Kv7 channels
have relatively slow activation times, but do not inactivate and thus typically generate a
steady outward current. They activate at subthreshold potentials and stabilise the
membrane potential in the presence of depolarizing stimuli (Brown and Passmore,
2009). Kv7-mediated currents are highly PIP2 dependent and have been shown to be
important regulators of excitability in neuronal models (Brown et al., 2007). The
contribution of Kv7-mediated currents to SGN excitability was therefore investigated.
To this end, we examined the effedcts the Kv7 blocker, XE991, had on SGN membrane
physiology.
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Under current clamp mode, bath application of 3 µM XE991 failed to increase AP firing
in five rapidly or slowly adapting SGNs (P12-15) (Figure 4.9A, B). Voltage clamp
recordings were also obtained from the same cells in order to determine if XE991 had
any effect on the native currents. Cells were depolarised from a holding potential of -73
mV in 10 mV steps for 1 second before returning to the holding potential. The extended
step length of 1 s was used to examine the effect of XE991 on the slower activating Kv7
channels (Figure 4.9C, D).
Figure 4.9 Effects of the Kv7 blocker, XE991, on SGN in vitro. A Representative voltage
response from a rapidly adapting SGN to 100 pA depolarizing current injections, before
(Control, left) and after the bath application of 3 µM XE991 (XE991; right). B In 5/5 cells, bath
application of 3 µM XE991 failed to increase or resulted in a decrease in the number of APs
fired. C Representative evoked current responses before (Control, left) and after the bath
application of 3 µM XE991 (XE991; right). Cells were held at a holding potential of -73 mV and
stepped from -93 mV to +17 mV in 10 mV increments. Voltage steps were held for 1 s before
returning to the holding potential. D Mean steady-state current-voltage relationships, from P12-
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P15 mice, before (Control, open squares), and after (XE991, filled squared) XE991 application
(1 mM; n = 5). Steady-state currents were measured between 900 ms and 1 s at the end of the
voltage steps described in C. E Current responses from mouse SGN using an “M-current
protocol” (Hernandez et al., 2008) before (Control, left) and after the bath application of 3 µM
XE991 (XE991; right). SGN, held at a potential of -73 mV and were depolarised to -43 mV for 1
s in order to activate neuronal Kv7 currents before being returned to a holding potential of -73
mV for 500 ms. M-current was calculated by measuring the peak amplitude of the tail currents
and subtracting it from the steady state currents at -73 mV (dotted lines). F Mean M-current
amplitudes as calculated from E. Bath application of 3 µM XE991 reduced neuronal M-currents
in 5/5 cells. *p<0.05.
3 µM XE991 blocked an outward Ik in a manner that was not reversible after 5 mins
wash. The effect of 3 µM XE991 on cellular M-currents was also examined. Recordings
were made using an “M-current protocol” (Hernandez et al., 2008) and the M-current
amplitude was calculated as described in Figure 4.9E. In 5/5 cells M-current amplitude
was reduced, with a mean current reduction of 40.7% (79.98 ± 16.06 pA; control vs
47.4 ± 6.5 pA; p = 0.041, paired Student’s t-test, Figure 4.9F) In light of these results,
despite substantial XE991-sensitive currents in SGNs, they do not seem likely to play a
major role in determining the excitability of SGN in vitro.
4.2.4 PLC activation does not inhibit SGN LVA currents
To test whether available PIP2 in SGN could be reduced via native physiological
mechanisms, we employed activators of normal metabolic pathways which may deplete
membrane bound PIP2. The initial approach was to target activation of the Gq/11 G-
protein-coupled receptor (GPCRs) pathway, which subsequently activates PLCβ and 
results in PIP2 hydrolysis. M1, M3 and M5 muscarinic receptors are metabotropic
GPCRs preferentially coupled to Gq/11 and activate PLCβ (Ishii and Kurachi, 2006), 
and so we examined the effects of Oxotremorine-M (Oxo-M), a broad muscarinic
agonist (Birdsall et al., 1978) on outward evoked Ik in SGNs. Under voltage clamp
mode, recordings were made in the absence and presence of 1-10 μM bath applied Oxo-
M. Oxo-M showed little effect upon outward evoked Ik between -73mV to -3mV
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(Figure 4.10A). LVA currents, measured at -53 mV, showed little inhibition at either 1
or 10 μM Oxo-M (1 μM, 93.5 ± 2.9% current remaining, n = 5, p = 0.08; 10 μM, 91.8 ± 
2.6% current remaining, n = 5, p = 0.054, paired Student’s t-test, Figure 4.10B).
Figure 4.10 Effects of muscarinic receptor agonism on the SGN LVA current. A
Representative evoked outward current responses to 200 ms voltage steps in 10 mV
increments from a holding potential of -73 mV. Traces shown are before (Control, Left) and after
(middle panel) bath application of 10 μM Oxo-M. Oxo-M-sensitive currents are shown in the 
right panel and were obtained by subtraction of 10 μM Oxo-M treated currents from control 
currents. B Mean steady-state current-voltage relationships before (Control, open squares), and
after 1 μM (grey squares) and 10 μM Oxo-M (Black squares, n = 5).  
The potential contribution of PLC was also examined using the PLC activator m-
3M3FBS. At doses of 10-50 μM, m-3M3FBS has been shown to increase the hydrolytic 
activity of PLC against membrane bound PIs (Bae et al., 2003). Recordings from SGNs
were made in voltage-clamp mode, and 10 μM m-3M3FBS was applied for a period of 
at least 10 mins to observe the effects. Application of 10 μM m-3M3FBS showed 
variable effects between different SGN currents. There was an inhibitory effect upon
hyperpolarising IH currents (not shown) as well as on the outward IK, an effect most
obvious at higher voltages (Figure 4.11A). Interestingly, in different cells the LVA K+
currents displayed variously, both inhibition and activation in response to 10 μM m-
3M3FBS. This variable drug response is demonstrated in Figure 4.11C by the
comparison of two individual SGNs isolated from a P21 mouse. The current responses
were obtained from single voltage step applied from -73 mV to -53 mV, showing both
an inhibitory (Figure 4.11C, left panel) or stimulatory response (Figure 4.11C, right
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panel). In total, 6/8 neurons showed a decrease in current at -53 mV, whilst 2/8 neurons
displayed increased current at this test voltage. The mean current remaining after 10
mins of 10 μM m-3M3FBS application was 88.2 ± 8.2% (P = 0.93, paired Student’s t-
test, n = 8, Figure 4.11A, B).
Figure 4.11 Effects of the PLC activator, m-3M3FBS, on the SGN LVA K+ current. A
Representative evoked outward current responses to 200 ms voltage steps in 10 mV
increments from a holding potential of -73 mV. Traces shown are before (Control, Left) and after
(middle panel) bath application of 10 μM m-3M3FBS. m-3M3FBS-sensitive currents are shown 
in the right panel and were obtained by subtraction of m-3M3FBS from control currents. B Mean
steady-state current-voltage relationships before (Control, open squares), and after 10 μM m-
3M3FBS application (Black squares, n = 8). C Current responces to a single voltage step, from -
73 mV to -53 mV, showing SGN currents before (black trace), and after 10 mins of 10 μM m-
3M3FBS application (red trace). m-3M3FBS application shows a variable effect on SGN LVA
currents. Inwards sodium transients can be observed in the “LVA stimulation” trace.
4.2.5 PIP2 sequestration inhibits Kv1.1/Kv1.2 heteromeric channel
currents
This work along with other studies has implicated both Kv1.1 and Kv1.2 as contributing
to the LVA current in SGN (Smith et al., 2015, Mo et al., 2002). Previous
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electrophysiological examination the Kv1 family of channels (Kv1.1/β1.1, Kv1.3, 
Kv1.4 and Kv1.5) expressed homomerically in heterologous systems has revealed an
apparent lack of sensitivity to PIP2 (Kruse et al., 2012). Kv1.2 homomeric channels
however, do display sensitivity to PIP2, with an approximate 20-30% reduction in
current amplitude upon PIP2 depletion, as well as an apparent leftward shift of the
voltage dependence (Kruse and Hille, 2013, Rodriguez-Menchaca et al., 2012).
However, there has been no investigation to date as to the effects of PIP2 modulation on
Kv1heteromeric channels expressed in heterologous systems.
In order to re-examine the effects of PIP2 depletion on Kv1.2 homomeric channels, the
Kv1.2 channel subunits were expressed transiently in HEK293 cells. In line with
previous findings, we observed that Kv1.2 currents were significantly decreased
following application of PIP2-PP (18.6 ± 5.5% at +57 mV, n = 6; Figure 4.12A, B).
Unlike previous findings however, no leftward shift in the V1/2 of activation was
observed (control: V1/2 = -11.7 ± 2.2 mV; PIP2-PP: V1/2 = -11.3 ± 2.2 mV, n = 6, p =
0.64, paired Student’s t-test). The notably greater reduction of the LVA current in SGNs
by PIP2-PP application and the proposal that Kv1.1/Kv1.2 heteromeric channels likely
mediate this LVA current (Smith et al., 2015), led to the investigation of the effects of
PIP2-PP application on Kv1.1/Kv1.2 heteromeric channels. Application of PIP2-PP to
Kv1.1/Kv1.2 channel currents resulted in larger inhibition (77.7 ± 5.1% at +57 mV, n =
5; Figure 4.12A, C) compared to the Kv1.2 homomers (p<0.001, unpaired Student’s t-
test). Once again, there was no significant shift in the V1/2 of activation (control: V1/2 = -
21 ± 3.7 mV; PIP2-PP: V1/2 = -19.7 ± 6 mV, n = 4, p = 0.63, paired Student’s t-test).
Intracellular dialysis with diC8PIP2-containing ICS produced a marked decrease in the
extent and slowing of the rate of inhibition by PIP2-PP (Figure 4.12C, D). This
confirmed that the effect of PIP2-PP on Kv1.1/Kv1.2 channels was caused by PIP2
sequestration rather than a direct action on the channel. It was noted that the reduction
of heterologous Kv1.1/Kv1.2 currents using PIP2-PP resembled the effect observed on
the LVA current in SGNs, further supporting the proposal that the LVA current is
mediated by Kv1.1/Kv1.2 heteromers.
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Figure 4.12 PIP2 sequestration preferentially inhibits Kv1.1/1.2 heteromeric channels
expressed in HEK293 cells. A Representative outward evoked current traces from Kv1.2
homomeric channels (left) and heteromeric Kv1.1/1.2 channels (right), before (top) and after 1
μM PIP2-PP application (middle). PIP2-PP-sensitive currents are shown (bottom) and were
obtained by subtracting PIP2-PP application traces from control traces. B Normalised steady-
state current-voltage plots for Kv1.2 homomeric channels before (control) and after the
application of PIP2-PP (PIP2-PP; 1 μM; n = 6). C Normalised steady-state current-voltage plots
for Kv1.1/Kv1.2 channels before (control) and after the application of PIP2-PP (PIP2-PP; 1 μM; n 
= 5). In B and C, steady-state currents were measured at the end of 200 ms voltage steps
applied in 10 mV increments from a holding potential of -73 mV. D Normalised slope
conductance (Gs) of Kv1.1/Kv1.2, calculated from a voltage ramp protocol applied every 10 s
(Gs; measured between -63 mV to -53 mV) decreases during application of PIP2-PP (Control; 1
μM; n = 7). The addition of diC8PIP2 (200 μM) to the intracellular solution, reduces the effect of 
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PIP2-PP (diC8PIP2; n = 5). E, Comparison of the rate of Kv1.1/Kv1.2 Gs inhibition by PIP2-PP in
the absence (control; n = 7) and presence of diC8PIP2 (200 μM) in the intracellular solution 
(diC8PIP2; n = 5). The time constant of Gs inhibition was calculated by fitting mono-exponential
functions to the Gs data in D.
4.3 Discussion
This chapter presents evidence for a dependence of rapid adaptation in murine, post
hearing-onset SGNs on endogenous PIP2 levels. This was demonstrated by depleting
membrane bound PIP2 levels via two separate methods; inhibition of PIP2 synthesis and
PIP2 sequestration. These experiments revealed that the effect of PIP2 on spike
adaptation was via Kv1.1/1.2 heteromeric channels. This work presents a new
mechanism of action for PIP2 in the regulation of neuronal excitability which merits
further investigation.
4.3.1 Experimental depletion of cellular PIP2
Initial work in this chapter focused on the effects of the inhibition of PIP2 synthesis on
SGN membrane electrophysiology. Here, three conditions of PI depletion were induced
- two focusing on PI3K inhibition and one on PI4K inhibition. Only the PI4K inhibition
produced marked reductions in rapid adaptation. A limitation to this approach is the
inability to make pre and post- incubation recordings from SGNs. Because of the high
degree of heterogeneity inherent in SGN, it is impossible to discern what changes in
SGN membrane properties might be giving rise to the observed differences in
population firing phenotypes. Another potential caveat to this approach is that
wortmannin affects other PI pathways. Though wortmannin discriminates between
PI3Ks and PI4K it shows little discrimination between subtypes of PI3Ks, or the
reactions they catalyse. In practice this means that whilst PI3K inhibition results in
reduced levels of PIP3, it also results in reduced pools of PI(3)P (and consequently
PI(3,5)P2), as well as reduced pools of PI(3,4)P2 (see Figure 1.11). This fact is often
neglected in discussions of wortmannin induced effects, probably because of a paucity
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of knowledge about the biological roles of these other PIs, but also because PI(4,5)P2
makes up 99%, by weight, of all the possible PIP2 molecules in the cell (Lemmon,
2008). Despite these concerns, the fact that PI3K does not substantially affect
excitability and the observation that the inclusion of diC8PIP2 in the patch pipette
rescued the effects of PI4K inhibition suggets that PIP2 is the best candidate as the
regulator of SGN excitability.
One substantial concern was the observed inhibition of outward Ik upon addition of
LY294002 to the bath. Due to rapid onset and wash off of this effect (~1 minute), this
was not believed to be a result of PI3K inhibition. Consistent with this idea, other labs
have noted similar effects of this drug. The first possible non-PI3K electrophysiological
involvement of LY294002 was a reported block of Kv currents in a MIN6 β cell line via 
direct action on the channel (El-Kholy et al., 2003). A detailed study of the effects of
LY294002 on the human Kv1.5 channel determined that it appears to act as an open
channel blocker, independently of its effects on PI3K activity, and provided evidence
for a putative binding site within the pore region of the channel (Wu et al., 2009). This
provides a substantial concern about the use of LY294002 when investigating the role
of PIP3 on ion channels and highlights the need for more specific, electrophysiologically
inert PI3K and PI4K inhibitors for the examination of PIP2 on membrane ion channels.
To overcome some of these potential limitations an alternative method of PIP2
sequestration was attempted. PIP2-PP provides a simple, efficient and rapid method of
PIP2 capture which had been characterised initially to inhibit the activity of the highly
PIP2 dependent Kv7.2/Kv7.3 channels in both heterologous expression systems as well
as rat superior cervical ganglion cells (Robbins et al., 2006). When this work began,
only the initial characterisation of the peptide had been published but since its initial
documentation it has now been employed successfully in a two different studies to
examine the effects of PIP2 on the human dopamine transporter and serotonin
transporter (Hamilton et al., 2014, Buchmayer et al., 2013). PIP2-PP takes advantage of
the known affinity of Kv7 channels for PIP2, and is comprised of a peptide sequence
known to be important in the interaction between PIP2 and Kv7.2/3 (Zhang et al., 2003).
PIP2-PP most likely acts by embedding within the plasma membrane and interacting
with PIs at the intracellular leaflet of the membrane. This is evidenced by the
ineffectiveness of the non-palmitoylated PIP2-PP analogue in our study and experiments
121
from Robbins et al. that report inhibition of M-current in response to intracellular
application of a non-palmitoylated PIP2-PP analogue. Interestingly, a concentration of at
least 10-fold higher of the non-palmitoylated peptide was required to produce an
equivalent inhibition to that of the externally applied PIP2-PP (Robbins et al., 2006).
This indicates that the palmitoyl group is not just essential in allowing access of the
PIP2-binding peptide to the inner leaflet of the membrane, but it also markedly
increased its ability to sequester PIP2, most likely by ensuring a high membrane
partitioning of the PIP2-binding peptide. This is consistent with experiments here and
from Robbins et al., that show strong targeting of a fluorescent PIP2-PP analogue the
plasma membrane.
The results here also demonstrated that although the palmitoylated peptide sequence,
Pal-HRQKHFEKRR, is sufficient to sequester PIP2, it is not obligatory for the peptide
to function. Rather, the evidence points to both palmitoylation and the strong cationic
nature of the peptide as the important features for activity. This is consistent with
findings from the original characterisation which also demonstrated the efficacy of
“poly K-PP” to inhibit M-current (Robbins et al., 2006). In the same work it was shown
that up to 2 positive residues in the PIP2-PP could be mutated to neutral alanine (net
peptide charge, +2) without losing considerable potency. Conversely they also showed
that a poly-aspartate or non-palmitoylated analogue of PIP2-PP did not sequester PIP2.
This suggests that PIP2-PP is not acting in the manner of classic protein-substrate
recognition but rather interactions are most likely driven by electrostatics.
Consequently, this also means that PIP2-PP most likely binds a range of anionic
phospholipids present in the plasma membrane. Interestingly, results from Thomas et al.
have shown that the C-terminus peptide from Kv7.1 pulls down a range of different PIs
in various abundances from cell lysates (Thomas et al., 2011). The homologous amino
acid sequence in Kv7.1 varies somewhat from the Kv7.2/7.3 sequence. Nonetheless, the
results from Thomas et al. suggest similar broad electrostatic interactions underlie the
Peptide-PIP2 affinity.
The excitatory effects of the PIP2 depletion were attributed primarily to its ability to
modulate SGN Kv1-mediated LVA currents, as opposed to other ionic conductances.
Other mechanisms cannot be completely ruled out, but some observations lead us to
believe it acts via modulation of Kv1-mediated current. Firstly, PIP2-PP has a negligible
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effect on cells which were previously treated with a Kv1 channel blocker (Figure 4.7),
or which had negligible LVA currents (not shown). Secondly, PIP2-PP recapitulates the
increased excitability observed by other KV1 blockers such as DTX-K (Figure 4.3B).
Finally, the contribution of the other major PIP2 sensitive conductance, Kv7, does not
seem to regulate spike firing (Figure 4.9) (Lv et al., 2010).
4.3.2 Physiological mechanisms of PIP2 depletion in SGN
The question of whether SGNs employ PIP2 modulation of LVA currents in a
physiological context remains open. The advent of recent genetic manipulations has
allowed highly responsive methods of PIP2 depletion; techniques such as voltage-gated
phosphatase activation or drug induced-membrane translocation of specific
phosphatases allow the experimenter to rapidly reduce membrane bound PIP2 levels in a
precise manner. However these techniques, along with the methods of PIP2
sequestration described here, do not fully address the question of whether the effects
observed can be induced by physiological means alone i.e. whether a cell can achieve
the same effects via endogenous methods of PIP2 depletion. Evidence in this direction
would support the hypothesis that PIP2 regulates SGN signalling in vivo. To this end we
employed two alternate methods of PIP2 reduction. The first method involved the
attempted activation of muscarinic G-protein-coupled receptors (GPCRs) to stimulate
PLC activation to hydrolyse PIP2, and the second method involved the use of a PLC
activator.
Based on the results observed in the PIP2 depletion experiments, muscarinic activation
was investigated as a possible mechanism of LVA current modulation. Muscarinic
receptors (mAChRs) respond to the presence of acetylcholine (ACh) and other
muscarinic agonists. They can be classified into 5 subtypes (M1-M5), which are
distinguished by their different G protein-receptor complexes, pharmacological
responses and differential distribution and expression. M1, M3 and M5 receptors act via
the Gq/11 GPCR pathway which signals through the Gα complex and resulting PIP2
hydrolysis. M2 and M4 act via the Gi/o pathway which signals via Gβγ (Brown, 2010). 
This work attempted to take advantage of the M1, M3 and M5 Gq/11 pathway as a
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means to reduce cellular PIP2, a pathway responsible for the muscarinic inhibition of
Kv7-mediated M-currents in neurons (Brown et al., 2007).
Evidence supports a function for Gq/11-linked muscarinic receptors in normal hearing.
Isolated SGNs from post hearing-onset animals showed increased intracellular [Ca2+] in
response to ACh and muscarine (Rome et al., 1999), and muscarinic agonists activate
transient nonselective cation currents in isolated rat SGNs (Ito and Dulon, 2002). The
recordings here did not show the transient cation conductance reported previously, but
slower, rather than transient effects, were the focus of this study. Oxo-M did produce a
small but non-significant reduction in SGN LVA current. The inability of Oxo-M to
produce significant inhibition of the LVA current could have many explanations.
Muscarinic receptor activation may simply not reduce PIP2 levels sufficiently to induce
PIP2 dissociation from the Kv1 channels. For example, the highly PIP2-dependent
channel Kir2.1 was shown to be insensitive to muscarinic activation, but it could be
inhibited by other forms of PIP2 depletion such as VSP activation (Kruse et al., 2012).
Other possible explanations are that mAChRs and PLC exist in spatially distinct
patterns to SGN Kv channels and are thus quite poor at modulation their activity. PLC
has been shown to exist in discrete microdomains within neurons and may act to exert
local control over proximate ion channels (Delmas et al., 2004).
We still have only an incomplete knowledge of the role of mAChRs in the cochlea. The
location and function of the various muscarinic receptors and subtypes in the cochlea
are still under investigation. Immunohistochemistry of the cochlea showed the presence
of moderate levels of M3 and M5 receptor subtypes in the rat SGNs and weak staining
observed for M1 receptor (Khan et al., 2002, Safieddine et al., 1996). These results are
consistent with RT-PCR findings. However, mice lacking the Gq-coupled mAChRs
(M1, M3, or M5) have been shown to display normal cochlear function, as measured by
auditory brainstem response and distortion product otoacoustic emission recordings,
casting doubt on a functional role for Gq-coupled mAChRs (Maison et al., 2010). The
function of such muscarinic signalling is still speculative. ACh represents the primary
neurotransmitter of the olivocochlear efferent system, which provides feedback to
cochlear hair cells and SGNs. Feedback from the lateral olivocochlear (LOC) nerves
therefore may modulate SGN excitability via mAChRs (Maison et al., 2010). The
depolarisation associated with mAChRs activation has been hypothesised to increase
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cochlear nerve fibres’ excitability in vivo, based on observations that cochlear nerve
fibres increase in excitability during ACh perfusion of the inner ear (Felix and
Ehrenberger, 1992). One final caveat to note when interpreting this result is to consider
the limits of the preparation used for these recording. Our cultured SGN preparations
are typically missing both peripheral and central neurites due to the mechanical and
enzymatic treatment of the ganglion prior to recording. In other neuronal systems, such
as the sciatic and vegus nerve, considerable levels of functional M1 and M3 are
localised to the nerve fibres (Day et al., 1991, Sierro et al., 1992). Our system is
necessarily limited to isolated somatic recordings. Repeating the experiment in a more
intact preparation, such as a cochlear slice model (Jagger et al., 2000) where the neurites
are left intact, could circumvent this limitation.
For these reasons, PLC activation was attempted directly, using m-3M3FBS (Bae et al.,
2003). m-3M3FBS considerably inhibited outward Ik in SGNs, but it produced
inconsistent and contradictory effects. One concerning issue was that m-3M3FBS might
be having a direct effect on the outward IK. Much of the (particularly HVA) current
inhibition seemed to occur through a PIP2 independent manner. Inhibition of the HVA
current was observed in cells with no LVA current and in cells with LVA, strong
inhibition of outward Ik persisted even when PIP2-PP had been added beforehand (not
shown). PLC independent effects have been noted for m-3M3FBS; m-3M3FBS has
been shown to increase intracellular [Ca2+] in a PLC-independent manner (Krjukova et
al., 2004), but it is also reported to block outward currents in murine colon cells (Dwyer
et al., 2010). Unfortunately m-3M3FBS is the only well-characterised PLC activator
available commercially, highlighting the need for more specific PLC activators for
electrophysiological investigation. Notwithstanding the above-mentioned caveats, the
lack of an effect Oxo-M and m-3M3FBS on excitability suggests PIP2 depletion via
PLC activation is insufficient for inhibiting SGN LVA in vitro.
4.3.3 Mechanism of PIP2 modulation
Despite the importance of PIP2 modulation across a range of K+ ion channels, the
molecular mechanisms of its actions remain elusive. What is understood, from the
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functional and structural study of K+ channels such as TRP, KCNQ, hERG, Kir and
HCN is that PIP2 seems to play an important role in the stabilisation of the open state
conformation of these channels (Brauchi et al., 2007, Hansen et al., 2011, Zaydman et
al., 2013, Rodriguez et al., 2010) despite its relatively low concentration within cells:
~1% total lipid content (Hilgemann et al., 2001). Whilst investigations into the action of
PIP2 on Kv1.1 and Kv1.2 regulation have been only very recent, the findings from those
studies will be the subject of the following discourse - with mention of the important
finding from both studies on Shaker and KCNQ channels where these may provide
mechanistic insights into the regulation of Kv1.1 and Kv1.2.
An array of biological lipids composes the physical and chemical environment of Kv
channels. They affect membrane channel function primarily in one of two ways. Global
or bulk effects are related to the structure and composition of the cell membrane and
how the channels embed and interact within it. For instance the activation of the Shaker
channel is markedly suppressed if it is reconstituted in a positively charged bilayer
(Schmidt et al., 2006). Changes in the lipid composition have also been suggested to
induce mechanosensory effects in ion channels related to changes in membrane lateral
tension (Combs et al., 2013). However these effects are to be unlikely to account for
PIP2 activity. The primary criticism has been that the levels of PIP2 within cells are
simply too low (~1%) to significantly impact the membrane biophysics in these ways
(Kasimova et al., 2014). Specific or cofactor lipid interactions, in contrast, involve
interactions between particular parts of the ion channel and the lipid (usually the
charged headgroup) which act to promote or restrict channel activity.
One notable effect is the ability of PIP2 to relieve the N-type inactivation that is a
characteristic of particular voltage-gated K+ channels, e.g. Kv1.4 and Kv3.4. These
channels display strong and rapid inactivation of their currents due to the presence of an
N terminus “ball domain” located on one of their α pore-forming subunits. But this form 
of PIP2 modulation and its mechanism will not be the focus here (Decher et al., 2008,
Oliver et al., 2004) but to note that Kv1.1 can show this N-type inactivation property
when it is co-expressed with the ball domain-containing accessory subunit, Kvβ1.1 and 
that the application of exogenous PIP2 in this context removes this N-type inactivation
(Oliver et al., 2004).
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The first direct evidence for PIP2 regulation of Kv channels was the discovery that PIP2
hydrolysis underlay the receptor-mediated inhibition observed in Kv7 channels (Zhang
et al., 2003, Suh and Hille, 2002). Kv7 channels show exquisite sensitivity to the
presence of PIP2 which has made them a useful tool in studying the PIP2 regulation of
ion channels. A series of experiments has now the determined that the long chain C-
terminus to be the most likely site of action for PIP2 on Kv7 channels. This was
elegantly demonstrated by Hernandez and co-workers who looked at the apparent
sensitivities of the Kv7.3 and Kv7.4 homomeric channels (the latter being ~100 fold
less sensitive to PIP2 than the former); by exchanging the long chain C-termini, they
could effectively reverse the apparent phosphoinositide sensitivity (Hernandez et al.,
2008). Mutational analysis of the Kv7 channel subunits lead to the identification of key
residues that bestow PIP2 sensitivity upon the functional channels. These were often,
but not exclusively, basic residues. At least two prospective binding sites for PIP2 have
now been proposed based on clusters of such key residues in close proximity within the
amino acid sequence (Hernandez et al., 2008, Telezhkin et al., 2013, Thomas et al.,
2011). Reduced interactions of the long chain flexible C-termini with the anionic
headgroups of membrane bound PIP2 was proposed to account for the reduced
probability of opening and reduced maximal opening observed in the mutant channels.
Interestingly, much of the same work has revealed that these so-called PIP2 sensitive
Kv7 channels show an affinity for many other phosphoinositides; the C-terminus
peptide effectively pulling down a range of PIs in vitro (Thomas et al., 2011).
Furthermore, PI(4)P, PI(3,4,5) and even some non-PI lipid phosphates have been shown
to be able to stimulate M-type channel activity when expressed in mammalian cells
lines (Telezhkin et al., 2012).
Unfortunately, a lack of homology between C-termini of Kv1 and Kv7 channels, and
the absence of a clear analogous PIP2 binding site, has made inferring information about
the activity of PIP2 on Kv1 channels difficult. In fact little was known about the PIP2
sensitivity of the greater Kv family of channels until 2012, when initial findings
suggested Kv channels may have little or no sensitivity to PIP2 (Kruse et al., 2012). The
Hille laboratory examined the effects of PIP2 depletion on, amongst others,
Kv1.1/Kvβ1.1, Kv1.3, Kv1.4 and Kv1.5 channels expressed in tsA-201 cells. They 
employed 3 distinct mechanisms of PIP2 depletion and found that apart from Kv7
channels, Kv channels were, in general, insensitive to PIP2 (Kruse et al., 2012). In 2012,
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Rodriguez-Menchaca et al., reported the first observed sensitivity of the Kv1.2 channel
to PIP2 in Xenopus oocyte excised patches (Rodriguez-Menchaca et al., 2012). This was
somewhat surprising given the previous findings that many other close members of the
Kv1 family were insensitive to the phosphoinositide. They reported that the presence of
PIP2 stabilised the voltage sensor of Kv channels, decreasing its sensitivity to changes
in membrane voltage (observed as a right-shifted I-V relationship) whilst
simultaneously promoting the stability of the open state of the channel (demonstrated by
an increase in open probability during single channel recording).
Through these experiments Rodriguez-Menchaca et al., also began to make the first
mechanistic insights into the possible mode of action of PIP2. Mutational analysis of a
number of positively charged residues in the N terminus and S4–S5 linker region of
Kv1.2 – a region which acts to couple changes at the voltage-sensor domain (VSD) to
the pore domain (PD) of the Kv channels – along with docking and molecular dynamic
simulations suggested key interaction of PIP2 with polybasic domains in these channels.
These interactions, they suggested, lead to the observed dual regulation of Kv1.2. These
results were soon replicated in the Shaker channel (Abderemane-Ali et al., 2012) which
observed similar decreases in currents and V1/2 shifts. Modelling of the Kv1.2 channel
found a similar site of action (S4–S5 linker region) but expanded the mechanism of
action to include positive residues from the S5 gate region. This model of PIP2
interaction has been leant credibility by its similar pattern of binding interactions to that
of PIP2 with Kir2.2 (Rodriguez-Menchaca et al., 2012, Hansen et al., 2011). The
interactions of PIP2 with positively charged residues in the S4–S5 linker region act to
constrain the movement of the VSD, resulting in desensitisation of the channel to
changes in membrane voltage, and also to stabilise and maintain the channel once it is
in its open state. In their 2012 paper, Abderemane-Ali et al. summarised these effects -
“PIP2 stabilises the gate in the open state and the voltage sensor in the resting state”
(Abderemane-Ali et al., 2012).
Interestingly, the two components of this dual regulation seem to be distinct and
separable phenomenon, distinguishable by differences in kinetics, PIP2 sensitivities and
molecular components i.e. mutation of protein residues could be shown to discriminate
between effects. This insight into the nature of these effects, and the hypothesis that
they may rely on distinct and separable interactions between PIP2 and specific cationic
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residues in Kv1.2, provide a plausible explanation for the difference in responses seen
across a range of experiments, including our own. Differences in the method of PIP2
depletion has been shown to be able to selectively affect the voltage dependence of
activation without reducing overall current amplitude (Rodriguez-Menchaca et al.,
2012). Further example comes from the effects of PIP2 depletion were examined in a
mammalian expression system. Although the effects on the evoked current amplitude
are reproduced (20-30% reduction depending on the method of depletion used), the
effects upon the voltage dependence vary considerably (only -3.5 mV shift in HEK293
cells, compared to -14 mV in oocytes (Kruse and Hille, 2013)). This study reports a
mean reduction of Kv1.2 current by ~20%, in line with others, but there was no
observed change in the V1/2 of activation in either Kv1.2 homomeric channels or
Kv1.1/1.2 heteromers. Without a comprehensive mechanistic understanding of how
PIP2 interacts with Kv1.2 at a molecular level it is impossible to offer a satisfying
explanation as to the variation in results across experiments. But it is conceivable that
differences in experimental conditions, expression systems, or membrane architecture
may differentially affect some PIP2 interactions over others and give rise to the
variations observed.
More in-depth molecular dynamics simulations have borne out the view that PIP2
modulation arises out of electrostatic interactions with the channel at the inner leaflet of
the membrane but has questioned if open-state stabilisation alone accounts for the gain-
of-function effects observed by PIP2. Kasimova et al., in agreement with the previous
work from Rodriguez-Menchaca et al., found that PIP2 made multiple robust salt bridge
interactions with positively charged residues in both the S4 VSD as well as the S4-S5
linker region (Kasimova et al., 2014). They suggested that the proximity of a number of
cationic residues from the S4–S5 linker with positive charges from the bottom of the S4
VSD lead to a pocket of excess positive charge at the inner membrane forming a sort of
“PIP2-binding pocket” for the highly negatively charged PIP2 molecules. Interestingly
however, they found that when the channel is in the activated state, the S4 helix is in a
conformational different position and embedded further in the membrane and none of its
positive residues are involved in electrostatic interactions with PIP2. However there
were still robust interactions between PIP2 and positive residues in the S4–S5 linker, as
well as new interactions made with the distal positive residues of S6 pore forming helix.
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In summary, the modulatory effects of PIP2 on Kv channels can be interpreted in two
ways. One view is that PIP2 stabilises the open configuration of the channel by making
energetically favourable interactions with positive residues when the channel is in its
open state, particularly those in the S5 or S6 gate region. In this model, in the absence
of PIP2, a depolarizing voltage activates the VSD, which is weakly couple to the
channel pore, and results in fluctuations of the channel between an open and closed
state, thus producing a small current. When PIP2 is present however, it interacts with the
channel to stabilise the open conformation, resulting in larger currents. This hypothesis
might suggest that channels lacking a VSD could also avail of this mechanism. This
has, incidentally, proved to be the best current understanding of how the Kir family of
channels are modulated by PIP2 (Huang et al., 1998). This is also consistent with results
from single channel recordings of voltage-independent potassium KATP channels, and
simulations of Kv7.1 and Kv11.1 currents that implicate PIP2 in stabilizing the open
state, by acting on the final concerted opening transition (Loussouarn et al., 2003,
Shyng and Nichols, 1998). It also explains the observations that mutations in the
positive residues which are involved in these putative open-state stabilising interaction
(such as those in the in the distal S6 helix region), significantly reduce the channels
sensitivity to PIP2 (Thomas et al., 2011).
A second interpretation is to reframe the view of PIP2 sensitivity in terms of a Kv
channel’s ability to effectively couple, in the absence of anionic lipids, changes in
membrane potential to changes in channel activity (Kasimova et al., 2014). Kv channels
such as Kv1.3 or Kv1.4 which show no sensitivity to reductions in endogenous levels of
PIP2 (Kruse et al., 2012), can be imagined to produce effective communication between
the VSD and the PD. Therefore, conformational changes in the channel can occur
without needing additional stabilisation from membrane-bound phospholipid. However,
in highly PIP2-dependent channels in the absence of PIP2, although a depolarizing
voltage may activate the VSD, the channel itself will remain closed as a result of
weakened interactions between the S4-S5 region and S6 region. As recent experiments
on the PIP2-dependent Kv7.1 channel have demonstrated, open state stabilisation is not
sufficient to explain PIP2 dependence but rather, this coupling of VSD-PD is not
possible without the stabilisation of anionic lipids (Zaydman et al., 2013). It is obvious
that these two mechanisms of action are, at least in theory, distinguishable with their
modes of action dependent on distinct and separable interactions. Future work should
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focus on identifying which mechanism, if either, best explains PIP2 activity. One key
difference is that the former interpretation requires only that PIP2 make contact with
residues which stabilise the open state of the channel, whilst the latter relies on the PIP2
binding site being at least partly formed by the S4–S5 linker (Kasimova et al., 2014).
Also noteworthy is the fact that this mode of action is distinguishable from that of
negatively charged lipids other than PIP2 that are known to regulate Kv channel activity
such as polyunsaturated fatty acids and ceramide-1-phosphate. In these cases the
negatively charged lipids are proposed to interact with channel at the external leaflet of
the membrane (Combs et al., 2013, Borjesson and Elinder, 2011).
An important finding in this study has been the higher sensitivity of heteromeric
Kv1.1/1.2 channels compared to that of homomeric Kv1.2 channels when expressed in
HEK293 cells. In light of the discussed mechanisms of PIP2 regulation of Kv1.2, there
may be a number of possible explanations for this effect. A simple explanation is that
the Kv1.1 subunit is highly PIP2-dependent and confers a strong PIP2-dependance upon
the heteromer. This is a somewhat naïve hypothesis and there is, of course, no guarantee
that even should Kv1.1 show high PIP2 sensitivity that the heteromer should, as
Kv1.1/Kv1.2 heteromers are known to show quite different pharmacological properties
than the sum of their constituent subunits would predict and even show different
pharmacological sensitivities depending arrangement of the subunits within the
heteromers (Al-Sabi et al., 2013). Notwithstanding these caveats, in order to examine
this possibility, recordings from HEK293 cells transiently transfected with the Kv1.1
subunit were attempted but were largely unsuccessful. The preponderance of transfected
cells displayed no voltage-evoked current responses and the few cells which displayed
voltage-evoked currents were too unstable to obtain meaningful recordings from. This
difficulty most likely arises from the poor protein trafficking ability and low cell surface
expression of the Kv1.1 homomer (Manganas and Trimmer, 2000). Experiments using
cDNA to express the Kv1.1 subunit in HEK293 cells show that although strong Kv1.1
subunit accumulation is seen at the Endoplasmic Reticulum less than 4% of transfected
cells show any Kv1.1 surface expression (Manganas and Trimmer, 2000). This is a
result of an ER retention motif in the Kv1.1 peptide (see Kv channel biogenesis). Kv1.2
homomers in contrast show much higher levels of cell surface expression (~20%). As a
result, Kv1.1 sensitivity to PIP2 has only previously been examined when co-expressed
with auxillary subunits, such as the Kvβ1.1 auxiliary subunit, where it seems to act via 
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different mechanism (Oliver et al., 2004). It would be instructive to learn if Kv1.1 could
confer sensitivity to PIP2 if coexpressed with other PIP2 insensitive subunits such as
Kv1.4, which have been shown to produce surface expressed heteromeric channels in
HEK293 (Manganas and Trimmer, 2000).
Another suggestion is that Kv1.1/Kv1.2 heteromeric channels may have a lower affinity
for PIP2 compared to the Kv1.2 homomer. As a result PIP2-PP may be able to compete
more effectively for channel-bound PIP2. A similar rational was employed to explain
the surprising ineffectiveness of PIP2-PP in inhibiting the highly PIP2-dependent Kir2.1
channel (Robbins et al., 2006). This distinction between “affinity” and “sensitivity” is
an interesting and important one. A channel may be highly PIP2 sensitive and almost
completely unable to function in its absence, but have such a high affinity for the PI that
PIP2 levels have to be reduced very low before PIP2 can reasonably be expected to
become dissociated. This has important experimental and physiological implications.
Channels highly sensitive to, and highly dependent on, changes in membrane bound
PIP2 levels will be best suited to responding to signalling cascades which result in PIP2
hydrolysis. For instance, the strong inhibition of M-current observed upon muscarinic
receptor agonism (Zhang et al., 2003). At a molecular level, it is easy to understand how
these effects arise out of distinct chemical interaction of PIP2 with the channel. The
sensitivity of a channel to the presence of PIP2 arises, as discussed above, from the
activity of PIP2 in stabilising the open configuration of the channel, or alternately, in the
coupling of the VSD with the PD. The affinity of PIP2 for a channel however is a
reflection of the strength of the interactions between PIP2 and the channel. These
interactions are primarily electrostatic interactions between the strongly negatively
charged headgroup of PIP2 and densities of positive charge located at the inner leaflet of
the channel. This distinction is an important consideration when interpreting results
which used PIP2 depletion or addition to modulate channel function.
From what is known about the binding site and putative mechanism of action of PIP2,
explanations of the observed effects based on sequence comparisons alone are difficult
to justify. Figure 4.13 shows the sequence of the putative Kv1.2-PIP2 interacting region
as predicted by mutagenesis and computational studies (Rodriguez-Menchaca et al.,
2012, Kasimova et al., 2014) aligned with mouse Kv1.1 and the Shaker channel
(Drosophila melanogaster). The alignment highlights important interacting residues that
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have been determined by molecular dynamics and docking simulations (yellow) as well
as residues that have been shown empirically to have a role in the channels sensitivity to
PIP2 (boxed). The primary sequences of the two proteins share a high sequence
homology and are identical within the putative PIP2 interacting region. There was no
difference between residues known, by mutagenesis experiments, to be important in
mediating PIP2 sensitivity. Neither, were there were any differences between residues
which have been implicated, by molecular dynamics and docking studies, to interact
with PIP2 at the channel (Figure 4.13). Changes in the molecular interactions which
occur at the putative PIP2 binding site, if responsible for the differences in PIP2
sensitivities between the Kv1.2 homomeric channel and Kv1.1/Kv1.2 heteromeric
channel, must arise out of more long distance residue effects. Finally, despite the high
similarity between Kv1.1 and Kv1.2 subunits within the putative PIP2 binding site, the
global effects of incorporating different subunits into a functioning channel are
unknown. Whether or not the heteromer resembles closely the binding site as projected
onto the crystal structure of the Kv1.2 homomer is not yet clear. Homology modelling
of the heteromer or, more ideally, a crystal structure is needed to speculate further on
the mechanisms that underlie these differences.
________S4______ _ S4-S5_ _ _______S5_________
Shaker KSSNQAMSLAILRVIRLVRVFRIFKLSRHSKGLQILGRTLKASMRELGLLIFFLFIGVVL
mKv1.1 QKGEQATSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKASMRELGLLIFFLFIGVIL
mKv1.2 QQGQQAMSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKASMRELGLLIFFLFIGVIL
:..:** ******************************:********************:*
_________ Pore Helix_ ________S6________
Shaker FSSAVYFAEAGSENSFFKSIPDAFWWAVVTMTTVGYGDMTPVGVWGKIVGSLCAIAGVLT
mKv1.1 FSSAVYFAEAEEAESHFSSIPDAFWWAVVSMTTVGYGDMYPVTIGGKIVGSLCAIAGVLT
mKv1.2 FSSAVYFAEADERDSQFPSIPDAFWWAVVSMTTVGYGDMVPTTIGGKIVGSLCAIAGVLT
********** . :* * ***********:********* *. : ***************
___________________
Shaker IALPVPVIVSNFNYFYHRETDQEEMQSQNFNHVTSCPYLPGTLGQHMKKSSLSESSSDMM
mKv1.1 IALPVPVIVSNFNYFYHRETEGEEQ--AQLLHVSS-PNLASDSDLS-RRSSSTISKSEYM
mKv1.2 IALPVPVIVSNFNYFYHRETEGEEQ--AQYLQVTSCPKIPSSPDLKKSRSASTISKSDYM
********************: ** : :*:* * : . :*: : *.*: *
Figure 4.13 Sequence alignment of the voltage-sensor domain and pore domains of the
Shaker, Kv1.1 and Kv1.2 channels. In bold are the important channel structures. In the Kv1.2
sequence, residues which are thought to be important to PIP2 modulation are highlighted.
Boxed: Mutations in these residues affect PIP2 modulation of the channel. Yellow: Interactions
observed by molecular dynamics and docking simulations. Data on important residues obtained
from Rodriguez-Menchaca 2012, Kasimova 2012, Abderemane-Ali 2012.
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Chapter 5
Investigating the effects of free fatty acids on Kv1.2-
mediated currents
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5.1 Introduction
5.1.1 Free fatty acids are modulators of neuronal electrophysiology
In the preceding chapter, Kv1.1 and Kv1.2-mediated LVA K+ currents were shown to
be highly dependent on the presence of the membrane phospholipid PIP2. For this
reason, further investigation of the effects of native membrane lipids on the constituent
LVA K+ channel, Kv1.2, was carried out. In this chapter the functional effects of
biological fatty acids were investigated for their activity against the heterologously
expressed Kv1.2 channel.
Fatty acids are biological lipids that are usually present as part of triglycerides or
phospholipids, where they play important roles in energy storage and as the structural
basis for the plasma membrane. Free fatty acids (FFAs), uncoupled to any such
structures, have distinct biological roles in energy metabolism, inflammation and
synaptic plasticity (Bazan, 2005, Hara et al., 2014, Tassoni et al., 2008). Alongside
diverse roles in metabolism and signalling, FFAs also influence the activity of
membrane-bound ion channels directly. Voltage-gated ion channels are ideally
positioned for modulation by FFAs. The TM domain of the channel is embedded within
a mass of FFAs and fatty acid precursors and channel gating involves movement of the
protein within this hydrophobic environment. External signalling molecules such as
neurotrophic factors and cytokines stimulate the production of the FFA signalling
molecules by activating their cleavage from the plasma membrane (Papackova and
Cahova, 2015). Combined with other long term changes in membrane fatty acid levels
due to dietary effects, disease etc. this allows short and long term regulation of
membrane ionic conductances. In neurons and cardiac muscle, fatty acids add further
diversity to the mechanisms of fine-tuning the electrical properties of the cell (Boland
and Drzewiecki, 2008).
The first recognised ion channel sensitivity to fatty acids was reported in 1992.
Arachidonic acid (AA) and other long-chain fatty acids modified the activity of voltage
dependent Ca2+ channels in heart and smooth muscle cells (Hallaq et al., 1992, Shimada
and Somlyo, 1992). This was shortly followed by the discovery that Nav channels and
Kv channels are also major targets for fatty acid modulation (Boland and Drzewiecki,
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2008). Fatty acid modification of Kv channel is common across a range of different K+
currents and tissue types. Fatty acids modulate Kv channel activity in cells and tissues
as diverse as glia (Visentin and Levi, 1998), myocytes (Smirnov and Aaronson, 1996),
pinealocytes (Poling et al., 1995), pancreatic islet beta cells (Jacobson et al., 2007),
hippocampal neurons (Keros and McBain, 1997) and IHCs (Sokolowski et al., 2004).
However, modelling how these changes might impact neuronal features has been
difficult. Dietary consumption of unsaturated fatty acids has been shown to change the
lipid composition of neurons in the brain and result in concomitant changes in firing
properties and behaviour (Arsenault et al., 2012, Yang et al., 2012). But the diversity of
potential neuronal targets has resisted any simple mechanistic explanation for the role of
fatty acids in determining this firing behaviour.
Experiments on Kv channels in recombinant expression systems have recapitulated
many of the observed effects of fatty acids on K+ currents in biological tissues.
Interestingly, fatty acids demonstrate clear trends in activity across tissues and channel
types. Typically, externally applied fatty acids (usually arachidonic acid (AA)) affect
the voltage sensitivity of the activation and inactivation, as well accelerating the
inactivation of the channel and/or inducing inactivation in previously non-inactivating
channels (Honore et al., 1994, Oliver et al., 2004, Poling et al., 1995). Table 5.1
catalogues these experiments, the types of fatty acid used, the expression systems and
range of effects observed. These findings point to a key role for fatty acids in
determining the activity of Kv channels.
5.1.2 The structural diversity of free fatty acids
In chemical terms a fatty acids fatty is a carboxylic acid connected to a long aliphatic
carbon chain or “tail”, which is typically unbranched and usually contains an even-
numbered of carbon atoms (McNaught et al., 1997). Figure 5.1 shows the structure of
the common mammalian fatty acid, arachidonic acid. It also highlights the important
structural motifs within the fatty acid structure, variation upon which gives rise to the
large families of fatty acids recognised today. Despite the surprising reproducibility of
effects caused by AA and docosahexaenoic acid (DHA) across diverse K+ channels and
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tissue types, individual fatty acid members can differ markedly in their efficacy and
type of effect produced upon a single channel (see Table 5.1).
Figure 5.1 The chemical structure of a fatty acid. A fatty acid is a carboxylic acid combined
with an aliphatic carbon tail, which is either saturated or unsaturated. Fatty acid family members
primarily differ in the length and organisation of the fatty acid tail and in the degree of saturation.
A The length of the terminal carbon chain is an important classification of fatty acids. In this
example molecule, arachidonic acid has its final carbon-carbon double bond six atoms from the
terminal atom (in the ω-6 position). In this way it is designated a ω-6 fatty acid. B One of the
most important descriptors of fatty acids is the presence or absence or double bonds.
Unsaturated fatty acids vary in the position, number and type (cis/trans) of double bonds
present along the fatty acid tail. C Similar to A the distance between the initial acid group and
first double bond varies between fatty acids. D The carboxylic head group is essential in order
to be a fatty acid. Functionalisation of this acid headgroup is a common metabolic pathway for
fatty acids.
A notable structural feature of fatty acids is the number of carbon atoms that make up
the length between the final carbon double bond and the terminal carbon in the fatty
acid chain (see Figure 5.1A). Counting from the terminal carbon, these acids are thus
classified ω-n fatty acids, where n is the number of carbon atoms. ω-n fatty acids are 
clustered into important groups of dietary fatty acids, most notably ω-3 and ω-6 fatty 
acids. The relative intake of these fatty acids (i.e the ω-3/ω-6 ratio) had been implicated 
as an important contributory factor in cardiac disease and other chronic conditions
(Simopoulos, 2008a, Simopoulos, 2008b). The presence (unsaturated) or absence
(saturated) of double bonds within the fatty acid tail is also an important structural
feature (Figure 5.1B). The number, position and type (cis/trans) of double bonds within
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the fatty acid chain all contribute to the variety of available fatty acids. Mammals have
the capacity to synthesise saturated fatty acid (SFAs) and to a limited extent fatty acids
with a single double bond in its tail (monounsaturated, MUFAs) (Boland and
Drzewiecki, 2008). However, mammals lack the capacity to synthesise fatty acids with
multiple double bonds (polyunsaturated) fatty acids and therefore ω-3 and ω-6 
polyunsaturated fatty acids (PUFAs) are often referred to as essential fatty acids since
they must be obtained from dietary sources or synthesised from precursor molecules
(Jakobsson et al., 2006). The presence and degree of unsaturation has been shown to be
important in the interaction of fatty acids with Kv channels (Honore et al., 1994, Poling
et al., 1996b, Borjesson et al., 2008).
Although not strictly fatty acids themselves, analogues of fatty acids based on esters of
the free carboxylic acid have also been shown to be able to mimic the effects of PUFAs
on Kv channels. For instance, N-arachidonoylethanolamine (AEA, commonly known as
anandamide) and methandamide have been shown to be able to recapitulate the effects
of AA independent of their activity on cannabinoid receptors (Oliver et al., 2004, Sade
et al., 2006). Although the subject of much research the precise relationship between the
structure and activity of fatty acids against various Kv channels is still unclear. The
ubiquitous nature of fatty acids within mammalian cells and their known interactions
with Kv channels however make them an ideal candidate for neuronal ion channel
modulation (Boland and Drzewiecki, 2008). This chapter examines the modulatory
effects of FFAs against the Kv1.2 subunits, which mediate the LVA K+ currents in
SGNs.
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Table 5.1 Fatty acid modulation of recombinant Kv channels. Abbreviations: DHA –
Docosahexaenoic acid; EPA - Eicosapentaenoic acid; AA - Arachidonic Acid; LnA - Linolenic
Acid; HA - Hexadecatrienoic acid; LA - Linoleic acid; αLA - α-Linolenic acid; OA - Oleic Acid; 
ArA - Arachidic Acid; LaA - Lauric acid; AEA - Anandamide; mAEA - Methandamide; VDM11 -
(N-(4-hydroxy-2-methylphenyl) arachidonylamide); SA - Stearic acid; PaA - Palmitic acid; CA -
Caprylic acid.
Recombinant
Kv channels
Expression
system
Fatty acid Effect on current References
Kv1-type
Shaker
Xenopus
oocytes
DHA, EPA,
AA, LnA,
HA, LA,
OA, ArA,
DHA, EPA, AA, LnA, HA, LA:
left-shifted activation curve. DHA
speeds up the on-gating current.
OA, ArA: No effect
(Borjesson et
al., 2008)
Kv1.1 Sf9 cells AA Concomitant acceleration of the
activation and inactivation kinetics
(possibly via Ca2+-independent
phospholipase A2)
(Gubitosi-Klug
et al., 1995)
Kv1.1 and
Kv3.4
Xenopus
oocytes
AA, DHA,
AEA,
ETYA,
VDM11
No inhibition of peak current
magnitude, acceleration of the
inactivation kinetics.
(Decher et al.,
2010)
Kv1.2 and
Kv3.1a
Mammalian
fibroblasts
DHA, AEA Inhibition + increased inactivation. (Poling et al.,
1996a, Poling
et al., 1996b)
Kv3.4 and
Kv1.1/β1.1 
Xenopus
oocytes
AA, AEA Inhibition + increased inactivation
of currents when N-type
inactivation had been removed by
PIP2
(Oliver et al.,
2004)
Kv1.5 CHO cells AA, DHA,
ETYA, OA
AA, DHA, ETYA: Inhibition +
increased inactivation. Left-shifted
inactivation curve. OA: no effect
(Honore et al.,
1994)
Kv1.5 Stably
transfected
fibroblast
cell line
EPA, DHA,
αLA 
EPA and DHA reduced steady-state
currents. ALA left-shifted
activation curve + accelerated
activation kinetics and slowed
deactivation.
(Guizy et al.,
2008)
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Kv1.5 HEK 293 AEA Reduced the magnitude of the peak
and steady-state currents and +
accelerated the rate of current decay
(Moreno-
Galindo et al.,
2010)
Kv1.5 and
Kv2.1
CHO cells αLA Inhibition + Increased rate of 
activation and left-shifted activation
curve.
(McKay and
Worley, 2001)
Kv2.1 HEK 293 AA Inhibition + increased inactivation (Jacobson et
al., 2007)
Kv 4 Xenopus
oocytes
AA, ETYA Inhibition + Increased in rate of
recovery from inactivation. Kv1,
Kv2 & Kv3 family unaffected
(Villarroel and
Schwarz,
1996)
Kv4.2 Xenopus
oocytes
AA, ETYA,
ETI
Inhibition + accelerated inactivation
when co-expressed with KChIP.
(Holmqvist et
al., 2001)
Kv4.2/
KChIPs
Xenopus
oocytes
AA, DHA Inhibition + increased inactivation
of currents.
(Boland et al.,
2009)
Kv4.3/
KChIPs
Xenopus
oocytes
AA, DHA Inhibition + increased inactivation
of currents.
(Boland et al.,
2009)
Kv4.3 CHO cells DHA Inhibition (Singleton et
al., 1999)
Kv7.1 and
KCNE1-
Kv7.1
Xenopus
oocytes
DHA Left-shifted activation curve (Liin et al.,
2015)
Kv7.1/mink Xenopus
oocytes
DHA, OA,
LaA
Increased currents (Doolan et al.,
2002)
BK HEK 293 AEA,
mAEA
Increased activity independent of
cannabinoid receptors or G-protein
activation
(Sade et al.,
2006)
BK Xenopus
oocytes
AA, DHA,
OA, SA,
PaA, CA
AA, DHA, OA: Increased current;
SA, PA, CA: No effect
(Sun et al.,
2007)
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5.2 Results
5.2.1 Arachidonic Acid inhibits Kv1.2 channels in a concentration
dependent manner
To examine the effects of fatty acids upon the Kv1.2 channel, a stable expression line
was first developed, in order to reduce variability between cells and increase
throughput. The construction of the Kv1.2-transfected HEK293 cell line was performed
as described in Material and Methods. Figure 5.2 shows the properties of the cell line as
determined by whole-cell patch clamp recordings. Due to the ability of HEK293 to
electrically couple to adjacent cells via gap junction, transfected cells were plated at a
low density and recordings were made from spatially isolated cells (Figure 5.2C).
Consistent with recordings from transiently transfected cells (see Chapter 4), stably
Kv1.2-transfected cells displayed outward currents upon depolarisation which activated
more rapidly with increasing depolarisation. Inactivation was largely absent during
small depolarisations, but some inactivation was observed for test potentials exceeding
+30 mV (Figure 5.2B, C). Comparable currents were not present in untransfected cells,
where only small outward currents were noted (not exceeding 200 pA at large
depolarisations). 100 nM TsTx inhibited 84.1 ± 3.1% of the current (Figure 5.2 D, E; n
= 3 cells). Residual TsTx-insensitive currents were comparable to native HEK293 cell
currents.
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Figure 5.2 Characterisation of a stably Kv1.2-transfected HEK293 cell line. A
Representative traces from a Kv1.2-transfected HEK293 cell (left) and untransfected HEK293
cell (right) in response to the same voltage step protocol. Cells were stepped from a holding
potential of -73 mV to voltages of between -93 and +57 mV in 10 mV steps. B Current traces
showing inhibitory effects of TsTx on outward K+ currents. Currents were obtained as in A. C
Transfected HEK293 cells were plated at low density and recordings were made from isolated
cells to avoid gap-junction coupling with other cells. Scale bar: 10 µM D I-V plot of Kv1.2-
transfected HEK293 (closed squares) and untransfected HEK293 cells (open squares).
Currents were measured 50 ms from the end of the voltage protocol described in A. E I-V plot of
Kv1.2 currents before (open squares) and after 100 nM TsTx (closed squares) application of
TsTx to Kv1.2 expressing cells. Currents were measured 50 ms from the end of the voltage
protocol described in A.
Figure 5.3 shows the effects of increasing concentrations of arachidonic acid (AA) on
the Kv1.2 currents characterised above. Addition of 1 µM, 10 µM or 100 µM AA was
found to inhibit Kv1.2 currents in a dose dependent manner. Addition of 1 µM or 10
µM AA accelerated activation, whilst reducing peak currents and increasing
inactivation. 100 µM produced rapid inactivation and 96% block of steady state currents
(Figure 3A, C). AA is a major substrate for the biosynthesis of the lipid messenger
molecule prostaglandin H2. Therefore, in subset of experiments, 10 µM indomethacin (a
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nonselective inhibitor of cyclooxygenase 1 and 2) was added to the culture medium 1 hr
prior to recording (Cuendet et al., 2006). Indomethacin did not prevent the inhibitory
effects of 100 µM AA in the experiments. Figure 5.3D shows the time course of activity
and reversibility of AA application. 100 µM AA reached a steady-state inhibition after
3-4 minutes bath application. Inhibition could be reversed by perfusion with bath
solution over a period of 12 minutes.
Figure 5.3 Effects of increasing concentration of arachidonic acid (AA) on Kv1.2 currents.
A Current traces from a Kv1.2-transfected HEK293 cell in the absence (control) and presence
of 1 µM, 10 µM and 100 µM AA. Cells were stepped, for 200 ms, from a holding potential of -73
mV to voltages of between -93 and +57 mV in 10 mV steps. B Chemical structure of AA. C I-V
plot of the steady-state Kv1.2 currents in the absence (control, open squares) and presence of 1
µM (light grey squares), 10 µM (dark grey squares), and 100 µM (black squares) AA. Currents
were measured from the end of the voltage protocol described in A. D Time course of Kv1.2
current inhibition by AA. AA inhibition was monitored by a voltage protocol applied every 10 s.
Currents were measured 20 ms before the end of the 400 ms ramp from -153 to +47 mV. Inorm
was calculated as the proportion of current remaining compared to the control Kv1.2 currents.
Wash off was carried out using bath solution alone.
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The AA-induced, rapid inactivating of Kv1.2 currents was subsequently characterised.
Figure 5.4A shows the AA treated Kv1.2 outward currents in response to a series of
voltage steps. The voltage dependence of activation AA-treated Kv1.2 current was
determined by plotting the normalised peak conductance against the membrane
potential; the derived GV plot (Figure 5.4C filled squares) could be fitted with a
Boltzmann function. There was no significant effect of the AA on the voltage of half-
maximal activation, V1/2, or slope values respectively. (AA treated V1/2: -16.6 ± 1.7 mV
vs. Control V1/2: -13 ± 2.2 mV, p = 0.08, n = 6, paired Student’s t-test; AA treated slope:
12.1 ± 1.6 vs. Control slope: 11.5 ± 1.2 mV, p = 0.31, n = 6, paired Student’s t-test).
The voltage dependence of steady-state inactivation was also determined using a two-
step voltage-clamp protocol outlined in Figure 5.4B. Briefly, AA-treated, Kv1.2-
transfected cells were exposed to a series of preconditioning voltage steps (-93 mV to
+17 mV) before being stepped to a test potential of +27 mV (corresponding to maximal
activation of Kv1.2, Figure 5.4C), Figure 5.4B shows typical currents obtained from
using this experimental protocol. The voltage dependence of AA treated Kv1.2
inactivation was described by a Boltzmann equation (Figure 5.4D), in which the V1/2 of
inactivation was -50.5 ± 1.1 mV (slope factor 3.9 ± 0.3; n = 7).
To explore the kinetics of recovery of the AA-induced inactivation, a two-step protocol
was employed (Figure 5.4E). A 200 ms depolarising pre-pulse was followed by a 200
ms test pulse after an interval of a variable duration (16 to 8192 ms). The relative peak
magnitudes from the two stimulus pulses could be compared to get a measure of
recovery. Plotting this recovery against the interstimulus interval yielded a single
exponential relationship (Figure 4E, F). Figure 5.4F shows the mean recovery from
inactivation kinetics expressed as normalised peak amplitude against interpulse interval
and fitted with a mono-exponential function, as in D. The time mean constant for the
recovery from inactivation (τ) was 1.11 ± 0.3 s (n = 6). 
144
Figure 5.4 Biophysical properties of AA treated Kv1.2 currents. A Representative currents
obtained from AA treated Kv1.2 transfected cells in response to voltage steps from −73 mV to 
potentials between −93 and +57 mV in 10 mV increments. B Steady-state inactivation of AA
treated Kv1.2 currents. Currents were obtained with a double pulse protocol: 200 ms
conditioning pulses to potentials between -93 and +17 mV were applied from a holding potential
of −73 mV and the steady-state inactivation was assessed from the peak outward current during 
the subsequent step to +27 mV. C Normalised GV plot showing the steady-state activation
obtained from peak outward K+ currents before (open symbols) and after 100 µM AA (closed
symbols). Data was fitted with a Boltzmann function. D Normalised current plot of steady-state
inactivation as obtained from the double pulse protocol described in B. Data was fitted with a
Boltzmann function. E The kinetics of recovery from AA induced inactivation was analysed with
a double pulse protocol shown above: A 200 ms prepulse from −73 mV to +27 mV was followed 
by a second 200 ms test pulse to +27 mV after an interstimulus interval of variable duration (16
to 8192 ms) at −73 mV. Recovery of peak amplitude could be fit with a single exponential 
function. The solid line show a superimposed fit for the normalised peak amplitude against
interpulse interval (τ = 1.91 s) F Mean recovery from inactivation kinetics expressed as
normalised peak amplitude against interpulse interval. Normalised peak amplitudes were fit with
a monoexponetial function as in D (τ = 1.11 ± 0.3 s; n = 6).  
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5.2.2 PUFAs inhibit Kv1.2 currents
Ion channels modulation is rarely a property of a single fatty acid family member but
rather fatty acids displays trends in activity across series of chemical analogues
(Borjesson et al., 2008, Guizy et al., 2008, Sun et al., 2007). Because of this, structurally
related fatty acids were also examined for potency against stably expressed Kv1.2
currents. Figure 5.5 shows the effects of a series of PUFAs against Kv1.2-mediated
currents: linoleic acid (LA), DHA, and linolenic (LnA) acid. These molecules are
PUFAs which vary in the length of their fatty acid tail and the position and number of
double bonds within their structure and are important biological lipids present in
significant quantities within mammalian cell membranes (Abbott 2012).
LA is an essential fatty acid in humans and used in the biosynthesis of AA. Like AA it
is a member of ω-6 fatty acid family, and it had comparable effects to AA on Kv1.2-
mediated currents (Figure 5A, C). Like AA, the effects were dose-dependent and
partially reversible upon wash off. However LA did not inhibit peak outward currents or
increase the rate of inactivation to the same degree. 100 µM LA resulted in a reduction
of steady-state current by 58.9 ± 9.5% (measured at +27 mV, n = 4). Of the series of
PUFAs tested, the ω-3 fatty acid DHA at 100 µM showed the most comparable effect to 
AA, inhibiting a mean 78.5 ± 6.8% of the steady-state current (Figure 5A, C). DHA is a
highly unsaturated molecule containing two additional carbon atoms and two additional
double bonds, compared to AA. The increased activity of AA and DHA over ALA is
consistent with findings from other channels that the degree of saturation is important
for the effects on ion channels (Borjesson et al., 2008, Sun et al., 2007). Somewhat
surprisingly therefore were the findings that the ω-3 PUFA LnA was largely inactive 
against Kv1.2-mediated currents (<5% block after 100 µM LnA application, n = 3)
despite the high degree of unsaturation in its tail.
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Figure 5.5 The effects of PUFAs on Kv1.2 currents. A Current traces from Kv1.2-transfected
HEK293 cells in the absence (control) and presence of various PUFAs (100 µM). B Chemical
structures of the PUFAs examined in A C Graph showing the normalised steady-state current
remaining after application of various concentrations of PUFAs. Steady-state currents were
measured at 10 ms from the end of a +27 mV voltage step shown in A. Currents were
normalised to the current magnitude as measured in normal bath solution. The number of
successful measurements is shown in parenthesises. Current measurements for “Wash”
represent 10 minutes of perfusion in normal bath solution post PUFA application.
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5.2.3 MUFAs show little activity against Kv1.2 currents
Alongside these PUFAs, a range of MUFAs were also examined for activity. A series of
naturally occurring dietary fatty acids of different lengths and double bond position
were chosen for investigation: palmitoleic acid (PA), oleic acid (OA), elaidic acid (EA),
nervonic acid (NA), erucic acid (ErA) and petroselinic acid (PSA) (Figure 5.6). As a
series, MUFAs caused considerably less inhibition and induced less inactivation than
PUFAs. The measured steady-state currents were reduced 0-23% across the series. 100
µM PA displayed the greatest inhibition (22.4 ± 3.6%, n = 3; Figure 5.6C). Three
MUFAs; EA, ErA and PSA showed no inhibition at any of the concentrations tested.
The general lack of activity of MUFAs as a series prevented any significant analysis of
the structure-activity relationship except to note that the relative inactivity of the
MUFAs is consistent with reports that SFAs and MUFAs are less active than their
polyunsaturated counterparts against some Kv channel members (Borjesson et al.,
2008).
In line with the analysis of the important structural features of fatty acids for their
activity against Kv1.2, the relative contribution of the fatty acid head group was
assessed (Figure 5.7). For that reason, the effects of externally applied ethyl
arachidonate (EtA) and AEA were assessed for activity. AEA, or anadamide is the
ethanolamine ester of AA, and has been the focus of considerable interest due to its
activity against the CB1 and CB2 cannabinoid receptors (Vemuri and Makriyannis,
2015). AEA was found here to have considerable inhibitory effects against Kv1.2-
mediated currents, blocking 16.2 ± 8.9% of the steady-state current at 10 µM and 77.9 ±
4.6% at 100 µM (Figure 5.7B, C; n = 3). This inhibition was slightly less than that
observed for the free AA and was comparable to DHA in the extent of its effect. EtA
also displayed a notable inhibition of Kv1.2 currents. Interestingly however this
inhibition was less than that of AEA (49.7 ± 8.5% at 100 µM; n = 3). These results
suggest that the free acid head group is not as important to the inhibitory effects of the
fatty acid as the presence and organisation of double bonds within the fatty acid tail.
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Figure 5.6 The effects of MUFAs on Kv1.2 currents. A Chemical structures of the MUFAs
examined. B Kv1.2 current traces in the absence (control) and presence of various PUFAs (100
µM). C Graph showing the normalised steady-state current remaining after application of
various concentrations of MUFAs. Steady-state currents were measured as in Figure 5.5C.
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Figure 5.7 The effects of carboxylic acid-functionalised fatty acids on Kv1.2 currents. A
Kv1.2 current traces in the absence (control) and presence of various AA, EtAA and AEA (100
µM). B Chemical structures of the carboxylic acid-functionalised fatty acids examined. C Graph
showing the normalised steady-state current remaining after application of various
concentrations of functionalised fatty acids. Steady-state currents were determined as in Figure
5.5C.
5.2.4 Synthesis of conformationally restricted fatty acid analogues
Fatty acids are highly flexible molecules. They are capable of the participating in highly
ordered structures, e.g. plasma membranes (Feller, 2008), but studies have shown that
even unsaturated fatty acids retain significantly flexibility within their molecule, and are
capable of occupying several distinct low energy conformations (Shaikh, 2012). The
role of polyunsaturation in determining the conformation and topology of fatty acids
was examined through a chemical biology approach. Chemical strategies were
employed to develop fatty acid molecules with inherent conformational restrictions
within their molecule.
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Conformational restriction (sometimes called “rigidification”) is a strategy aimed at
reducing a molecules inherent flexibility. This can help ligands obtain the “best”
conformation for binding and minimise the entropic loss in taking up the bioactive
conformation, thus enhancing the potency and selectivity of a drug (Fang et al., 2014).
This can be achieved by introducing unsaturated double or triple bonds to prevent
rotational movement around carbon-carbon bonds or by the introduction of steric or
chemical moieties which help favour particular conformational states over others.
Additionally, intramolecular interactions through the use of covalent and non-covalent
interactions can significantly alter and restrict the free movement of a molecule (Figure
5.8). Here, the incorporation of ring systems or cycles into saturated or unsaturated fatty
acids was examined to determine its effect on Kv1.2 inhibition. Ring systems can be
either aliphatic or aromatic. Aromatic ring systems were chosen due to their increased
rigidity over aliphatic ring systems and for their better chemical tractability (synthesis
feasibility). Aromatic rings can be comprised of exclusively hydrocarbons, or
Alternatively, contain heteroatoms in their ring system, known as heteroaromatic
systems.
Figure 5.8 Design of conformationally restricted fatty acid analogues. An example of how
conformational restriction can be achieved in AA by creating intramolecular cheminal rings or
cycles. The example cycle comprises 6 atoms, linking atom N and N+3, but could be expanded
to link more distant atoms. These cycles can either be aliphatic or aromatic.
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Incorporation of a phenyl moiety within the aliphatic “tail” of the fatty acid (Scheme
5.1) required the alkylation of a benzene core with the requisite alkyl and acid groups.
The approach adopted here used palladium-catalysed cross-coupling alkynylation to
form the important carbon-carbon bonds. This approach had the advantage of making
fatty acids which, alongside the desired aromatic group, contained multiple alkyne
features. These could be reduced partially and in a stereoselective manner to give access
to the polyunsaturated series of analogues (Scheme 1). Or alternatively they could be
reduced completely to yield saturated aromatic fatty acids. Scheme 5.1A and B shows
the synthetic route to obtain both the 1,4- and 1,3- functionalised aromatic fatty acid
analogue of AA.
Scheme 5.1 Synthesis of aromatic analogues of AA. (i) Pd(PPh3)4, CuI, DIPEA, THF, 40⁰C,
24hr (ii) 1,5-Decadiyne (For condition See Table 5.2) (iii) H2, Lindlar catalyst. Dotted arrows and
grey structures show unsuccessful steps.
The initial synthetic step (Scheme 5.1(i)) involved the cross-coupling of the carboxylic
acid chain with the aromatic core via palladium coupled sonogashira reaction. The
reaction proceeded with good yields (40-70%), under mild temperatures and reacted
selectively with the iodo-functionality. However the 2nd cross-coupling alkynylation
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step proved very difficult and was ultimately the limiting step in this synthesis (Scheme
5.1(ii)). Reaction of the bromophenyl-hexynoic acid product with 1,5-Decadiyne under
thermal conditions showed no appearance of the bi-functionalised benzene, as
monitored by LCMS. Increased temperature, reaction times and catalyst loading (2-10
mol%) also failed to facilitate the alkynylation. Similarly, modifying the amine base
used in the reaction (Et3N/DIPEA/Piperidine) made no impact. Table 5.2 shows the
extensive reaction conditions examined in this study.
A recent advance in transition-metal catalysed reactions has been the use of designer
amphiphiles or surfactant molecules to considerably increase the rate and efficiency of
reactions (Klumphu and Lipshutz, 2014). These surfactant molecules form nanomicelles
in water which are proposed to serve as nanoreactors for transition-metal chemistry. To
this end we examined the effects of performing the alkynylation step in nanoparticles
composed of the surfactant DL-α-Tocopherol methoxypolyethylene glycol succinate 
(TPGS). Accordingly the reaction was carried out in the presence of 2% TPGS in water
at room temperature. After 24 hours agitation, no product could be observed by LCMS.
As an alternative synthetic strategy, microwave-assisted sonogashira chemistry was
explored. Microwave chemistry involves using microwave irradiation to promote
chemical reactions instead of the conventional externally applied thermal heating.
Microwave-assisted reactions have many advantages over traditional thermal heating
and can be associated with increased chemical reaction rates and higher chemical yields
than thermal heating alone (de la Hoz et al., 2005). Microwave-assisted sonogashira
chemistry has been employed successfully in a number of studies and has been shown,
in some cases, to radically improve reaction times and efficiencies (Erdelyi and Gogoll,
2001, Mehta and Van der Eycken, 2011). Because of the higher throughput, a range of
conditions and catalysts were tested. Three different Pd catalysts were examined:
Pd(PPh3)4, Pd((o-tolyl)3P)2Cl2 and Pd(PPh3)2Cl2 along with two other pre-catalyst Pd(II)
complexes: Pd(acac)2 and Pd(OAc)2 which were reduced to their active complexes in
situ by addition of PPh3. Further, Cu(I)I (10 mol%) was either added or left absent from
the reaction mix. These various permutations gave rise to 12 unique reactions (detailed
in Table 5.2). Although trace amounts of the bi-functionalised aryl could be identified
by LCMS, no successful product was yielded by this approach.
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Table 5.2 Reaction conditions examined for the 2nd cross-coupling alkynylation step. As
detailed in Scheme 5.1(ii). Abbreviation: TPGS - DL-α-Tocopherol methoxypolyethylene glycol 
succinate DIPEA - Diisopropylethylamine; Solv. - Solvent; DMF - Dimethylformamide.
Catalyst mol
%
CuI PPh3 Base Solv. Therm
/µW
Temp Time
Pd(PPh3)4 2 ●  DIPEA THF Therm 66⁰C 24 hr
Pd(PPh3)4 2 ●  DIPEA DMF Therm 80⁰C 24 hr
Pd(PPh3)4 5 ●  DIPEA DMF Therm 80⁰C 24 hr
Pd(PPh3)4 10 ●  DIPEA DMF Therm 80⁰C 24 hr
Pd(PPh3)4 5 ●  Et3N DMF Therm 80⁰C 24 hr
Pd(PPh3)4 5 ●  DIPEA DMF Therm 120⁰C 24 hr
Pd((PPh3)2Cl2 6 ●  Piperidine DMF Therm 116⁰C 24 hr
Pd(PPh3)4 2 Et3N H20,
TPGS
NA RT 24 hr
Pd(PPh3)4 5 Et3N DMF µW 100⁰C 5 min
Pd((o-tol)3P)2Cl2 5 Et3N DMF µW 100⁰C 5 min
Pd(acac)2 5 Et3N DMF µW 100⁰C 5 min
Pd(PPh3)4 5 ●  Et3N DMF µW 100⁰C 5 min
Pd((o-tol)3P)2Cl2 5 ●  Et3N DMF µW 100⁰C 5 min
Pd(acac)2 5 ●  Et3N DMF µW 100⁰C 5 min
Pd(PPh3)2Cl2 5  ● Et3N DMF µW 100⁰C 5 min
Pd(OAc)2 5  ● Et3N DMF µW 100⁰C 5 min
Pd(PPh3)4 5 ● ● Et3N DMF µW 100⁰C 5 min
Pd((o-tol)3P)2Cl2 5 ● ● Et3N DMF µW 100⁰C 5 min
Pd(OAc)2 5 ● ● Et3N DMF µW 100⁰C 5 min
Pd(PPh3)2Cl2 5 ● ● Et3N DMF µW 100⁰C 5 min
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Finally, the order in which the reactants were attached to the benzene scaffold was also
reversed. Monitoring with LCMS showed the formation of the 1,5-Decadiyne aryl
product which could be purified out and isolated, but subsequent reaction with the
alkyne carboxylic acid resulted in the same non-reactivity. Additional modification of
the synthesis replaced the 1,5-decadiyne reactant in the original synthetic pathway with
potentially more reactive alkyne reagents. Accordingly, the bromophenylhexynoic acid
intermediate was reacted with other terminal alkynes such as Heptyne, Pentyne and
Propargyl alcohol. This failed to improve reactivity however.
For this reason an alternate synthetic approach was pursued. The incorporation of a
heteroaromatic rings into the fatty acid tail provided a much wider scope for chemical
synthesis due to the availability of reactive nitrogen-containing starting reagents and the
ability to form the aromatic structure in situ. To this end, a synthetic approach utilizing
1,3-dipolar cycloaddition was developed. This approach, often referred to as “click
chemistry” was chosen due to its reported effectiveness and versatility. “Click
chemistry” refers to a subset of chemical reactions which are particularly high yielding;
generating products quickly and reliably, usually under relatively mild conditions (Kolb
et al., 2001). This also had the advantage of allowing access to aromatic fatty acid
structures in a single step.
Scheme 5.2A-F shows the synthetic route used to obtain a series of heteroaromatic fatty
acid analogue of varying length. Note that the orientation of the triazole group could be
altered depending on arrangement of the functional groups on the starting materials. The
alkyl azide intermediate was formed in situ and further reaction with the alkyne was
done without isolation of the azide. This effectively allowed heteroaromatic fatty acids
to be formed in a single chemical step. Reactions proceeded rapidly under mild
conditions with total conversion of materials to product after 24 hours. Adjustment of
the resulting reaction mixture to pH3 followed by filtration and extraction yielded pure
product without the need for further purification. Yields varied widely (15-59%) and
correlated with the tail length of the fatty acid being synthesised. The longer chained
fatty acids were isolated in significantly higher yields. This was proposed to result from
the poorer organic solubility of short fatty acids at the extraction step. To examine the
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effect of differences in fatty acid length two acids from each of the medium-chain fatty
acids (MCFAs, 6-12 carbon atoms), long-chain fatty acids (LCFAs, 13-21 carbon
atoms) and very long-chain fatty acids (VLCFAs, 22< carbon atoms) (Lemarie et al.,
2015) were designed and tested for their inhibitory potential against Kv1.2.
Scheme 5.2 Synthesis of heteroaromatic fatty acids. (i) NaN3, Cu(I)O, MeOH, 40⁰C, 24hr.
Yields are shown in parenthesises.
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Figure 5.9 The effect of heteroaromatic fatty acids on Kv1.2 currents. A Chemical
structures of the aromatic fatty acids examined. B Kv1.2 current traces in the absence (control)
and presence of various aromatic fatty acids (100 µM). C Graph showing the normalised
steady-state current remaining after application of various concentrations of aromatic fatty acids
fatty acids. Steady-state currents were measured as in Figure 5.5C.
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Figure 5.9 shows the effects of the six aromatic fatty acid analogues tested against
Kv1.2 currents. The two MCFAs, LPB-01 and LPB-02, displayed a modest inhibitory
effect against Kv1.2. At 100 µM, LPB-01 and LPB-02 reduced the steady-state current
magnitude by 12.3 ± 6.6% (n = 3) and 21.8 ± 2.8% (n = 3) respectively. This effect was
dose dependent and reversible upon washing out. LCFA analogues, LPB-03 and LPB-
04, showed a similar inhibitory potency against Kv1.2. At 100 µM, LPB-03 and LPB-
04 reduced the steady-state current magnitude by 20.8 ± 5.9% (n = 5) and 22.3 ± 4.9%
(n = 5) respectively. This was equivalent to the effects of the most potent MUFAs such
as nervonic acid or palmitoleic acids (Figure 5.6) but considerably less effective than
the PUFAs. The VLCFAs, LPB-05 and LPB-06, produced a current inhibition of 21.7 ±
12.9% (n = 4) and 15.4 ± 11.1% (n = 3) respectively, at 100 µM. At the maximal
VLCFA dose tested however (100 µM), a precipitate was observed. Therefore, the
tested concentration of LPB-05 and LPB-06 were probably less than the desired 100
µM.
5.3 Discussion
Kv1.2-containing channels are important mediators of SGN LVA K+ currents. In this
chapter the effect of native and synthetic fatty acids against the Kv1.2 channel were
investigated. PUFAs, exemplified by AA, were found to be strong inhibitors of stably
expressed Kv1.2 currents, markedly increasing the inactivation rate of the channel.
These effects were also seen in PUFA analogues modified at the carboxylic head group,
such as AEA. The inhibitory effect of fatty acids, however, declined sharply with
increasing saturation of the fatty acid tail, pointing to a key role of the fatty acid chain in
the activity of FFAs. A chemical biology approach was pursued, focusing on
conformational restriction of the free fatty acid carbon tail. Accordingly, a simple and
efficient synthesis was developed to access a range of novel aromatic fatty acid
structures in a single step. Although low activity was noted in the initial series of
analogues, chemically modified fatty acids could provide a useful approach to adjust the
activity and biophysical properties of FFAs against Kv1.2.
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5.3.1 Physiological functions for FFA modulation of voltage-gated ion
channels
Alongside its myriad roles in cellular signalling pathways, FFAs exert important effects
upon membrane bound ion channels directly (Boland and Drzewiecki, 2008). The
modulation of various ion channels has been implicated as an important determinants in
neuronal transmission, synaptic plasticity, cardiac and ischemic disease and aging (Lee
et al., 2008, Horrocks and Farooqui, 2004, Michael-Titus and Priestley, 2014, Boland
and Drzewiecki, 2008).
Evidence of a physiological role for fatty acid modulation in neuronal signalling comes
from the action of PUFAs on ion channels and synaptic plasticity. Kv4 channels are
highly localised to post-synaptic membranes in the hippocampal CA1 region and
regulate long-term potentiation (LTP) through their role in the integration of high
frequency trains of synaptic activity (Tkatch et al., 2000, Andrasfalvy et al., 2008).
Application of DHA or AA to Kv4 currents results in marked inhibition and increase
inactivation (Boland et al., 2009). Inhibition of phospholipase A2 (an enzyme that
produces free fatty acids from a precursor glycerol molecule) blocked LTP in a manner
that could be reversed by direct application of DHA or AA (Fujita et al., 2001, Wolf et
al., 1995). In this way FFAs have been proposed as signalling molecules in synaptic
plasticity.
FFAs have also been proposed as important ameliorators of hyper-excitability in
neurons. Under conditions of ischemic-reperfusion injury and seizure, neurons release
high quantities of AA into the surrounding media (Lipton, 1999). AA has been
postulated to have a neuroprotective effect by dampening the pathological excitability
that may arise under these conditions (Bazan et al., 2002). This effect is achieved
primarily through its inhibitory actions on Na+ and Ca2+ channels. This is of particular
importance in injured neurons where structural degradation of the axolemmal bilayer
can lead to chronically left-shifted or “leaky” Nav channels (Morris et al., 2012). There
is now  considerable evidence to suggest that fatty acids, and in particular ω-3 fatty 
acids, can act as neuroprotective molecules in disease and aging (Michael-Titus and
Priestley, 2014, Lin and Perez-Pinzon, 2013, Denis et al., 2015).
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However, PUFA inhibition of K+ channels might also be expected to oppose these
protective effects. It has been suggested that local differences in the FFA concentration
might lead to preferential inhibition some channels over others (Boland and Drzewiecki,
2008). A simpler and more satisfying explanation is that the neuroprotection observed
in studies of disease and aging arise from the pleiotropic effects of FFA in vivo,
including vasodilation of brain arteries, and neuroplasticity (Blondeau et al., 2015).
An alternative hypothesis suggests that PUFAs can act to reduce the excitability of
neurons by left-shifting the voltage-sensitivity of certain Kv channels in neurons.
Specifically, PUFAs were demonstrated to left-shift the voltage dependence of
activation of the Shaker Kv channel (Borjesson et al., 2008, Borjesson and Elinder,
2011). More recently these effects were recapitulated in the Kv7.1 and KCNE1/Kv7.1
mammalian channel (Liin et al., 2015). These results have not been validated in brain
tissue however so the extent of this effect on neuronal firing is unknown. Together,
these results suggest that FFAs may have heterogeneous effects across different tissue
and channel types.
As shown in this this study, an important factor in determining whether channel
function will be affected is the concentration at which various FFAs are present in the
ion channel environment. In the blood plasma, free fatty acid concentration is heavily
buffered by the presence of fatty acid binding proteins and albumin. On average, two
FFA molecules are bound to each albumin molecule under normal physiological
conditions. Accordingly, serum concentrations of unbound FFAs can regularly be less
than 20 nM (Oliveira et al., 2015). Whilst the relative composition of FFAs within
tissues is routinely reported, considerably less is reported about the absolute
concentrations of these various FFAs. For free AA, the levels are typically described as
“low”. Resting leukocytes reportedly contain around 0.5–1 µM free AA (Chilton et al.,
1996) whilst isolated islets of Langerhans cells, by comparison, have resting level of
AA of about 15 µM, as measured by mass spectrometry (Ramanadham et al., 1992).
Nonetheless, free AA is disproportionately low compared with the vast quantities of the
esterified AA motif contained within the cells’ plasma membrane. This has been
calculated as corresponding to approximately 5 mM in platelets (but in specific
subcellular compartments such as membranes, this may be substantially higher) (Brash,
2001). The low level of AA detected in the cytosol likely reflects the activity of
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enzymes, such as cyclooxygenases and acyl transferases which use AA as a substrate
(Irvine, 1982). This low concentration of free AA would suggest relatively little K+
channel modulation under non-pathological, resting conditions. However, the vast
reservoirs of esterified arachidonate contained in the plasma membrane means receptor-
mediated liberation of as little as 1% of this reserve could give up to 50 µM local
concentration of FFA. In fact, in platelets, the percentage of esterified arachidonate
liberated upon activation is around 10% (Neufeld and Majerus, 1983). Ion channels in
tissues under pathological conditions may also experience abnormally high levels of
FFAs. In samples of inflamed skin tissue from psoriasis patients, free AA is abundant,
with approximately 30 µg/g of free AA detected. This represents an effective cellular
concentration of 100 µM free AA; equivalent to the highest dose tested in our study
(Hammarstrom et al., 1975). This suggests a role for FFA K+ channel modulation in
tissues under conditions of receptor-mediated activation or under conditions of
pathological dysregulation.
Subsequent experiments, building on work in this chapter, should focus on the effects of
FFAs on the membrane properties of SGNs. AA has already been shown to affect the
electrophysiology of SGNs in neonatal rats (Ruel et al., 2008), potentiating the
excitatory effects of NMDA signalling. Further experiments should examine whether
AA inhibits Kv1.2-mediated LVA currents in isolated SGNs and whether AA and other
FFAs can change their firing properties as observed under the influence of other agents
elsewhere in this thesis.
5.3.2 How do fatty acids modulate the activity of Kv1.2?
The fatty acid motif is ubiquitous in the plasma cell membrane, comprising an
important component of both structural phospholipids and triglycerides. The presence of
free FFAs is dynamic and tightly regulated however. These FFAs may modulate the
function of membrane embedded ion channels in a number of ways (Moreno et al.,
2012). First, they may change the biophysical properties of the membrane, changing the
mechanical forces upon the channel or how the membrane conducts charge. Secondly,
they can modify the hydrophobic interactions between the ion channel and the lipid
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bilayer. Finally, they can interact directly with specific amino acids in the ion channel,
altering gating or affecting the conduction of ions through the pore.
One caveat anticipated here is the heterologous nature of the Kv1.2 expression system
and the differences the Kv1 channels in SGNs. Expressed in HEK293 cells, the Kv1.2
gene produces functional Kv1.2 homomers with an expression profile determined by the
translation and trafficking properties of the cell line as well as the copy number of the
gene. These channels may differ from those in SGNs in a myriad of ways, not least
because they represent a purely homomeric population of Kv channel. Heterologous
channels are also absent co-expression with any auxillary subunits, which can radically
alter the functional and expression characteristics of the Kv channel. Heterologous
channels may also experience different post translation modifications compared to
SGNs. The differences in physical properties of the membrane and the lipid species
which are present can also alter the gating and conductive properties of the channel
(Combs et al., 2013). Finally, the relative proportions and concentrations of FFA most
likely differ in HEK293 cells from those experienced by SGNs in vivo. Nonetheless,
Kv1.2 channels, stably expressed in HEK293 cells, offer a practical and efficient way to
examine the effects of FFAs on LVA K+ channels, which can be subsequently validated
in the isolated SGN preparation. This allows for a much higher throughput than would
be possible in an isolated SGN preparation.
In this study, stably expressed Kv1.2 currents showed a marked sensitivity to externally
applied PUFAs. AA provided the greatest inhibition; 10 µM AA reduced the steady
state current by approximately half. The inhibitory activity of AA at low µM
concentrations is in line with the values reported for plasma concentrations of free,
unesterified AA (1–15 µM) (Burtis et al., 1999). Because of the dynamic
interconversion of fatty acids products near plasma membrane and the potential for
receptor mediated liberation of AA, it is very conceivable that local concentrations of
AA are, at times, much higher (Boland and Drzewiecki, 2008). The induction of rapid
inactivation observed in this study is notable effect of PUFAs across various Kv
channels (Table 5.1). The molecular basis for this effect is still controversial.
Nonetheless, the general effect of PUFAs on the fluidity and mechanics of the lipid
environment has been disfavoured as an “imprecise” explanation for their effects since
not all ion channels are targets for PUFA modulation (Boland and Drzewiecki, 2008).
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There is now a strong body of work suggesting PUFAs make important direct
intermolecular interactions with residues within the Kv channel.
The site of action of PUFAs is also controversial. The current consensus is that PUFAs
act at the cytoplasmic side of the membrane. Evidence for this arrives from multiple
independent observations. TEA reduces the fractional block of AEA against Kv1.5
when applied intracellularly but not when TEA is applied externally (Moreno-Galindo
2010). Similarly, mutation in key pore residues at the intracellular side of the membrane
abolish the inhibitory effects of applied AA against Kv1.1 (Decher et al., 2010). Finally,
external application of the membrane impermeant arachidonoyl-coenzyme A failed to
replicate the inhibition and inactivation displayed by AA against Kv4/KChIP expressed
in Xenopus oocytes (Boland 2009). However, some reports have shown evidence for a
preferential effect of PUFAs on the external leaflet of the membrane and have suggested
they exert their effect by interaction with an external binding site on the channel
(Honore et al., 1994, Guizy et al., 2008). These reports are complicated by the fact that
FFAs can cross the plasma membrane easily to access both sides of the channel.
The exact binding site of FFAs to the Kv channel has also been the focus of some
investigation. Currently the most likely hypothesis has come from Decher and
colleagues, who carried out a systematic mutational analysis of the important
intracellular residues for AA binding to the inner cavity of Kv1.5. This study is
particularly relevant for the analysing AA binding as the inner cavity of Kv1.5 is
identical in sequence to all Kv1.x channels (Decher et al., 2010). They identified a
number of key hydrophobic residues which, when mutated, abolished the effects of AA
current inhibition (Figure 5.10). These residues, representing a “binding site” for AA,
were all in close proximity to the central conducting pore region. Virtual simulations of
AA interaction with these residues suggested a physical occlusion of the central pore via
hydrophobic interactions between the aliphatic tail of the FFA and the pore.
Interestingly the proposed binding overlaps considerably with the binding site for the
Kvβ1.1- and Kvβ1.3- peptide binding site (Decher et al., 2005, Decher et al., 2008, 
Zhou et al., 2001a). AA acid inhibition superficially resembles the N-type inactivation
induced by Kvβ1.1- and Kvβ1.3 action in Kv channels. In fact, when the Kv1.1 
channels are co-expressed with Kvβ1.1, the fractional block of AA was significantly 
reduced. This provides appealing evidence that AA and the Kvβ1.1 ball peptide are 
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competing for the same binding site at the inner pore of the channel (Decher et al.,
2010). The molecular mechanism of AA acid induced inactivation of Kv channels can
be seen as analogous to the N-type inactivation imparted by Kvβ1 auxiliary subunits. 
This proposed mechanism of action is by no means shared across Kv channel subtypes,
or in other voltage-gated ion channels in general. In certain cases such as Kv7.1 and BK
channels, where currents are enhanced by FFA application, this is almost certainly not
the case. But there is some experimental evidence to support the idea of an open channel
block across channel subtypes, and further speculation that implies that this may in fact
be the case. The strongest evidence for a shared mechanism comes from the common
etiology of the fatty acid effect. The inhibition of Ik magnitudes and increased rates of
inactivation are observed in both non-inactivating and inactivating currents alike (Table
5.1). Similar changes in the voltage sensitivity are also observed. Furthermore, these
effects are commonly observed in both Nav and Cav channels (Bendahhou et al., 1997,
Xiao et al., 2006, Chemin et al., 2001, Talavera et al., 2004). Empirical evidence for this
shared mechanism is also provided by evidence that FFA modulation is sensitive to
analogous mutations across different ion channels. Mutation of a key isoleucine residue
which is located in the inner cavity of the pore of the potassium channel Kv1.1 (I400V)
abolishes the modulatory effects of externally applied AA and AEA. This insensitivity
to FFAs can be introduced into other Kv channels such as Kv3.1 channels by making
mutations to the analogous isoleucine residue in the inner cavity (I428). Molecular
dynamics and docking simulations have also reached similar conclusion about the sites
of action of FFAs across different ion channels (Decher et al., 2010).
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______Inner pore region________
Kv1.1 WAVVSMTTVGYGDMYPVTIGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETEGEEQ 424
Kv1.2 WAVVSMTTVGYGDMVPTTIGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETEGEEQ 426
Kv1.5 WAVVTMTTVGYGDMRPITVGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETDHEEP 532
Shaker WAVVTMTTVGYGDMTPVGVWGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETDQEEM 494
****:********* * : ***********************************: **
Figure 5.10 A putative binding site for AA at the inner pore region of Kv1 channels.
Sequence alignment showing the inner pore region of the Kv1.1, Kv1.2 and Kv1.5 channels
along with the Kv1-like Shaker channel. Highlighted residues are sites that were mutated in the
Kv1.5 channel to examine their effect on AA binding. Each residue was mutated to an alanine to
examine its effect on binding, except for A501, A503, and A509 which were mutated to valines
and L510 which was mutated to a methionine. Red: Mutations which resulted in a loss of
channel block in response to AA. Blue: Mutation which enhanced the channels sensitivity to AA.
Grey: residues which made no impact on AA block when mutated. Results from Decher at al.,
2010.
5.3.3 The structure-activity relationship of fatty acids and voltage-gated
ion channels
Despite the activity of certain PUFAs such as AA and DHA against a wide range of
channels, there is surprisingly little room to accommodate changes in the fatty acid
structure itself. Any variation on the structure of AA was found to reduce the activity of
FFA against Kv1.2 or abolish it completely. The most significant effects occurred with
changes to the structure of the fatty acid tail. This is consistent with experiments which
suggest open channel block is achieved through interactions between hydrophobic
residues in the pore region and the hydrocarbon tail of the fatty acid (Decher et al.,
2010).
The effect of FFAs on Kv1.2 showed a sharp drop off in activity between FFAs that
contained multiple double bonds and those that contained just one. In fact, apart from
the notable exception of linolenic Acid, all PUFAs displayed notable Kv1.2 modulation
at 100 µM. In contrast MUFAs displayed little or no effect at the same concentration.
This trend has been replicated in other Kv channels (Borjesson et al., 2008, Honore et
al., 1994) and Nav channels (Xiao et al., 1995). Against the Cav3.1, Cav3.2, and Cav3.3
channels, Chemin et al., starting with the fully saturated arachidic acid, showed a linear
increase in potency with the addition of 1, 2, 3, 4 and 5 double bonds to the molecule
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(Chemin et al., 2007). Some MUFAs, in particular oleic acid, do modulate the activity
of a subset of Kv channels which were positively modulated by PUFAs, i.e Kv7.1 and
BK channels (Sun et al., 2007, Liin et al., 2015).
The relative inactivity of SFAs and MUFAs across voltage-gated ion channels is
difficult to explain in terms of molecular interaction alone. In fact, virtual docking
simulations based on the interaction of AA and the ‘open channel’ Kv1.2 crystal
structure found multiple docking solutions that differed in the orientation of the AA tail.
This suggests that some considerable flexibility is allowed within the proposed binding
site. So why is there such a cliff in activity as FFAs move towards a single double bond
in their chain? One suggestion, which was pursued here, draws on an idea from
medicinal chemistry that a drug-like molecule has a bioactive conformation they must
adopt before it will bind to a target. Double bonds or unsaturation restricts the
movement of the molecule by preventing the free rotation of its atoms. Decreasing the
number of double bonds increases the flexibility of a molecule and greatly increased the
number of conformations it can adopt. In theory, molecules which are hindered in their
movement or have the range of possible conformations restricted are more effective
binders as they do not have to overcome the a entropic loss it requires to adopt a
specific pose (Fang et al., 2014). By synthetically restricting the free movement of
FFAs it was hoped the potency and selectivity of these molecules could be tailored to
the channel.
5.3.4 Click chemistry yields access to aromatic fatty acids in a single step
The introduction of aromatic rings into the chemistry of fatty acids stretches back more
than 120 years when the introduction of phenyl groups into various length fatty acids
was shown to improve their antimicrobial effects (Laws, 1894). Since then, the
incorporation of aromatic groups into fatty acids employed for many different ends. For
instance, novel photo-optic surfactant molecules can produced by the incorporation of
4,4'-substituted stilbenes into the tail of long chain fatty acids (Brown and Whitten,
1985).
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Here the incorporation of aromatic cycles into the fatty acid structure was used to
reduce the flexible movement and free rotation in at least some of the molecule.
Traditional approaches to introducing phenyl rings into the fatty acid tail have focused
on electrophilic addition, i.e Friedel Crafts acylation, to achieve this (Wan et al., 1983).
This is a useful approach but it is limited by the type of starting materials than can be
used for addition to the aromatic ring (reactive carbonyls with no other electrophilic
substituents). The initial approach used here involved a multistep synthetic pathway
involving the bi-functionalisation of a central benzene scaffold with two alkyne
substituents. This had the advantage of allowing access to both saturated and
unsaturated aryl fatty acids by subsequent reduction. In this study the alkyne
functionalisation of the 1,4-halobenzene scaffold could only be partially accomplished
(scheme 5.1) with the second functionalisation step proving to be insuperable. This was
unexpected as the bi- and tri-functionalisation of benzene with alkyne substituents has
been successfully reported using Pd-catalysed sonogashira reactions (Chanteau and
Tour, 2003).
The construction of a central aromatic core was achieved instead by forming a
heteroaromatic 1,2,3-triazole structure in situ. The simple and effective construction of
1,2,3-triazole structures has become a vital tool in the production of a range of
biomolecules and bio-conjugates (Nwe and Brechbiel, 2009). 1,2,3-triazole are
important functionalities across a range of important drugs including anti-cancer drugs
(Soltis et al., 1996) and anti-biotics (Sheng et al., 2011), as well as in the design of drug
delivery nano-structures such as polymeric nanocarriers and “designer micelles” (Avti
et al., 2013).
Cu catalysed 1,3-Dipolar cycloaddition allows access to aromatic fatty acid of any
length and triazole position by simply varying the lengths and functionalisation of the
starting material. Aromatic fatty acids of chain length 12 – 25 atoms were synthesised
successfully by this method. Here, the construction of the 1,2,3-triazole core was
achieved in a one-pot synthesis without the need to isolate the alkyl azide intermediate.
The alkyl azide intermediate was a stable compound and its production and
consumption could be monitored by LCMS during the reaction. Initial reaction
conditions involved reducing Cu(II)SO4 to catalytic Cu(I) in situ using sodium
ascorbate as a co-catalyst within the reaction. The resulting reaction mix could be
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purified by column chromatography to obtain the desired acid. However, replacing
Cu(II)SO4/sodium ascorbate with the catalytic Cu(I)O allowed the final product to be
isolated with in purity without the need for column chromatography. The heterogeneous
nature of the Cu catalyst as well as the production of ionic salts as the only bi-products
allowed the isolation of the fatty acid by filtration and extraction alone. This synthesis
yields access a wide range of aromatic fatty acids in a single step and without the need
for further purification. In order to reproduce the high inhibitory effects of PUFAs on
Kv1.2, future work should focus on modifying the structures of the reactants to
incorporate double bonds within the alkyl chain of the aromatic fatty acid.
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Chapter 6
Final Discussion
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6.1 Summary
The aim of this study was to examine intrinsic firing properties of SGNs and probe their
regulation by native and synthetic lipid molecules. In Chapter 3, the intrinsic firing
properties of SGNs were examined and found to correlate with the magnitudes of
particular ionic currents, notably LVA K+ current and Ih. These LVA K+ currents were
DTX-K- and TsTx-sensitive, implicating Kv1.1 and Kv1.2 as contributing to the
subunit composition of the LVA channels. The elucidation of some of the molecular
subunits of SGN LVA led to an examination of their potential regulation. Chapter 4
detailed an investigation into the phosphoinositide sensitivity of SGN LVA K+ currents.
Depletion of PIP2 by wortmannin or PIP2-PP had a significant effect on SGN adaptation
rates via the inhibition of Kv1.1- and Kv1.2-mediated LVA K+ current. Finally, in
Chapter 5 the effects of native and synthetic free fatty acid molecules were examined on
Kv1.2 currents stably expressed in a HEK293 cell line and a series of polyunsaturated
fatty acids were shown to provide strong inhibition of Kv1.2 currents.
Understanding the molecular basis of SGN excitability is essential for a complete
understanding how the auditory nerve encodes sound. Understanding the difference in
membrane electrophysiology in the distinct SGN subpopulations may also shed light on
the heterogeneous firing patterns observed in ANFs in vivo. Furthermore, identifying
biological targets that alter SGN firing provides a potential mechanism to adjust the
output of the AN. This is of particular interest for improving the functioning of cochlear
implants to aid “electrical hearing” or for modifying inputs to the central auditory
pathway in cases of aberrant neural signalling i.e. tinnitus. The wider utility of LVA K+
currents in the auditory system are now discussed and some of the important questions
that remain unanswered are addressed. Finally, the potential therapeutic implications of
SGN modulation are discussed along with a discussion of the practical limitations to
pharmacologically treating SGNs in humans.
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6.1.1 The wider role of LVA K+ currents in the auditory system
LVA currents are a prominent feature of neurons throughout the auditory system
(Schwarz and Puil, 1997, Brew and Forsythe, 1995, Smith, 1995, Barnes-Davies et al.,
2004, Bal and Oertel, 2001). This is consistent with findings from Grigg et al., which
reported heavy Kv1.1 subunit expression in the auditory brainstem, in particularly in
octopus and bushy cells of the VCN, the MNTB, the MSO and LSO (Grigg et al.,
2000). Strong Kv1.1 and Kv1.2 channel expression has also been reported in regions of
the VCN (Rusznak et al., 2008) and the MNTB (Tong et al., 2010). Kv1.1/Kv1.2
heteromeric channels therefore, have been proposed as likely mediators of LVA
currents throughout the auditory system (Brew et al., 2007, Dodson et al., 2002), with
the Kv1.6 subunit also implicated in some tissues. Functional examination of these
current indicate that the exact composition and stoichiometry of these channels may
differ between tissues, most likely to accommodate the diverse functional roles of their
tissues in signal propagation and integration. Notable interspecies variation in LVA
composition and stoichiometry is also apparent, perhaps contributing to the variation in
auditory characteristics observed across species (Dodson et al., 2002).
Behavioural studies on Kcna1 (Kv1.1) knockout mice report significant deficits in the
animals ability to localise sound (Allen et al., 2008, Allen and Ison, 2012, Brew et al.,
2003). In vivo single-unit recordings from the VCN and MNTB cells of Kcna1-null (-/-)
mice and littermate control (+/+) mice show that whilst the thresholds and spontaneous
firing rates of these neurons may remain unchanged between genotypes, the evoked
firing rates of these neurons were significantly lower in -/- mice at higher sound
stimulus (Kopp-Scheinpflug et al., 2003). Further deficits were observed at high rates of
sinusoidal amplitude modulation, where MNTB neurons from Kcna1-/- mice discharged
on significantly fewer cycles of the stimulus than their Kcna1+/+ littermates. The
observed cognitive deficits are likely a result of increased temporal variability in the
onset response of neurons, known as jitter. This increased jitter reduces a neuron’s
ability to code acoustic information at the required millisecond or even sub-millisecond
accuracy (Brew et al., 2007).
These behavioural and single-unit experiments are correlated with results from in vitro
experiments that show a significant reduction in the LVA K+ currents of brainstem
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nuclei that mediate binaural processing (Kopp-Scheinpflug et al., 2003). Neurons in the
MSO process sound localisation cues via a process known as binaural coincidence
detection. This process uses excitatory synaptic inputs from each ear and separates them
onto different branches of a bipolar dendritic structure. These inputs are then summed at
the soma and axon of the neuron with submillisecond timings. LVA K+ channels have
been shown to accelerate membrane repolarisation improve the temporal resolution of
synaptic integration (Mathews et al., 2010).
LVA K+ current also contributes to synaptic integration in the cochlear nucleus.
Octopus cells in the VCN receive inputs from ~50 ANFs across the tonotopic axis; APs
are only evoked robustly and consistently when these inputs are synchronised to
millisecond accuracy. Octopus cells have a low input resistance and membrane time
constant, ensuring the amplitude of voltage changes associated with a synaptic input is
small. LVA K+ currents prevent the slow temporal summation of inputs and ensure that
octopus cells fire only when they are depolarised quickly by multiple synchronous
inputs. Blockage of Kv1-mediated LVA currents with α-dendrotoxin results in a 
significant loss of this synchronisation (Ferragamo and Oertel, 2002).
LVA K+ currents are also present in presynaptic terminals such as at the Calyx of held
where their presence prevents the occurrence of aberrant spikes following an incoming
AP (Dodson et al., 2003). LVA K+ currents have been shown to enhance the signal-to-
noise ratio of MSO neurons in vitro by filtering out weak synaptic conductance
transients (Svirskis et al., 2002).
6.1.2 Implications for cochlear implants and “electrical” hearing
Many forms of sensorineural hearing loss are characterised by the loss of the
mechanosensory hair cells and their afferents. The loss of the SGN peripheral processes
can precede SGN cell death by some considerable period however. As a result many
individuals with sensorineural hearing loss retain considerable numbers of SGN bodies
within their modiulos capable of sending signals to the brain. This is the basis for
auditory prostheses. Cochlear implants (CIs) are a series of electrodes positioned along
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the spiral of the cochlea close to the cell bodies of the SGNs (Yawn et al., 2015). An
external component positioned outside the head detects acoustic inputs which are
translated into evoked current along the internal electrode array. Auditory prostheses
have helped restore functional hearing to many deaf individuals. CI can enable good
speech understanding in ideal listening conditions. However CIs are suboptimal in more
challenging listening conditions i.e, understanding speech in noisy environments,
discerning multiple competing speeches, listening to music, etc.
In electrical hearing acoustic information is limited to signalling from the CI down
different electrodes or “channels”. The most significant difficulty arises from the poor
spectral resolution provided by implants. CI studies have revealed that basic speech
recognition in quiet listening conditions requires as few as 4 spectral channels (Shannon
et al., 1995). However for the more challenging task of speech recognition in noise (10
dB signal-to-noise ratio or less) 8 spectral channels are needed (Fu et al., 1998, Friesen
et al., 2001). For more complex tasks, such as perceiving music or discerning competing
speeches, even more channels are required (Shannon et al., 2004). The limitations in
spectral resolution are not on the CI side; commercial CI signal processing devises
provide up to 22 channels. Despite this, current CIs have exhibited a notable upper limit
in their efficacy with CI recipients rarely performing better than as if they had 8-10
effective channels (Landsberger et al., 2012).
The major limitation to CI improvement is the phenomenon of current spread in the
cochlea. Channel electrodes provide stimulation to the cochlea by charging the SGN
bodies with current. This current is most effective in proximity to the electrode but
current spread from the electrode source can also charge more distant neurons. As a
result CI users are often able to discriminate between channel activation when compared
in isolation. However stimulation of adjacent channel electrodes is often perceived as a
single intermediate pitch (McDermott and McKay 1994). Thus, the spectral resolution
of CI users is significantly limited by channel interactions. This has been proposed as
the primary limiting faction for CI performance (Fu and Nogaki, 2005). Bingabr et al.
showed that a reduction in the spread of current excitation improved performance
during speech discrimination tasks in patients with only a few spectral channels.
However this reduced overall performance, suggesting both strong excitation of SGNs
and narrow current spread are needed for good CI performance (Bingabr et al., 2008).
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To overcome the limitations imposed by current spread in the cochlea, many strategies
have been proposed, such as experimenting with different methods of current
application to reduce the spread of excitation, e.g. (Landsberger et al., 2012) and
(Srinivasan et al., 2013). Other studies have suggested reducing the neural gap by
stimulating the regrowth of SGN neurites towards the stimulus electrode with
neurotrophins such as BDNF (Pinyon et al., 2014). The advent of new optogenetic
techniques has also opened the door to the promising new idea of optical cochlear
implants. Incorporation and stimulation of light sensitive proteins into the membranes
of SGNs would allow considerable greater stimulus precision and sidestep the
limitations imposed by current spread. For a discussion of the possible application for
optogenetic stimulation for cochlear implants see (Jeschke and Moser, 2015).
A complementary approach could be to adjust the excitability of SGNs via
pharmacological manipulation of neuronal LVA K+ currents. Whilst LVA K+ currents
play an important role under normal physiological conditions, they may hinder the
activity of CIs in providing electrical hearing to the damaged ear. LVA K+ currents
reduce the membrane resistance of SGNs, requiring significantly more current to charge
the membrane. Indeed, maintaining a strong current stimulus is necessary to maintain a
fixed loudness in CI, but as current increases so does the spread of excitation along the
cochlear axis (Landsberger et al., 2012). Minimizing the necessary input energy to elicit
the same loudness precept would reduce the current spread and area of excitation. In
theory this would increase the number of perceptual channels available to CI users.
Methods of LVA K+ currents modulation could provide a new and complementary
approach to optimising CI technologies.
6.1.3 Localised drug delivery to the inner ear
Attempts to medicate neuronal tissue in the inner ear face some significant challenges.
Conventional routes of drug bioavailability such as injection or oral administration are
not effective because of the presence of the blood-perilymph barrier (BPLB) that
separates the inner ear from the blood (El Kechai et al., 2015). The BPLB is a
continuous capillary endothelium which lines the blood vessels of the cochlea. The
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BPLB acts to protect the cochlea and maintain the homeostasis of the inner ear fluids
(Juhn et al., 2001). Importantly it acts as a barrier to undesirable chemicals and contains
efflux pump systems such as P-glycoprotein and multidrug resistance-related protein-1
(Saito et al., 2001a, Saito et al., 2001b). Like the blood-brain barrier, the BPLB is only
permeable to highly lipophilic molecules, excluding other molecules based on size,
charge and water-solubility (Swan et al., 2008). The absence of a viable systemic drug
route has led to the development of strategies for localised drug delivery to the inner ear
(Staecker and Rodgers, 2013, Pararas et al., 2012, McCall et al., 2010). There are
primarily two approaches for local drug delivery; administration into the middle ear
(intratympanic) or directly into the cochlea itself (intracochlear). Both have shown
effectiveness in delivering drugs to cochlear tissues (Pararas et al., 2012).
Intratympanic administration is achieved by the direct application of drugs to the round
window of the cochlea. This can be achieved by direct injection of the drug solution
into the middle ear cavity and subsequent diffusion across the round window. Though
still used for some drugs such as corticosteroids, the reliance on passive diffusion along
the cochlea results in a longitudinal drug gradient from base to apex (Salt and Plontke,
2009). In reality this means drugs often do not reach the apical regions (Mynatt et al.,
2006). Combined with rapid elimination via the Eustachian tube other methods of
prolonged intratympanic drug administration have been developed. Implantable medical
devices such as microcatheters and osmotic pumps have been shown effective in
humans for sustained drug application for anything up to 6 weeks (El Kechai et al.,
2015). Intracochlear administration avoids these diffusion based problems but
encounters the considerable task of accessing the interior of the cochlea. Furthermore
any drug that is introduced must be careful to maintain a relatively constant fluid
volume, ion composition and osmolality. Intracochlear injection has been achieved
(Stover et al., 1999) but is technically difficult and not viable for continued drug
administration (Pararas et al., 2012).
Once present in the perilymph, drugs access the tissues of the cochlea by diffusion.
Access to the SG has now been demonstrated in numerous studies (Zhang et al., 2012,
Buckiova et al., 2012, Warnecke et al., 2012). Typically, these studies have used the
neurotrophic agent BDNF as their drug and measured SGN neuroprotection as an
assessment of the efficacy of their drug delivery. Typically, delivery of the drug to the
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round window or directly into the perilymph is sufficient to provide neuroprotection to
the SGNs. This provides an important proof of concept that SGNs are in practice
druggable, with delivery of the drug to the cochlear perilymph the primary practical
limitation.
Finally, the nature of CI implant technology may provide an intriguing opportunity for
drug delivery to the SGN. By design, CI electrodes are inserted along the cochlear
spiral, in proximity to the SGN cell bodies. Combined CI/drug delivery systems have
drawn considerable interest as a means of reducing local tissue trauma during CI
surgery and for delivering neurotrophins and growth factors to promote sensorineural
cell growth (Quesnel et al., 2011a, Quesnel et al., 2011b, El Kechai et al., 2015).
Biodegradable polymeric coatings on the surface of cochlear implant electrodes have
been proposed as a means to deliver drug along with the implant. Embedding the
cochlear implant in a polymeric matrix has already been shown to be effective in
delivering drugs to the scala tympani of guinea pig (Kikkawa et al., 2014). Drug release
can be sustained for up to several months using this method depending on the polymer
and drug under investigation (Astolfi et al., 2014, Kikkawa et al., 2014, Wrzeszcz et al.,
2015), although the long term effects of this approach have yet to be tested. The
development of novel neuromodulatory agents in combination with improving drug
delivery strategies for the inner ear could provide a powerful new approach to adjusting
the output of the AN, particularly in the deafened ear.
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